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Abstract 
 
In S. cerevisiae, Cdc13-Stn1-Ten (CST) caps chromosome ends (telomeres).  
Cdc13 binds telomeric single-stranded DNA and with Stn1 and Ten1 protects 
the telomere end from attack by DNA damage response (DDR) factors.  All 
three CST genes are essential for cell viability, however the requirement for 
CDC13 can be bypassed in strains lacking the nonsense-mediated mRNA 
decay (NMD) gene NMD2 and the DDR genes EXO1 (encoding a 3’-5’ 
exonuclease) and RAD24 (encoding a DNA damage checkpoint protein).   
 
This PhD aimed to determine the mechanisms underlying Cdc13 bypass.  One 
mechanism identified was that Stn1 is at telomeres in the absence of Cdc13, 
suggesting that Stn1 has a telomere protection role separate from Cdc13.  To 
uncover the mechanisms underlying Cdc13 bypass, a synthetic genetic array 
(SGA) screen was conducted using an nmd2 exo1 cdc13 query strain 
crossed with a library of single gene deletion mutants.  Rif1, which has 
telomeric and genome-wide roles, was found to be an absolute requirement for 
Cdc13 bypass.  This result was confirmed by low-throughput methods.  By 
analysing the phenotypes of rif1 mutant alleles in a viable cdc13 strain it was 
possible to deduce the functions of Rif1 required for Cdc13 bypass.  
Remarkably, the putative HEAT-repeat domain and Glc7 (Protein Phosphatase 
1) interaction sites were found to be essential.  It is proposed that Rif1 uses this 
domain to interact with Ten1 to link CST with Rif1/Rap1/Rif2 to form a shelterin-
like complex.  Finally, evidence was found that Rad52-mediated recombination 
and long telomeres, with extended TG1-3 repeats, promote Cdc13 bypass.  
Overall, multiple mechanisms underlie Cdc13 bypass: Stn1 activity, Rif1 
interactions and recombination of telomeric TG1-3 repeats. 
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Chapter 1. Introduction 
 
1.1 Telomere function 
 
Telomeres are the ends of eukaryotic chromosomes and typically contain tracts 
of repeated, non-coding nucleotide sequences.  Telomeres protect DNA at the 
chromosome end from degradation and so stabilize chromosome ends.  The 
length of telomeres varies between species, for example human telomeres can 
be from 5,000-15,000 base pairs of TTAGGG repeats whereas budding yeast 
(the unicellular eukaryotic organism Saccharomyces cerevisiae) telomeres are 
typically 300 75 bp and consist of series of TG1-3 repeats (Larrivée et al., 
2004).  Yeast also contains subtelomeric Y’ elements (5.2 kb repeats) and X 
repeats (0.3-0.375 kb; Figure 1) (Chan and Tye, 1983). 
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Figure 1. S. cerevisiae telomere phenotypes.   
 
Normal yeast telomeres contain subtelomeric X repeats and Y’ elements and 
terminate with G-rich (TG) repeats (Y’ telomere and X telomere) (Lydall, 2003).  
Type I survivors amplify Y’ elements, which contain autonomous replication 
sequences, using homologous recombination (Lydall, 2003).  Type II survivors 
amplify G-rich repeats using homologous recombination (Lydall, 2003).   
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When telomeric DNA is replicated, the ‘end replication problem’ is encountered 
(Watson, 1972; Olovnikov, 1973).  Replication of the C-rich leading strand 
occurs continuously such that no overhang is generated (Figure 2).  Replication 
of the G-rich lagging strand occurs discontinuously in Okazaki fragments, using 
RNA primers (Figure 2).  However, when the end of the 5’-3’ template strand is 
reached, the RNA primer cannot bind and thus the final tract of DNA cannot be 
replicated.  This leaves a tract of single-stranded DNA (ssDNA), the 3’ 
overhang, caused by the parental strand overhanging the daughter strand 
(Figure 2).  In mammalian somatic cells the ‘end replication problem’ means 
that telomeres shorten every time DNA is replicated, protecting protein-coding 
DNA from degradation (Harley et al., 1990).  When telomere length becomes 
critically short cells senesce or die (Blackburn, 2000).   
 
Human germ cells and stem cells can maintain telomere length using the 
telomerase enzyme, which is not expressed in somatic cells.  Telomerase is a 
ribonucleoprotein complex, containing both RNA and protein components, and 
is a reverse transcriptase that adds telomeric repeats to telomere ends (Greider 
and Blackburn, 1987).  In humans, telomerase comprises a template RNA 
sequence (TER) (Feng et al., 1995) and a catalytic subunit (TERT), which uses 
TER as a template to add telomeric repeats (dTTAGGG) to the 3’ end of the 
telomere (Figure 3) (Meyerson et al., 1997; Nakamura et al., 1997).  Extension 
of the 5’-3’ strand facilitates fill-in of the 3’-5’ strand by DNA polymerase alpha 
and telomere length is maintained.  
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Figure 2. The telomere end replication problem.   
Eukaryotic telomeres all contain a G-rich strand and a C-rich strand; the G-rich 
strand overhangs the C-rich strand.  During telomere replication, the leading C1-
3A strand is synthesized continuously and the lagging TG1-3 strand is 
synthesized discontinuously (short arrows) via Okazaki fragments (Lydall, 
2003).   Lagging strand replication results in a 3’ overhang once the RNA primer 
of the final Okazaki fragment has been removed (Lydall, 2003). 
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Telomerase is conserved across eukaryotes, for example budding yeast 
expresses telomerase and so maintains telomere length.  The 5’-3’ TG1-3 strand 
of the budding yeast telomere terminates in a 3’overhang over the C1-3A strand 
at the telomere end.  The length of this overhang alters depending on the cell 
cycle phase; in most phases the overhang is 10-15 nucleotides long, however 
in late S/G2 phase the overhang is longer (Larrivée et al., 2004).  Telomerase 
maintains telomere length throughout the budding yeast cell cycle and consists 
of the subunits Est1, Est2, Est3 and Tlc1 (Figure 3).  Est2 is the reverse 
transcriptase element of yeast telomerase (Lingner et al., 1997a; Lingner et al., 
1997b) and uses the template RNA provided by Tlc1 to add telomeric repeats to 
the 3’ end of the telomere (Singer and Gottschling, 1994). 
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Figure 3. Telomere structure in yeast and humans.   
S. cerevisiae telomeric double-stranded DNA is bound by Rap1, which recruits 
Rif1 and Rif2.  Single-stranded telomeric DNA is capped by CST (Cdc13, Stn1, 
Ten1) (Lydall, 2009).  In H. sapiens, telomeric DNA is capped by the Shelterin 
complex (TRF2, RAP1, TIN2, TPP1, TRF1, POT1), which binds double- and 
single-stranded DNA. Yeast telomerase consists of Est1, Est2 (telomerase 
reverse transcriptase, orthologous to human Tert), Est3 and Est4 (telomerase 
RNA, ortholgous to human Ter) (Lue,2010). Human telomerase consists of 
EST1A, TER, and TERT subunits (Lue, 2010). 
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1.2 Telomeres in cancer and ageing 
 
1.2.1 Telomere maintenance 
 
Telomerase is not normally expressed in human somatic cells, but telomerase 
is active in the majority (85%) of cancerous tumours (Günes and Rudolph, 
2013).  Cancer cells use telomerase to maintain telomere length, this allows 
cells to escape replicative senescence and divide indefinitely (Kim et al., 1994).  
Telomere length may be inversely correlated with age, since a number of 
epidemiological studies have shown that telomere length decreases as age 
increases (Sanders and Newman, 2013).  This is likely to be a function of the 
end replication problem, in which telomeres shorten with each successive round 
of replication (Sanders and Newman, 2013).  Also, short telomere length is 
reported in age-related disorders, e.g. artherosclerosis, and premature ageing 
disorders e.g. Werner syndrome, Coats plus and Dyskeratosis congenita 
(Blasco, 2005). 
 
1.2.2 Alternative lengthening of telomeres 
 
15% of cancerous tumours have long, heterogeneous telomeres maintained by 
a telomerase-independent mechanism termed ‘alternative lengthening of 
telomeres’ (ALT) (Bryan et al., 1995; Grobelny et al., 2001).  Telomere-capping 
appears to be defective in ALT cells, which may have decreased levels of TRF2 
and other shelterin components relative to the level of telomeric DNA in the cell 
(Conomos et al., 2013).  Defects in the telomere cap promote homologous 
recombination (HR), which is used to copy telomeric repeats from the same 
telomere, the sister chromatid or a non-homologous chromosome (Dunham et 
al., 2000; Muntoni et al., 2009; Conomos et al., 2013). The nuclei of ALT cells 
contain promyelocytic nuclear bodies that contain the Mre11-Rad50-Nbs1 
(MRN) complex, which facilitates HR (van den Bosch et al., 2003; Conomos et 
al., 2013).  The budding yeast MRX complex (Mre11-Rad50-Xrs2) is a 
functional orthologue of the MRN complex and Mre11 and Rad50 are highly 
conserved.  MRX functions include telomerase recruitment, HR, Rad51-
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independent repair of double-strand breaks (DSBs) and non-homologous end 
joining (Symington, 2002; Faure et al., 2010).   
 
Yeast cells can also maintain telomeres without telomerase (e.g tlc1Δ mutants) 
using a mechanism similar to break-induced replication (BIR) (Lundblad and 
Blackburn, 1993).  During BIR at a DSB, 5’ DNA ends are resected to form a 3’ 
overhanging tract of ssDNA, to which Rad51 binds (Wu et al., 2008).  Rad51-
coated 3’ ended ssDNA searches for homology in another chromosome and 
invades the homologous dsDNA (Aylon and Kupiec, 2004).  The DNA 
replication machinery then proceeds to copy the missing genetic information 
(Wu et al., 2008).  Rad51 is highly conserved between yeast and humans (59% 
homology) (McEachern and Haber, 2006).  Rad51-dependent recombination 
also requires Rad52, Rad54, Rad55 and Rad57.  In Rad51-independent 
recombination, complementary DNA either side of the DSB is annealed together 
(single-strand annealing) in a process catalysed by Rad52 in the presence of 
RPA (Wu et al., 2008).  The process also involves Rad50, Mre11, Xrs2, Rad59 
and Tid1 (McEachern and Haber, 2006). 
 
Yeast cells in which telomeres have been amplified without telomerase are 
classed as Type I survivors (which amplify subtelomeric Y’ regions) and Type II 
survivors (which amplify TG1-3 repeats; see Figure 1) (Lundblad and Blackburn, 
1993; Chen et al., 2001).  Type I survivors require Rad51, Rad52 Rad54, 
Rad55 and Rad57 and recombination between Y’ regions and telomeric TG 
repeats occurs since Y’ regions contain homologous TG repeats (Lundblad and 
Blackburn, 1993; Paques and Haber, 1999; McEachern and Haber, 2006).  
Type II survivors require Rad52 in budding yeast and also MRX and Rad59 
(Symington, 2002; McEachern and Haber, 2006).   
 
In budding yeast the generation of survivors is dependent on Rad52, which is 
essential to BIR (Lundblad and Blackburn, 1993; Chen et al., 2001).  Rad52 
both facilitates the binding of Rad51 to ssDNA and facilitates annealing of 
ssDNA during DSB repair by homologous recombination (Symington, 2002).  
When Rad51-dependent recombination occurs the rad51 mutants are 
defective in Rad51-dependent HR but the effects on fitness is mild since the 
Rad51-independent pathway takes over. At the telomere, single-strand 
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annealing may occur by the 3’ telomeric overhang being annealed to another 
telomere end (McEachern and Haber, 2006).  Since Rad52 is involved in both 
Rad51-dependent and Rad51-independent DSB repair by HR, rad52 mutants 
are severely defective in DNA repair by HR/BIR and thus tlc1 rad52 strains 
fail to form survivors and they senesce rapidly (Lundblad and Blackburn, 1993; 
Wu et al., 2008). 
 
1.3 Telomere end protection: distinguishing telomeres from double-
strand breaks 
 
1.3.1 Double strand breaks 
 
Double-strand breaks may occur during DNA replication and must be repaired 
faithfully to ensure genome stability.  At a double strand break (DSB), the DNA 
damage response (DDR) is initiated and involves repair of the lesion with 
concurrent inhibition of the cell cycle; or apoptosis if the lesion is irreparable 
(Lydall, 2009).  Lesion repair can occur via either non-homologous end joining 
(NHEJ), in which the ends of the DSB are joined together, or homologous 
recombination (HR), which allows faithful replication of the chromosome by 
using homologous template DNA and is the major repair pathway in budding 
yeast (Li and Heyer, 2008; Lydall, 2009). 
 
Rad24 is involved in the DDR for DSBs at G1, S and G2/M phases and in 
meiosis (Siede et al., 1994; Lydall et al., 1996; Paulovich et al., 1997).  When a 
DSB occurs (which contains ssDNA tracts), Rad24-Replication Factor C (RFC) 
complex loads the Rad17/Mec3/Ddc1 sliding clamp.  Upon clamp loading, 
Ddc1-dependent activation of Mec1 occurs, the Dpb11 checkpoint sensor is 
recruited and Rad24-RFC promotes resection of the DSB end to promote repair 
by homologous recombination (the major DNA repair pathway in budding yeast) 
(Ngo and Lydall, 2015).  A second pathway, independent of Rad24, involves 
Rad9, which activates Rad53 and Chk1 and is active at DSBs throughout the 
cell cycle (Weinert and Hartwell, 1988; Weinert and Hartwell, 1989; Siede et al., 
1993; Paulovich et al., 1997).  Rad9 stimulates Mec1 to phosphorylate Chk1 
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and Rad53, which causes a downstream signalling cascade leading to cell 
cycle arrest (Blankley and Lydall, 2004; Sweeney et al., 2005; Ma et al., 2006). 
 
1.3.2 DNA damage response 
 
During DSB repair in budding yeast (outlined in Figure 4), the MRX and the Ku 
complex (Yku70/Yku80) are recruited to the lesion and the 5’-3’ strand of the 
DSB is resected by the co-ordinated action of helicases and nucleases (e.g. 
Exo1) (Tran et al., 2002).  MRX also has 3’-5’ exonuclease activity at DSBs 
(Paull and Gellert, 1998).  In addition, MRX binds telomeric ssDNA, where it 
generates ssDNA for the CST complex to bind to, but it may also have a role in 
recruiting telomeric proteins (Faure et al., 2010).  Similarly, Ku binds to 
telomeric double-stranded DNA (dsDNA) and has a number of roles at 
telomeres (discussed below).   
 
RPA binds the region of ssDNA created by 5’-3’ resection (Figure 5) and is 
highly conserved between yeast and other eukaryotes.  It is formed from the 
subunits RPA1, RPA2 and RPA3 in mammals and in budding yeast the 
subunits are called Rfa1, Rfa2 and Rfa3 (Iftode et al., 1999).  RPA is 
functionally orthologous to CST, in that it is a heterotrimer that binds ssDNA 
(Krejci and Sung, 2002; Gao et al., 2007; Miyake et al., 2009; Sun et al., 2009).  
Recently, it has been shown that RPA has a role at budding yeast telomeres, in 
that it binds to the two daughter strands during telomere replication and 
facilitates telomerase activity (Luciano et al., 2012).  At a DSB, RPA helps to 
recruit Rad51 and Rad52, which are required for lesion repair by HR, and also 
recruits Rad24 and the Rad17/Mec3/Ddc1 heterotrimer (9-1-1 complex) which 
are checkpoint proteins that are required to inhibit cell cycle progression during 
DNA damage repair (Plate et al., 2008; Lydall, 2009; Sugiyama and Kantake, 
2009).  In addition, RPA binds Mec1 and Ddc2, which stimulate cell cycle arrest 
and the capping of the telomere by CST, preventing the telomere from being 
recognized as a DSB (Lydall, 2009).   
 11 
 
 
 
Figure 4. Double-strand break repair 
Proteins recruited to the telomere end are shown in the top panel, proteins 
recruited to a double-strand break (DSB) end are shown in the bottom panel.  
At telomeres, the Mre11/Rad50/Xrs2 (MRX) complex resects DNA to produce 
single-stranded DNA for CST (Cdc13/Stn1/Ten1) to bind (Lydall, 2009).  
Yku70/Yku80 binds double-stranded DNA.  CST recruits telomerase and Tel1 
regulates telomere length.  At a DSB, nucleases (such as Exo1, shown) resect 
DNA to produce overhanging ssDNA (Lydall, 2009).  RPA (Rfa1/Rfa2/Rfa3) 
binds the single-stranded DNA and helps recruit the checkpoint proteins Rad24 
(in complex with Replication Factor C), Rad17/Mec3/Ddc1 and Mec1/Ddc2 
(Lydall, 2009).  Recruitment of Rad9 then pauses the cell cycle at the G2/M 
checkpoint until the damage is repaired (Lydall, 2009). 
 
 
 
 12 
 
Figure 5. RPA and CST 
(A) CST in mammals and budding yeast (S. cerevisiae).  Mammalian CTC1 is 
the functional orthologue of Cdc13 (Miyake et al., 2009). (B) RPA heterotrimer 
binds ssDNA and is highly conserved.  (C) Structural homologies between CST 
and RPA (Rfa1/2/3 in budding yeast). OB folds and winged helix (WH) motifs 
are shown.  Dashed lines indicate potential structural homologies between 
Cdc13 and Rfa1; Stn1 and Rfa2 and Ten1 and Rfa3.  Not drawn to scale.  
Details of structures of RPA and CST were obtained from Sun et al. (2011) and 
Lewis et al (2014). 
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RPA (Rfa1, Rfa2 and Rfa3) is detectable at budding yeast telomeres during S-
phase, where it binds telomeric DNA to facilitate replication and loads the 
telomerase subunit Est1 onto telomeres (Schramke et al., 2004).  Also, Rfa2 
(Rpa2) co-immunoprecipitates with Yku80, Est2 and Cdc13 and Rfa1 (Rpa1) 
co-immunoprecipitates with Cdc13 and Est1 and interacts with Tlc1, which may 
indicate that a transient Cdc13-Yku70/Yku80-RPA- Telomerase complex is 
formed during telomere replication (Luciano et al., 2012).  In both budding and 
fission yeasts, RPA genes are essential and mutations in Rfa1 in fission yeast 
leads to telomere shortening.  Also in fission yeast, RPA has been shown to 
prevent the formation of G-quadruplex structures during lagging strand 
replication (Audry et al., 2015).  During lagging strand replication, the C-rich 
strand is filled in discontinuously which leaves the template G-rich strand 
vulnerable to G-quadruplex formation (Audry et al., 2015).  G-quadruplexes 
impede progression of the DNA replication machinery during C-rich strand 
synthesis. 
 
1.3.3 Telomere end protection 
 
Telomere ends resemble DSBs, but they are not recognized as such due to the 
presence of the Rif1-Rap1-Rif2 and the CST and Ku capping complexes in 
budding yeast (Figure 3).  Ku, Rif1-Rap1-Rif2 and CST are discussed in detail 
in the following sections.  In humans the telomere is protected by the shelterin 
complex, which comprises TRF1, TRF2, TIN2, RAP1, POT1 and TPP1 (Figure 
3).  RAP1 is highly conserved among eukaryotes, but human RAP1 does not 
directly bind telomeric DNA unlike budding yeast Rap1 (Li and de Lange, 2003).  
Pot1 is conserved in Schizosaccharomyces pombe.  Due to the shelterin 
complex, human CST does not play as significant a role in telomere capping as 
it does in budding yeast (Palm and de Lange, 2008).  In humans, telomere ends 
are also structurally protected from DSBs by telomeric t-loops and D-loops, in 
which the 3’ overhang invades telomeric dsDNA (creating the t-loop), and 
displaces the G-rich strand at this location (creating the D-loop) (Palm and de 
Lange, 2008). 
 
 14 
1.3.4 Telomeric repeat-containing non-coding RNA (TERRA)  
 
Protein complexes distinguish telomeres from DSBs to protect yeast and human 
telomeres (as well as T-loops in human cells).  However, in human cells, a 
further mechanism of telomere protection may be employed: the telomeric C-
rich strand is transcribed, from the subtelomeric region to the telomere end, by 
RNA Polymerase II into telomeric repeat-containing non-coding RNA (TERRA), 
where it forms a transient DNA:RNA hybrid (Azzalin et al., 2007).  TERRA is 
conserved in budding yeast where it is also transcribed from the telomeric C-
rich strand by RNA polymerase II (Luke et al., 2008), but currently it is unknown 
whether it protects the telomere end.   
 
TERRA has a significant role in the formation of yeast survivors or human ALT 
cells, which lack telomerase but maintain telomeres by homologous 
recombination.  Yeast cells deficient in the THO complex (involved in 
transcription elongation, mitotic recombination and mRNA export) and the 
telomerase RNA component Tlc1, formed Type II survivors due to defective 
telomere transcription (Yu et al., 2014).  Strains lacking THO components and 
TLC1 also expressed higher levels of telomere-associated TERRA compared to 
wild-type cells and TERRA expression induced the formation of Type II 
survivors (Yu et al., 2014).  ALT-positive cancer cell lines show high levels of 
TERRA expression compared to telomerase-positive cancer cell lines (Ng et al., 
2009; Arora et al., 2014).  Induced TERRA transcription in an ALT cell line 
(U2OS-derived) elevated TERRA levels and caused telomere instability and 
increased recombination (Arora et al., 2014).  This suggests that TERRA 
expression can facilitate ALT initiation in cancer cells, similar to TERRA-induced 
Type II survivor formation in yeast. 
 
Increased levels of TERRA lead to loss of telomeric tracts in human cells and 
hinder DNA replication in budding yeast, which fail to complete S-phase in a 
rat1-1 mutant (Luke et al., 2008).  TERRA levels therefore need to be regulated 
by the cell.  In yeast, Rat1 is a 5'-3' exonuclease that directly degrades TERRA 
and terminates the activity of RNA polymerase II, which transcribes TERRA 
from the telomeric C-rich strand (Luke et al., 2008; Park et al., 2015).  TERRA is 
also regulated by Ribonuclease H (H1 and H2) in both yeast and humans (Balk 
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et al., 2013; Arora et al., 2014; Balk et al., 2014; Chan et al., 2014).  In human 
ALT cancer cell lines, Ribonuclease H1 depletion increased TERRA levels and 
stabilized DNA:RNA hybrids (Arora et al., 2014).  Overexpessing Ribonuclease 
H1 reduced telomere recombination and increased the number of telomere 
signal-free ends in ALT cells (Arora et al., 2014).  Deleting RNH1 and RNH201 
(the catalytic subunit of yeast Ribonuclease H2) increased the levels of 
DNA:RNA hybrids globally and at telomeres (Balk et al., 2013; Chan et al., 
2014).  Overexpressing RNH1 in yeast reduced Rad52-dependent telomere 
recombination and caused telomerase-negative yeast cells to senesce at a 
faster rate, providing further evidence that TERRA is important for survivor 
formation in yeast (Balk et al., 2013).   
 
1.3.5 Ku 
 
The Ku complex (Yku70 and Yku80 heterodimer) has a major role in NHEJ but 
also has a separate role at telomeres (Boulton and Jackson, 1996; Gravel et al., 
1998).  Unlike Rap1, Ku binds DNA non-specifically, using its ring structure to 
slide onto DNA termini (i.e. a DSB or telomere end, Figure 4, right panel) 
(Walker et al., 2001; Pfingsten et al., 2012).  When Ku is non-functional (i.e. a 
yku70 or yku80 mutant), cells exhibit short telomeres and increased ssDNA 
(Boulton and Jackson, 1996; Polotnianka et al., 1998).  Ku interacts with Cdc13 
and Tlc1 (telomerase RNA) and facilitates the localization of telomerase to the 
nucleus (Stellwagen et al., 2003; Gallardo et al., 2008).  When the Ku binding 
site in Tlc1 is deleted, cells have shorter telomeres; on the other hand when 
multiple copies of the Ku binding site are present, the abundance of telomerase 
increased indicating that Ku plays a role in regulating telomerase levels 
(Peterson et al., 2001; Zappulla et al., 2011).  Ku also has a role in the TPE as 
there is evidence that Yku80 binds to Sir3 and helps to form telomeric 
heterochromatin-like structures (Roy et al., 2004).  It was previously thought 
that Ku tethered telomerase to the telomere in order to initiate fill-in of the C-
strand, however more recent evidence has indicated that Ku regulates nuclear 
levels of telomerase instead (Pfingsten et al., 2012). 
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1.3.6 Rif1, Rap1 and Rif2 
 
Rap1 binds Rif1, which silences subtelomeric transcription and regulates 
telomere length (Levy and Blackburn, 2004).  rif1 mutants have abnormally 
long telomeric TG1-3 repeats and replicate telomeres early, indicating that Rif1 is 
required to count TG1-3 repeats and delay telomere replication until S-phase 
(Hardy et al., 1992; Levy and Blackburn, 2004; Lian et al., 2011).  Rif2 is 
functionally similar to Rif1 and binds to both Rif1 and Rap1, which suggests that 
Rap1 recruits Rif1 and Rif2 (Figure 3, Figure 5) to regulate telomere length 
(Wotton and Shore, 1997).  Interestingly, RIF1 is only at damaged telomeres in 
human cells.  At unprotected telomere ends the DDR is activated and telomeric 
RIF1 foci increase (Silverman et al., 2004).  This suggests that RIF1 has a role 
in DNA damage signalling (Kumar and Cheok, 2014). 
 
Rif1 regulates genome-wide DNA replication as well as having a telomeric role. 
Rif1 inhibits pre-replication complex activators, namely Cdc7, Dbf4, Dpb11 and 
Sld3 (but not pre-replication complex assembly) by recruiting the PP1 
phosphatase Glc7 to replication origins (Hiraga et al., 2014; Mattarocci et al., 
2014).  Rif1 interacts with Glc7, through its RVxF and SILK motifs, and uses 
these motifs to recruit Glc7 to telomeres, where Rif1-Glc7 controls firing of 
telomere-proximal origins (Hiraga et al., 2014; Mattarocci et al., 2014).  During 
replication initiation, the MCM pre-replication complex (Mcm2-7) is loaded onto 
replication origins and is phosphorylated by the Dbf4-dependent kinase, DDK 
(Cdc7-Dbf4 complex).  Glc7 is directed by Rif1 to dephosphorylate MCM and 
counteract DDK phosphorylation, in order to control the timing of replication 
origin firing (Labib, 2010).  Rif1 also controls the timing of telomere replication 
by recruiting Glc7 to telomeres to control telomeric origin firing: at two telomeres 
studied, telomeric origins fired earlier in the absence of Rif1 (Hiraga et al., 2014; 
Mattarocci et al., 2014).  Overall, yeast Rif1 represses origin firing in order to 
orchestrate timely DNA replication both throughout the genome and at 
telomeres.  Recently, it was reported that human RIF1 has a role in controlling 
sister chromatid cohesion during replication.  RIF1 binds ultrafine DNA bridges, 
which form between sister chromatids during DNA replication.  Binding of RIF1, 
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along with PICH, BLM and RPA1 resolves ultrafine DNA bridges such that sister 
chromatids can fully separate at the end of replication (Hengeveld et al., 2015). 
 
Rif1 plays a role in resecting dsDNA and there is evidence regarding that it both 
promotes and inhibits resection in budding yeast.  In wild-type cells, Rif1 
promotes resection of DSBs, to promote repair by HR, and in the absence of 
Sae2 and MRX, Rif1 promotes resection (Martina et al., 2014).  Therefore 
deletion of Rif1 inhibits resection in these conditions.  Also, Rif1 appears to 
inhibit resection in cells with defective Cdc13.  A rif1 cdc13-1 strain had severe 
fitness defects above 20°C, and one underlying cause was the accumulation of 
ssDNA (resulting from enhanced resection) (Anbalagan et al., 2011).  It was 
shown that deletion of the 5'-3' exonuclease EXO1 reduced ssDNA 
accumulation and increased strain fitness at restrictive temperatures, as in 
cdc13-1 exo1 strains (Zubko et al., 2004; Anbalagan et al., 2011).  Deletion of 
RIF2 or the C-terminus of Rap1 was shown to significantly increase resection at 
a de novo telomere, but deletion of RIF1 only marginally increased resection, 
indicating that Rif1 may only be a weak promoter of telomere resection (Martina 
et al., 2012; Martina et al., 2014). 
 
Rif1 is thought to stimulate CST activity, since rif1 cdc13-1 strains lose viability 
above at temperatures above 23°C and a rif1 stn1C strain is inviable, 
whereas rif2 cdc13-1 and rif2 stn1C strains are viable (Anbalagan et al., 
2011).  Expressing only the N-terminal portion of Stn1, (the N Terminal is used 
for Ten1 interaction), leads to ssDNA accumulation at the telomere end but not 
in subtelomeric regions (Puglisi et al., 2008).  Moreover, cells expressing Stn1-
N terminal show no alternations in subtelomeric gene silencing (the TPE), 
suggesting that the effects of Stn1-N occur at the telomere end, independently 
of the Rap1-mediated TPE (Puglisi et al., 2008).  
Conversely, human RIF1, together with 53BP1, inhibits resection of DSBs by 
BRCA1 in G1 phase, to promote NHEJ at DSBs (Chapman et al., 2013).  Rif1 is 
of increasing interest in understanding cancer, given that human RIF1 and 
53BP1 inhibit BRCA1, to inhibit resection of DSBs in G1.  BRCA1 inhibition 
promotes NHEJ in G1 rather than repair by HR (class switching), which occurs 
in G2 (Silverman et al., 2004).  BRCA1 mutations carry a high risk of breast and 
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ovarian cancer in humans, since mutations lead to defective DNA damage 
repair and hence genome instability.  Human RIF1 is only present at 
dysfunctional telomeres, however this may indicate a DDR signalling role in 
addition to DNA repair class switching (Kumar and Cheok, 2014).  Another 
recently identified role of RIF1 in DNA replication is that it resolves ultrafine 
DNA bridges between sister chromatids after replication, to ensure timely 
separation (Hengeveld et al., 2015).  RIF1 therefore appears to be directly 
involved in maintaining genome stability in human cells, by regulating DNA 
damage repair, signalling DNA damage at telomeres and ensuring sister 
chromatid separation. 
 
There is evidence that Rif1 controls the threshold at which ssDNA 
accumulation, caused by telomere uncapping, activates the DDR at telomeres.  
Significantly, Rif1 represses the DDR by independently associating with ssDNA 
lesions to stop DDR proteins such as RPA, Mec1, Rad24, Ddc1, Ddc2 and 
Rad9 sensing the damage and inducing cell cycle arrest (Xue et al., 2011; 
Ribeyre and Shore, 2012).  It has been proposed that Rif1 stimulates CST 
activity, by perhaps making contacts with Stn1 or Cdc13 to form a shelterin-like 
dsDNA-ssDNA telomere capping complex, since rif1 cdc13-1 strains have 
poor viability and rif1 and stn1C mutations are synthetic lethal (Anbalagan et 
al., 2011).  However, temperature-sensitive cdc13-1 strains (discussed below) 
accumulate long tracts of ssDNA at restrictive temperatures (Zubko et al., 
2004).  It is conceivable that in cdc13-1 strains, grown at permissive 
temperatures (<25°C), ssDNA is generated at the telomere due to telomere 
capping defects and DDR activation is inhibited by Rif1 (Xue et al., 2011).  
 
At restrictive temperatures, ssDNA tracts extend beyond the telomere and the 
reach of Rif1, which activates the DDR and causes cell cycle arrest (Xue et al., 
2011).  Therefore, rather than stimulating Cdc13/CST activity, Rif1 could protect 
against damage caused by Cdc13/CST dysfunction.  Rif1 and Rif2 have been 
shown to block DNA damage checkpoint activation at short tracts (80 bp) of 
telomeric TG repeats by binding to ssDNA to form a protective cap (Ribeyre and 
Shore, 2012).  However, Rif1 and Rif2 do not cap longer TG tracts (250 bp) or 
block accumulation of DDR factors, yet the tracts do not undergo resection 
(Ribeyre and Shore, 2012).  In fact, at long and short TG tracts, Rif1 blocks 
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Cdc13 binding (Rif2 has no effect) and Cdc13 protects against resection 
(Ribeyre and Shore, 2012).  There is clearly still much debate over the roles of 
Rif1 in resection, CST activity and DNA damage checkpoint activation.  This 
thesis hopes to contribute to these debates in Chapter 4. 
 
1.4 Cdc13, Stn1 and Ten1 telomere end protection 
 
1.4.1 CST function 
 
Budding yeast CST is thought to be a heterotrimer formed by Cdc13, Stn1 and 
Ten1 (Figure 5) and is conserved between yeast, plants and vertebrates (Jain 
and Cooper, 2010).  Yeast CST binds telomeric ssDNA, which is the 3’ 
overhang at the telomere end.  CST is structurally analogous to the highly 
conserved RPA (Replication Protein A) heterotrimer (Figure 5), in that both are 
heterotrimers with ssDNA binding capability and subunits contain a similar 
number of OB folds in both yeast and humans (Gao et al., 2007; Miyake et al., 
2009; Sun et al., 2011).  Binding of CST to telomeric ssDNA stops the 
chromosome end from being recognised as a DSB and therefore stops 
induction of the DNA damage response (Garvik et al., 1995).  It is essential that 
telomeres are not treated as DSBs, since repair of telomere ends by HR or 
NHEJ can lead to telomere end-to-end fusions, circular chromosomes and 
genomic instability (Larrivée and Wellinger, 2006; Lopez et al., 2015).   
 
CST was first identified in budding yeast and components are conserved 
between yeasts and mammals (Figure 5) (Giraud-Panis et al., 2010).  In 
humans and other mammals CST consists of CTC1, STN1 and TEN1, which 
are functional orthologues of budding yeast Cdc13, Stn1 and Ten1 respectively 
(Miyake et al., 2009; Surovtseva et al., 2009).  Evidence that CST is a 
heterotrimer is that CST purifies as a trimeric complex from human cells (Chen 
et al., 2012) and Stn1, Ten1 and Cdc13 associate in budding yeast in yeast-two 
hybrid experiments (Grandin et al., 2000; Grandin et al., 2001b).  Interestingly, 
budding yeast CST subunits have not yet been co-purified.  Both CTC1 and 
STN1 (also called OBFC1) in humans have been shown to regulate telomere 
length, similar to budding yeast Cdc13 and Stn1 (Nugent et al., 1996; Puglisi et 
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al., 2008; Wan et al., 2009; Mangino et al., 2012).  Human CST has an affinity 
for telomeric ssDNA and binds using OB folds 1 and 2 of CTC1, whereas Cdc13 
binds ssDNA using the OB3 fold (Mitton-Fry et al., 2004; Miyake et al., 2009). 
 
There is evidence from budding yeast and humans that the CST subunits also 
have distinct roles at telomeres.  In humans, CTC1-, STN1- and TEN1-depleted 
cells exhibit different phenotypes.  TEN1-depleted cells showed a larger 
increase in chromosome ends lacking telomeres compared to STN1- and 
CTC1-depleted cells, and both TEN1- and STN1-depleted cells have increased 
levels of aberrant T-loops compared to CTC1-depleted cells (Stewart et al., 
2012; Kasbek et al., 2013).  In budding yeast, Cdc13 recruits telomerase to 
telomere ends (Nugent et al., 1996; Chandra et al., 2001) whereas Stn1 can 
inhibit telomerase (Puglisi et al., 2008).  Both Cdc13 and Stn1 bind to DNA 
polymerase alpha to promote C-strand fill-in (after G-strand extension) at the 
telomere end.  Cdc13 binds to Pol1, the DNA polymerase subunit of DNA 
Polymerase alpha (Qi and Zakian, 2000), and Stn1 also directly binds to the 
Pol12 regulatory subunit of DNA Polymerase alpha at its C-terminus (Petreaca 
et al., 2006; Puglisi et al., 2008). The other two subunits of DNA Polymerase 
alpha are Pri1 and Pri2, primase subunits involved in the synthesis of a short 
RNA primer (7-10 nt), which allows DNA Polymerase alpha to initiate synthesis 
of Okazaki fragments.  This is required for replication of the telomeric lagging 
strand (Figure 2), in which the C-rich strand is synthesised discontinuously.  In 
Candida glabrata, CST stimulates the primase activity of DNA Polymerase 
alpha and stimulates the switch to polymerase activity (Lue et al., 2014).  
Specifically, CST was found to shorten the RNA primers and promote 
elongation of DNA synthesised by DNA polymerase alpha (Lue et al., 2014). 
 
CST components also co-purify with DNA Polymerase alpha in mammalian 
cells (Casteel et al., 2009). Recently it has been shown that in mouse and 
human telomeres, CST has a role in filling in the C-rich strand of the telomere, 
perhaps through DNA Polymerase alpha recruitment (Casteel et al., 2009; Gu 
et al., 2012; Wang et al., 2012).  Mouse and human CST also facilitated the 
progression of the DNA replication fork at telomeres (Gu et al., 2012; Stewart et 
al., 2012).  Human STN1, and mouse CTC1, has a role in restarting stalled 
replication forks throughout the genome, which may indicate a role for CST 
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outside the telomere (Gu et al., 2012; Stewart et al., 2012).  A non-telomeric 
role for CST has also been reported in the yeast Candida glabrata, where 
Cdc13 and CST have been shown to have a low affinity for non-telomeric DNA 
(Lue et al., 2013).  As yet, a non-telomeric role for budding yeast CST has not 
been identified. 
 
Deletion of CDC13, STN1 or TEN1 is lethal in budding yeast.  However, in S. 
pombe, deletion of STN1 is lethal but ten1 strains are viable; in C. glabrata, 
cdc13 strains are inviable but stn1 and ten1 strains are viable (Sun et al., 
2009).  Several studies have been conducted using human cell lines depleted 
for CST subunits, however these are telomerase-positive or ALT cell lines that 
have abnormal telomere maintenance.  Depletion of STN1 in somatic cells 
(fibroblasts) that lack telomerase activity, leads to telomere dysfunction, erosion 
of telomeric tracts and acceleration of senescence (Boccardi et al., 2015).   
Mutations in human CTC1 result in diseases associated with short telomeres 
and premature ageing, such as Coat’s plus and Dyskeratosis congenita 
(Savage, 2012).  Given the severity of the CTC1-null phenotype in mice, the 
premature ageing diseases caused by heterozygous CTC1 mutations and the 
severity of STN1 depletion in somatic cells, it seems reasonable to conclude 
that CST is an essential telomere-related complex in higher eukaryotes.  Since 
deletion of any CST component is lethal to budding yeast, it is arguable that 
budding yeast is a good model to understand the essential functions of CST. 
 
1.4.2 Cdc13 
 
Cdc13 is the most extensively studied component of the budding yeast CST 
complex.  Along with Stn1 and Ten1, Cdc13 is essential and cells cannot 
survive without it.  Cdc13 binds strongly to single-stranded TG1-3 repeats and 
tethers the CST complex to telomeric ssDNA (Lin and Zakian, 1996; Nugent et 
al., 1996).  Cdc13 then recruits telomerase by interacting with Est1, a regulatory 
element of telomerase, using its recruitment domain (Figure 5 C) (Chandra et 
al., 2001; Wu and Zakian, 2011). Cdc13 is both a positive and negative 
regulator of telomere length, in that Cdc13 first recruits telomerase for G-rich 
strand extension then recruits Stn1 to a binding site overlapping with Est1 
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(Nugent et al., 1996; Chandra et al., 2001).  Recruitment of Stn1 inhibits 
telomerase G-rich strand extension and promotes C-rich strand fill-in by DNA 
polymerase alpha, facilitated by Stn1-Cdc13 (Chandra et al., 2001).   
 
Intriguingly, Cdc13 is less conserved than Stn1 and Ten1, since S. pombe has 
no Cdc13 homologue.  There is some debate as to whether Pot1 in S. pombe 
and POT1 in mammals, which is the ssDNA binding protein of the shelterin-
like/shelterin complex of these organisms, is the Cdc13 homologue.  POT1 
suppresses the DNA damage response at human telomeres, which is similar to 
Cdc13 function, and possesses OB folds for DNA binding (Theobald and 
Wuttke, 2004; Churikov et al., 2006).  Whilst Stn1 has significant sequence 
homology to human STN1, the two STN1 binding proteins identified in humans 
(CTC1 and TEN1) show little significant sequence homology to Cdc13 and 
Ten1 (Miyake et al., 2009).  However, both CTC1 and TEN1 contain 3 and 1 OB 
folds, respectively, which is similar to the 4 OB folds of Cdc13 and 1 OB fold of 
Ten1 (Miyake et al., 2009; Sun et al., 2011).   
 
Yeast Cdc13 contains 4 OB (DNA-binding) folds (Figure 5) (Sun et al., 2011).  
OB1 is situated at the N terminus of Cdc13 and binds transiently to the 
elongated 3’ overhangs of S/G2 phase, where it helps to recruit the Pol1 
subunit of DNA Polymerase alpha for fill-in of the AC1-3 strand (Qi and Zakian, 
2000; Hsu et al., 2004; Mitchell  et al., 2010).  The OB3 fold is the DNA binding 
domain of Cdc13 and binds strongly to telomeric ssDNA (Mitton-Fry et al., 
2004).  The function of OB4 is currently unknown.  It has been postulated that 
Cdc13 shares homology with Rfa1, since it contains 4 OB folds (Gao et al., 
2007; Gelinas et al., 2009), however the structures of the Cdc13 OB folds are 
markedly different from those of Rfa1 and Cdc13 binds ssDNA with a single OB 
fold (OB3) unlike Rfa1 which uses two (Sun et al., 2011; Lewis et al., 2014). 
 
A further difference between Cdc13 and Rfa1 is that Cdc13 undergoes 
homodimerization using the N-terminal OB fold (OB1) to bind to the Pol1 
subunit of DNA Polymerase alpha (Sun et al., 2011).  Rfa1 is not known to 
homodimerize (Lewis et al., 2014).  Cells expressing Cdc13 defective in OB1-
mediated homodimerization have wild-type fitness at temperatures up to 30 °C, 
however slight fitness defects are apparent at 37 °C (Sun et al., 2011).  More 
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recently it has been shown that OB2-mediated dimerization is required for 
efficient Stn1 binding to Cdc13 (Mason et al., 2013).  The OB2 domain does not 
bind telomeric DNA or Stn1, which suggests that OB2 dimerization is required 
for the assembly of the CST complex (Mason et al., 2013).  Cdc13 dimerization 
has no effect on ssDNA binding, since both wild-type and monomer forms 
bound with DNA equal affinity (Lewis et al., 2014).  
 
1.4.3 The cdc13-1 mutation 
 
In genetic studies of Cdc13 function, conditional mutants of the CDC13 gene 
are used.  The most extensively studied conditional mutant is cdc13-1, which 
caps telomeres at 23 °C but is defective in capping at temperatures above 25 
°C (Culotti and Hartwell, 1971; Garvik et al., 1995).  The cdc13-1 mutation is a 
P371S mutation, which disrupts Cdc13-Stn1 binding (and hence CST 
assembly) (Grandin et al., 2001a; Mason et al., 2013).  There is evidence that 
within the CST complex, Stn1 is primarily responsible for telomere protection, 
since budding yeast cdc13Δ strains are viable when they express Stn1 fused to 
the Cdc13 DNA binding domain (the strain is defective in telomerase 
recruitment, however) (Pennock et al., 2001). 
 
At restrictive temperatures, cdc13-1 cells accumulate telomeric ssDNA and cell-
cycle arrest occurs at G2 phase (Garvik et al., 1995).  The 5’-3’ exonuclease 
Exo1 generates ssDNA in cdc13-1 mutants, by resecting telomeric DNA at the 
chromosome end (Tsubouchi and Ogawa, 2000).  Deleting EXO1 reduces 
ssDNA levels and increases the fitness of cdc13-1 strains at 27 °C (Zubko et 
al., 2004).  It is evident therefore that Cdc13 (together with Stn1 and Ten1)  
protects telomere ends from Exo1 nuclease activity.  The DDR occurs at 
telomeres when telomere uncapping is induced in cdc13-1 mutants.  Rad24, 
which loads the Rad17/Mec3/Ddc1 checkpoint clamp during the DNA damage 
response, also helps generate ssDNA in cdc13-1 mutants and, along with the 
Rad9 checkpoint protein, induces cell cycle arrest at restrictive temperatures 
(Lydall and Weinert, 1995; Zubko and Lydall, 2006).  Deleting the checkpoint 
genes RAD24 or RAD9 partially restores fitness of the cdc13-1 mutant at 28 °C 
(Lydall and Weinert, 1995; Zubko et al., 2004). 
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1.4.4 Cdc13 bypass in a pif1 exo1 strain 
 
Although CDC13 is an essential gene, its function may be bypassed if cdc13 
is combined with deletions of genes associated with the DDR (see Table 1 for a 
complete list).  It has been previously reported that a small fraction of cdc13-1 
exo1 rad24 cells formed colonies at 36°C, and that CDC13 could be 
completely deleted from these strains (Zubko and Lydall, 2006).  CDC13 can be 
deleted from a pif1 exo1 strain, although cdc13 pif1 exo1 spores only 
form small colonies compared to CDC13+ strains (Dewar and Lydall, 2010).  
Pif1 is a DNA helicase that unwinds dsDNA during replication, and there is 
evidence to suggest that along with Exo1, it regulates nuclease activity at 
telomeres.  That is, cdc13 pif1 exo1 mutants do not senesce or generate 
telomerase-independent survivors and they are dependent on telomerase to 
maintain their telomeres (Dewar and Lydall, 2010).  This supports the model of 
DDR induction at uncapped telomeres, since attenuation of the DDR by deleting 
EXO1 and PIF1 appears to allow telomerase to access telomere ends. 
 
1.4.5 Cdc13 bypass in a rad9 sgs1 exo1 strain 
 
Another genetic background in which Cdc13 function can be bypassed is rad9 
sgs1 exo1 (Ngo and Lydall, 2010).  Rad9, Sgs1 and Exo1 are DDR proteins; 
Rad9 is a cell cycle checkpoint protein associated with the DDR, Sgs1 is a DNA 
helicase involved in ALT and, along with Exo1, regulates resection of dsDNA to 
ssDNA at telomeres (Huang et al., 2001; Johnson et al., 2001; Ngo and Lydall, 
2010).  cdc13-1 rad9 sgs1 exo1 strains were viable at 36°C, furthermore 
cdc13 rad9 sgs1 exo1 spores formed colonies, indicating that telomere 
capping counteracts specific proteins associated with the DDR (Ngo and Lydall, 
2010).  After many passages, a proportion of cdc13 rad9 sgs1 exo1Δ 
strains escaped senescence and resembled telomerase-deficient survivors 
(Ngo and Lydall, 2010).  Viability of cdc13 rad9 sgs1 exo1 strains 
indicates that Cdc13 is not required for telomere capping in the absence of 
DDR proteins Rad9, Sgs1 and Exo1. 
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Genetic 
manipulation 
Gene function Reason for Cdc13 
bypass 
Reference 
pif1 exo1 PIF1: DNA helicase, 
regulates nuclease 
activity at telomeres. 
 
EXO1: Exonuclease 
associated with 
DDR, resects DNA at 
telomeres to 
produces ssDNA. 
 
Deleting PIF1 and EXO1 
attenuates the DDR and 
allows telomerase to 
access the telomere end 
Dewar and 
Lydall 
(2010) 
sgs1 exo1 
rad9 
SGS1: DNA 
helicase, involved in 
ALT, regulates 
resection at 
telomeres. 
 
EXO1: As above. 
 
RAD9: Checkpoint 
protein activated by 
the DDR. 
 
Deleting SGS1 and EXO1 
attenuates the DDR, 
reducing the treatment of 
telomeres as DSBs.  
Deleting the DDR 
checkpoint protein Rad9 
stops cell cycle arrest in 
response to DNA damage 
(e.g. an uncapped 
telomere that resembles a 
DSB). 
Ngo and 
Lydall 
(2010) 
nmd2 exo1  
 
nmd2 
rad24 
 
nmd2 exo1 
rad24 
 
NMD2: Part of the 
NMD pathway, which 
regulates levels of 
telomeric proteins 
such as Stn1 and 
Ten1. 
 
EXO1: As above. 
 
RAD24: Checkpoint 
protein associated 
with the DDR and 
repair of DSBs. 
 
Deleting NMD2 increases 
levels of Stn1 and Ten1, 
which may cap the 
telomere in the absence of 
Cdc13.  NMD2 deletion 
also attenuates ssDNA 
production.  Deleting 
EXO1 along with NMD2 
attenuates the DDR by 
reducing ssDNA 
production. 
 
Deleting RAD24 alongside 
NMD2 inhibits the initiation 
of cell cycle arrest in 
response to telomere 
uncapping. 
 
Deleting EXO1 and RAD24 
along with NMD2 
attenuates the DDR and 
cell cycle arrest. 
 
Holstein et 
al. (2014) 
 
Table 1. Gene deletions permitting Cdc13 bypass
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1.4.6 Cdc13 bypass in an nmd2 and exo1 or rad24 strain 
 
Recently it was reported that cells could survive without CDC13 in an nmd2 
and exo1 or rad24 background (Holstein et al., 2014).  Nmd2 is required for 
the nonsense-mediated mRNA decay (NMD) pathway and interacts with Nam7 
and Upf3 (Figure 6).  NMD is conserved between yeast and humans (where the 
major factors are UPF1, UPF2 and UPF3) and degrades mRNA that contains 
premature stop codons (nonsense mutations) to stop production of truncated 
proteins (Isken and Maquat, 2008).  By degrading aberrant mRNA, NMD 
regulates cellular levels of 1-10% of proteins in yeast and humans (Isken and 
Maquat, 2008).  NMD also regulates levels of telomeric proteins through 
degradation of mRNA, for example NMD regulates Stn1 and Ten1 levels 
(Enomoto et al., 2004).  When NMD2 is deleted, over 200 proteins are 
overexpressed, including Stn1 and Ten1 (Dahlseid et al., 2003; Guan et al., 
2006).  Overexpression of Stn1 and Ten1 appears to cause the short telomere 
phenotype of nmd2 cells but delays their senescence by perhaps reinforcing 
CST telomere capping and blocking nuclease access (Dahlseid et al., 2003; 
Enomoto et al., 2004). 
 
STN1 and TEN1 deletion mutants are inviable in an nmd2 and exo1 or 
rad24 background (Holstein et al., 2014).  This indicates that Cdc13 function 
can be bypassed in certain circumstances but Stn1 and Ten1 functions cannot.  
The lethal phenotype of ten1 and stn1 strains is rescued by expression of the 
wild-type genes on plasmids (Holstein et al., 2014).  Bypass of Cdc13 in an 
nmd2 and exo1 or rad24 background is supported by previous reports that 
overexpression of truncated or full-length Stn1 and Ten1 bypasses the 
requirement for Cdc13 (Petreaca et al., 2006; Petreaca et al., 2007; Gasparyan 
et al., 2009).  
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Figure 6. Nonsense-mediated mRNA decay 
mRNA (shown as a black line with a poly-A tail) can contain premature 
translation termination (nonsense) codons (indicated by ‘STOP’).  When the 
ribosome reaches a nonsense codon, eukaryotic release factors eRF1 and 
eRF3 bind to the ribosome and recruit Nam7 (Upf1), Nmd2 (Upf2) and Upf3 to 
initiate degradation of the mRNA (Iksen and Maquat, 2007).  This prevents 
synthesis of a truncated or mutated protein. 
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1.4.7 CTC1 mutations and disease 
 
There is recent evidence that mutations in CTC1, the mammalian functional 
orthologue of Cdc13, are tolerated in humans and mice.  CTC1-null mice have 
been generated, however they die prematurely from bone marrow failure due to 
G2/M checkpoint arrest.  CTC1-null mice exhibit telomere loss, chromosome 
end-to-end fusions and ssDNA from an enlarged telomeric G-rich overhang, 
caused by defective C-rich strand fill-in.   
 
Bone marrow failure has been reported in Coats plus patients, which concurs 
with evidence from mice (Bisserbe et al., 2015).  Patients inherit a CTC1 allele 
containing a frameshift mutation and the other allele containing a missense 
mutation, and therefore are heterozygous for CTC1 mutations (Gu and Chang, 
2013).  Presumably, homozygous deletions are lethal, given the short lifespan 
of CTC1-null mice (Gu and Chang, 2013).  So far, 14 missense mutations, 8 
frameshift mutations and 3 in-frame deletions have been identified in CTC1 in 
humans (Gu and Chang, 2013).  A number of point mutations and in-frame 
deletions have been shown to interfere with STN1-TEN1 binding or DNA 
Polymerase alpha recruitment (Chen et al., 2013; Gu and Chang, 2013).   
 
Mutations in CTC1 have been reported in patients with Coats plus, 
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) and 
Dyskeratosis congenita, which are diseases associated with telomere defects 
(Anderson et al., 2012; Polvi et al., 2012; Romaniello et al., 2012; Walne et al., 
2013).  CTC1 frameshift mutations associated with these diseases abolished 
interaction with STN1 and TEN1 and reduced STN1 interaction with DNA 
polymerase alpha in vivo (Gu and Chang, 2013).  Interestingly, no mutations in  
STN1 and TEN1 have been reported in the same sets of patients, indicating 
that in mammals, as in yeast, STN1 and TEN1 may be more important for 
telomere maintenance than CTC1.  In mice, CTC1 knockouts are viable but do 
not survive into adulthood; however no STN1 or TEN1 knockouts have been 
reported as yet (Gu et al., 2012).   
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Although no STN1 or TEN1 mutations have been reported in diseases with 
telomere defects, single nucleotide polymorphisms (SNPs) have been found in 
STN1 (and CTC1), although it is unknown what effects these have on protein 
function.  Large-scale genome-wide association studies have shown that SNPs 
in human STN1 (OBFC1) correlate with shorter telomere length, as do SNPs in 
CTC1 (Levy et al., 2010; Burnett-Hartman et al., 2012; Mangino et al., 2012; 
Codd et al., 2013).  As yet, no SNPs or other mutations have been reported for 
Ten1.  Two studies have knocked down STN1 and TEN1 in human cells by as 
much as 95%, however the cells were immortalised tumour cell lines expressing 
telomerase (Bryan et al., 2013; Kasbek et al., 2013).  A more recent study 
examined the effect of STN1 depletion in normal somatic cells (human 
fibrolasts) and found that STN1 depletion resulted in telomere erosion and rapid 
entry into senescence (Boccardi et al., 2015).  Interestingly, fibroblasts 
overexpressing telomerase and depleted for STN1 maintained telomere length 
and did not rapidly senesce, indicating that telomerase can compensate for 
deficits in STN1 (hence the effects of STN1 depletion may be masked in 
telomerase-positive cells) (Boccardi et al., 2015). 
 
1.4.8 Stn1 
 
Stn1 physically associates with Cdc13 and Ten1 in yeast two-hybrid 
experiments (Grandin et al., 1997; Grandin et al., 2001b).  Stn1 also physically 
interacts with the Pol12 subunit of DNA polymerase alpha to stimulate fill-in of 
the C-rich telomeric lagging strand in yeast and higher eukaryotes (Grossi et al., 
2004; Petreaca et al., 2006; Gasparyan et al., 2009; Derboven et al., 2014; Lue 
et al., 2014).  Stn1 is more highly conserved than Cdc13, since homologues are 
present in S. pombe as well as in higher eukaryotes, and human STN1 has 
significant sequence homology to yeast Stn1 (Miyake et al., 2009).  Stn1 has an 
N-terminal OB fold and two winged helix motifs at the C terminus (Sun et al., 
2011) whereas human STN1 has an N-terminal OB fold but no winged helix 
motifs (Miyake et al., 2009).  In yeast, the N-terminus of Stn1 is required for 
interaction with Ten1 whilst the C-terminus is required for interaction with Cdc13 
(Petreaca et al., 2006; Petreaca et al., 2007).  Expressing the N-terminus of 
Stn1 (amino acids 1-281) was sufficient to rescue the lethality of stn1, however 
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expressing the C-terminal of Stn1 was insufficient (Puglisi et al., 2008).  This 
indicates that Stn1-Ten1 interaction is essential for cell viability but Stn1-Cdc13 
interaction is dispensable (Puglisi et al., 2008). 
 
The stn1-13 mutation (T101S, D134V, T203A, I209V, S393R, M416T) disrupts 
Stn1 binding to Ten1 and Cdc13 at restrictive temperatures and is synthetic 
lethal with the cdc13-1 temperature-sensitive mutation (Grandin et al., 1997; 
Grandin et al., 2001b).  Studying the phenotype of the stn1-13 temperature-
sensitive allele at a restrictive temperature (38°C) showed that stn1-13 cells 
accumulate ssDNA, activate the Rad9 and Mec3 G2/M DNA damage 
checkpoints and undergo cell cycle arrest, similar to cdc13-1 mutants (Grandin 
et al., 1997).  At semi-permissive temperatures, stn1-13 cells exhibit long, 
heterogeneous telomeres perhaps because the stn1-13 mutations interrupt 
Stn1-Cdc13 interaction (Grandin et al., 1997).  Lack of Stn1 binding to Cdc13 
may lead to higher levels of Est1 recruitment, since Est1 competes for Cdc13 
binding with Stn1 (Chandra et al., 2001).  This may result in longer telomeres, 
since telomerase has more access to the telomere end.  The stn1-63 mutation 
is a D99E substitution in the Stn1 N-terminus that leads to telomere uncapping 
and ssDNA accumulation at restrictive temperatures, although the phenotype is 
milder than cdc13-1 grown at restrictive temperatures.  This implies that Stn1-
Ten1 interaction is important for telomere capping and prevention of DDR 
activation at the telomere end. 
 
A growing body of evidence suggests that Stn1 is more important for telomere 
protection and replication than Cdc13.  Stn1 fused to the DNA-binding domain 
of Cdc13 rescues the lethality of a CDC13 deletion, however telomere 
replication is defective as Cdc13 is required to recruit telomerase (Pennock et 
al., 2001).  Overexpression of Stn1 or the Stn1 N-terminal and Ten1 together 
suppresses the temperature-sensitivity of a cdc13-1 strain and permits growth 
of 16% of cells deleted for CDC13.  However, cells deleted for CDC13 
senesced without telomerase (Grandin et al., 1997; Petreaca et al., 2006). 
Overexpression of the Stn1 C-terminus, which interacts with Cdc13, only 
partially rescued the cdc13-1 phenotype (Petreaca et al., 2006).  Given that 
cdc13-1 disrupts Stn1 binding (Mason et al., 2013) it is perhaps unsurprising 
that there was only partial rescue.  Conversely, overexpression of Cdc13 does 
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not rescue the stn1-13 mutation at restrictive temperatures (Grandin et al., 
1997).  Overexpression of stn1-13 rescues the cdc13-1 phenotype up to 30°C 
(the permissive temperature for cdc13-1 is below 25°C) and partially rescues 
cdc13-1 up to 32°C (Grandin et al., 1997). 
 
Stn1 binds to telomeric ssDNA with higher affinity compared to non-telomeric 
DNA (Gao et al., 2007), which indicates that Stn1 may not require Cdc13 
binding to access telomeric DNA.  Indeed, it has been reported that Stn1 is at 
telomeres in the absence of Cdc13, in a strain defective in NMD and the DDR 
(Holstein et al., 2014).  Furthermore, in Candida glabrata, Stn1 alone is 
responsible for stimulating the primase activity of DNA Polymerase alpha and 
the OB fold domain or the winged-helix domains on their own can stimulate 
primase activity (Lue et al., 2014).  However, only winged helix 2 interacted with 
the Pol12, the regulatory subunit of DNA polymerase alpha (Lue et al., 2014).  
Human STN1 also stimulates DNA Polymerase alpha alone and remarkably, 
intra-species interactions between Stn1/STN1 and Pol12 are observed using 
purified proteins from Candida glabrata and humans (Lue et al., 2014). 
 
Stn1 appears to share homology with the Rpa2 subunit, since it has a single OB 
fold and complexes with a larger and smaller subunit (Figure 5) (Gao et al., 
2007; Gelinas et al., 2009; Sun et al., 2009).  However, the multiple roles of 
Stn1 in negatively regulating telomerase and regulating DNA polymerase alpha 
fill-in of the telomeric C-strand would suggest that Stn1 is functionally different.  
Also, as discussed above, Stn1 and Cdc13 carry out multiple separate roles, 
which would indicate that they are not necessarily always acting together in a 
complex. 
 
1.4.9 Ten1 
 
Ten1 is an essential protein yet is the smallest component of CST and is 
conserved in S. pombe and in higher eukaryotes (although, as mentioned 
above, human TEN1 shares no significant sequence homology with yeast 
Ten1).  It has been proposed that Ten1 is analogous to Rpa3, the smallest Rpa 
subunit, since both share a single OB fold (Gao et al., 2007).  In humans, TEN1 
depletion has a different phenotype to either STN1 or CTC1 depletion.  As 
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mentioned above, in TEN1-depleted cells there is a larger increase in telomere 
signal-free chromosomes compared to STN1 and CTC1-depleted cells (Kasbek 
et al., 2013) indicating that TEN1 may carry out separate telomeric roles to 
STN1 and CTC1 and may not solely act in complex with its partner proteins. 
 
Ten1 interacts physically with both Stn1 and Cdc13 and Stn1-Ten1 binding is 
not disrupted by the cdc13-1 mutation, which disrupts Cdc13-Stn1 binding 
(Grandin et al., 2001b; Mason et al., 2013).  Overexpression of Stn1 and Ten1 
together suppress the temperature sensitivity of a cdc13-1 strain, indicating that 
Ten1 binding is important for Stn1 activity in either inhibiting telomerase 
recruitment or stimulating fill-in of the telomeric C-rich lagging strand by DNA 
polymerase alpha (Grandin et al., 2001b; Petreaca et al., 2006).  Interestingly, 
in Arabidopsis thaliana, TEN1 represses telomerase activity but STN1 has little 
effect (Song et al., 2008; Leehy et al., 2013).  Mutants deleted for STN1 or 
CTC1, or with mutated TEN1, rapidly lose telomeric tracts.  
 
In budding yeast, there is evidence that Ten1 represses telomerase activity.  At 
semi-permissive temperatures, ten1 temperature-sensitive alleles (ten1-3 
(Q107R), ten1-6 (K12E) and ten1-13 (F94L)) had very long, heterogeneous 
telomeres similar to stn1-13 mutants at semi-permissive temperatures (Grandin 
et al., 2001b).  Telomere elongation in the ten1-3, ten1-6 and ten1-13 strains 
was dependent on telomerase (Grandin et al., 2001b), indicating that (similar to 
Stn1) Ten1 may negatively regulate telomerase activity. 
 
Ten1 overexpression does not rescue the temperature-sensitive phenotype of 
cdc13-1, however overexpression of Stn1 and Ten1 together does rescue the 
lethality of cdc13-1 at restrictive temperatures (Grandin et al., 1997; Petreaca et 
al., 2006).  Mild overexpression (2-fold) of Ten1 in a stn1 strain does not 
restore viability, nor does mild overexpression of Stn1 in a ten1 strain (Holstein 
et al., 2014).  However, overexpression of Ten1 in a stn1-13 strain does reduce 
the elongated telomeres of a stn1-13 mutant.  Similar to stn1-13 and cdc13-1, 
two temperature-sensitive alleles of TEN1, ten1-16 (F154I) and ten1-31 (E58K, 
L76P, E91V, V115A) accumulate ssDNA, activate the Rad9-mediated G2/M 
DNA damage checkpoint and undergo cell cycle arrest (Grandin et al., 2001b).   
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Interestingly, ten1-16 and ten1-31 are not rescued by overexpression of either 
Stn1 or Cdc13 (Grandin et al., 2001b), indicating that neither Stn1 nor Cdc13 
can compensate for the role(s) of Ten1.  Given that overexpression of Stn1-N 
terminus and Ten1 together can bypass the requirement for Cdc13 in 16% of 
cells; Stn1-N terminus expression rescues stn1 lethality and expression of a 
Stn1-13-Ten1 fusion protein rescued the telomere elongation phenotype of 
stn1-13 mutants (Grandin et al., 2001b; Petreaca et al., 2006; Puglisi et al., 
2008), it seems likely that Ten1-Stn1 interaction is important for the function of 
both proteins.  Indeed, Stn1 and Ten1 together can perhaps orchestrate 
aspects of their telomere-capping activity independently of Cdc13 (Petreaca et 
al., 2006; Holstein et al., 2014).  Temperature-sensitive alleles of Ten1 
accumulated ssDNA and activated the Rad9 G2/M checkpoint at restrictive 
temperatures, similar to cdc13-1 and stn1-13 alleles (Grandin et al., 2001b).  
However, ten1-3, ten1-6 and ten1-13 strains were not defective in Cdc13 and 
Stn1 binding (Grandin et al., 2001b), which suggests novel additional role(s) 
independent of Stn1 and Cdc13.   
 
1.4.10 A new model of CST function 
 
CST in yeast has long been assumed to be an obligate heterotrimer, existing in 
a 1:1:1 ratio of Cdc13/Stn1/Ten1. The recent research discussed above, both in 
yeast and humans, has shown that Stn1 and Ten1 have individual roles that 
may be independent in Cdc13.  Furthermore, in C. glabrata, CST exists in a 
2:4:2 or 2:6:2 arrangement and in budding yeast, the stoichiometry of CST 
components at telomeres can be altered (Lue et al., 2013; Holstein et al., 2014). 
The evidence indicates that CST is not necessarily a heterotrimer, as previously 
thought, and that CST components have separate roles.   
 
Three modes of Cdc13 bypass have been discovered so far (pif1 exo1; 
sgs1 exo1 rad9 and nmd2 exo1 rad24), but no genetic manipulations 
that generate stn1 or ten1 strains have been found.  Therefore, Stn1 and 
Ten1 appear to be more important for telomere end protection than their partner 
protein Cdc13.  It is possible that Stn1 and Ten1 interact with telomeric proteins 
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other than Cdc13 in order to protect the telomere end.  Candidate proteins are 
Rfa1/2/3 (RPA), which form an ssDNA-binding heterotrimer.   
 
This thesis investigates the role of Stn1 and Ten1 in Cdc13 bypass using 
genetic and biochemical methods (Chapter 3).  Chapter 4 investigates the 
cellular mechanisms underlying Cdc13 bypass using a genome-wide screen of 
single gene deletions that stop Cdc13 bypass.  Chapter 5 investigates whether 
TERRA has a role in Cdc13 bypass, since TERRA may protect the telomere 
end and promote telomere recombination in the absence of telomerase (which 
is recruited to the telomere end by Cdc13 interactions).  Chapter 6 reports a 
discovery that diploids with elongated telomere rearrangements can produce 
cdc13 strains with genotypes not previously known to be viable.  It is hoped 
that these results will cast new light on how cells with telomere dysfunction, a 
hallmark of cancer, evade cell death or senescence.  Through further 
understanding of Cdc13 bypass, it is hoped that promising strategies for future 
cancer therapies can be developed. 
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Chapter 2. Materials & Methods 
 
2.1 Yeast strains 
 
S. cerevisiae strains used are given in the Appendices, listed by figure 
(Appendix A) and by strain number (Appendix B).  All strains are in the W303 
RAD5  genetic background, apart from strains used for Synthetic Genetic Array 
screening (see below, 2.23) which are S288C. 
 
2.2 Plasmids 
 
Plasmids are listed in Appendix C. 
 
2.3 Media 
 
Yeast extract, peptone, dextrose, adenine (YPD) was 10g/L yeast extract, 20g/L 
bactopeptone, 2% (w/v) dextrose and 0.0075% (w/v) adenine.  Selective 
dropout (SD) media lacking uracil (-URA), tryptophan (-TRP), leucine (-LEU), 
histidine (-HIS), arginine (-ARG) or lysine (-LYS) or combinations thereof was 
1.3 g/L dropout  powder lacking the specified amino or nucleic acids (detailed 
below), 6.7 g/L yeast nitrogen base, 5 g/L ammonium sulphate and 2% (w/v) 
dextrose.  Enriched sporulation media (ESM) was 1 g/L yeast extract, 0.05% 
(w/v) dextrose, 1% (w/v) potassium acetate, 12.5 mg/L histidine, 62.5mg/L 
leucine, 12.5 mg/L lysine, 12.5 mg/L uracil.  Antibiotics were added to media, 
where specified, at the following concentrations:  G418 (200 mg/L), clonNAT 
(100 mg/L), hygromycin B (300 mg/L).  Canavanine and/or thialyisine were 
added to media, where specified, at 50 mg/L.  5-fluoroorotic acid (5-FOA) plates 
were made with –URA dropout power (1.3 g/L), yeast nitrogen base (1.7 g/L), 
uracil (50 mg/L), 5-FOA (1 g/L) and dextrose (2% w/v).   
 
Solid agar plates were made from the same media but with the addition of 2% 
(w/v) agar.   
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Amino/nucleic acids dropout powder recipe 
Adenine 2.5g 
L-arginine (HCl) 1.2g 
L-aspartic acid 6.0g 
L-glutamic acid (monosodium salt) 6.0g 
L-histidine 1.2g 
L-leucine 3.6g 
L-lysine (mono-HCl) 1.8g 
L-methionine 1.2g 
L-phenylalanine 3.0g 
L-serine 22.5g 
L-threonine 12.0g 
L-tryptophan 2.4g 
L-tyrosine 1.8g 
L-valine 9.0g 
Uracil 1.2g 
  
Amino/nucleic acid dropout powder was made by omitting the relevant amino 
acids from the dropout mix. 
 
2.4 Sporulation 
 
Single diploid colonies were inoculated into 2 mL selective media and incubated 
overnight in a rotating wheel at 30°C.  The culture was then resuspended in 2 
mL YPD and incubated overnight at 30°C. 0.3-0.5 mL of culture were extracted, 
washed twice in 5 mL sterile water, and were resuspended in 2 mL ESM.  
Cultures were incubated at 23°C for 3-5 days in a wheel, until tetrads of spores 
were visible. 
 
2.5 Tetrad dissection 
 
Sporulated culture was washed twice in sterile water and resuspended in 500 
μL sterile water.  20 μL of cells were incubated with 1.2 μL glusulase (Perkin 
Elmer) for 11-13 minutes at 30°C.  Digestion of the asci were monitored by 
microscopy.  Cells were resuspended in 1 mL water and 50 μL of cell 
suspension were applied, in a line, to a YPD plate and allowed to dry.  Standard 
tetrad dissection techniques were used, using a microscope with a 10X 
magnification lens and a microneedle to dissect spores onto YPD plates.  
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Spores were germinated at 23°C for 5 days before photographing and were 
then patched to YPD for replica-plating to appropriate selective media to 
determine genotype.  Spore viability was determined by counting the number of 
strains with a given genotype and by counting the number of spores (of the 
given genotype) that failed to germinate.  The genotypes of spores that failed to 
germinate were determined by inference from a group of three spores from a 
tetrad (the inference could be made in all cases) or from a group of two spores 
from a tetrad (the inference could be made in some cases where, for example, 
two out of four tetrads had the same genotype). 
 
2.6 Random spore analysis 
 
Spores were washed 3 times in sterile water.  The pellet was resuspended in 
0.5 ml Zymolyase-20T solution (1 mg/mL in sterile water) and 10 μL of β-
mercaptoethanol.  Cells were transferred to a 15 mL screw-cap conical tube 
incubated overnight at 30°C on a wheel to preferentially lyse the diploid cells. 5 
ml of 1.5% (v/v) NP-40 were added and cells were vortexed.  Spores were 
pelleted at 3000 rpm for 5 minutes.  Most of the supernatant was poured off, 
leaving 1 mL.  Spores were resuspended in the remaining 1 mL and transferred 
to a 1.5mL microcentrifuge tube.  Samples were incubated on ice for 15 minutes 
and were then sonicated (Sanyo Soniprep) on ice for 30 seconds at 10 microns 
power.  Samples were cooled on ice and sonicated again as before.  Spores 
were centrifuged for 30 seconds at 13,000 rpm and the supernatant was 
removed.  Spores were resuspended in 1 mL of 1.5% (v/v) NP-40 and were 
vortexed and sonicated twice as before.  Spores were centrifuged for 30 
seconds at 13,000 rpm.  The supernatant was removed and spores were 
resuspended in 1 mL sterile water and vortexed.  Spores were sonicated once 
as before and a 1/10 dilution was counted using a haemocytometer.  Spore 
suspensions were diluted to 1000 spores/mL and 100 μL spores were plated 
onto YPD (or appropriate selective media if spores contained a plasmid).  
Spores were germinated at 23°C for 5 days then strains were patched out onto 
YPD (or selective media if spores contained a plasmid).  Strains were 
genotyped by replica-plating to selective media. 
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2.7 Growth assay ('spot-testing') 
 
Cultures were inoculated from YPD plates into 2 mL YPD (or selective media if 
the strain had a plasmid) and incubated in a wheel at 23°C if temperature 
sensitive, otherwise 30°C, until saturated.  Serial 1 in 6 dilutions in water were 
performed using a 96-well plate and multichannel pipette.  Dilutions were 
spotted onto agar plates, YPD or selective media as appropriate, using either a 
sterilised 8 x 6 pin tool (Sigma Aldrich) for round plates or a sterilised 8 x 12 pin 
tool (Sigma Aldrich) for rectangular plates. Plates were incubated at 23°C or a 
range of temperatures, as appropriate, for 3 days. 
 
For growth assays where a strain expressed two plasmids (i.e. RIF1-URA3 and 
mutant alleles of RIF1 on a TRP1 plasmid), culture densities were equalised by 
counting with a haemocytometer and diluting down to 2 x 107 cells/mL in 
selective media (i.e. –TRP –URA) and samples were sonicated for 30 seconds 
(5 microns power, 6 seconds; Sanyo Soniprep) prior to spotting.  Plates were 
incubated for 5 days at 23°C before photographing. 
 
2.8 Genomic DNA preparation 
 
For polymerase chain reaction (PCR), genomic DNA was prepared using 
phenol extraction using the Dewar and Lydall (2012b) method.  2 mL of 
stationary phase culture were washed twice in water and the cell pellets were 
stored at -80°C.  Pellets were thawed and resuspended in 400 μL of lysis buffer 
(2% (v/v) Triton X-100, 1% (w/v) SDS, 100 mM NaCl, 10 mM Tris–HCl, pH 8.0, 
100 mM EDTA, pH 8.0) and 0.6 g glass beads were added.  400 μL 
phenol:chlorofom:isoamyl alcohol (25:24:1, v/v/v) were added and cells were 
lysed using a Precellys 24 ribolyser on 5.5 power setting for 6 x 10 seconds (2 
minutes pause where samples chilled on ice water between each 10 second 
lysis).  400 μL Tris-EDTA (10 mM Tris–HCl, pH 8.0, 1 mM EDTA pH 8.0) were 
added and samples were spun at 13,000 rpm, 4°C, for 5 minutes to separate 
aqueous and organic phases.  2 mL light phase lock gel tubes (5-Prime) were 
centrifuged at 13,000 rpm for 1 minute.  750 μL of aqueous phase were 
transferred to the phase lock tubes and 750 μL phenol:chlorofom:isoamyl 
alcohol (25:24:1, v/v/v) were added.  Tubes were centrifuged at 13,000 rpm for 
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5 minutes.  The aqueous (upper) phase were transferred to a 2 mL 
microcentrifuge tube and 100% (v/v) ethanol was added to fill the tube.  Tubes 
were left for 5 minutes at room temperature.  Nucleic acids were harvested by 
centrifuging at 13,000 rpm for 3 minutes.  The pellet was air-dried for 5 minutes 
and was then resuspended in 806 μL TE/RNAse solution (7.5 μg/mL RNAseA) 
with incubation at 37°C for 30 minutes.  26 μL of 3 M sodium acetate (pH 5.2) 
were added along with 100% (v/v) ethanol (to fill the tube) to precipitate DNA for 
15 minutes.  DNA was harvested by centrifugation at 13,000 rpm for 3 minutes 
and pellets were air-dried.  DNA was resuspended in 40 μL TE and incubated at 
37 °C for 20 minutes.  DNA yield and purity was determined using a Nanodrop 
2000 (Thermo Scientific).  
 
For Southern blotting and also PCR, genomic DNA was prepared using the 
Yale method (Maringele and Lydall, 2004).  2 mL saturated cultures were spun 
down, resuspended in 250 μL of 0.1M EDTA (pH7.5), 1:1000 β-
mercaptoethanol and 2.5 mg/mL zymolyase 20T (Sigma Aldrich) and incubated 
at 37°C for one hour.  55 μL of 0.25M EDTA (pH 8.5), 0.5M Tris, 2.5% (w/v) 
SDS) were added and samples were incubated at 65°C for 30 minutes.  68 μL 
of 5M potassium acetate (KAc) were added and samples were incubated on ice 
for 30 minutes.  Samples were spun for 20 minutes at 13,000 rpm and the 
supernatant transferred to a new tube, which was filled with 100% (v/v) ethanol.  
Samples were inverted and spun for 10 minutes as before.  The supernatant 
was removed and pellets were briefly dried before being resuspended in 130 μL 
TE containing 1 mg/mL RNAase A and incubated at 37°C for 35 minutes.  150 
μL isopropanol were added, samples were inverted and spun for 20 minutes as 
before.  Samples were washed with 100 μL 70% (v/v) ethanol by centrifuging 
for 5 minutes as before.  The ethanol was removed and pellets were dried for 
30 minutes.  Pellets were resuspended in 40 μL TE by incubation at 37°C for 30 
minutes.   
 
2.9 Genomic/Plasmid DNA PCR 
 
PCR was performed using genomic DNA or plasmid DNA for gene/cassette 
amplification.  Oligonucleotides used for PCR are listed in Appendix D.  Primers 
used for gene amplification from genomic DNA were 500bp upstream and 
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downstream of the target gene.  Primers for amplification from plasmid DNA 
had 20bp homology upstream/downstream of the target plasmid insert and 
40bp homology to the genomic DNA site in which the target plasmid DNA was 
to be inserted.  20 μL PCR reactions using genomic or plasmid DNA comprised 
0.3 μM each primer, 0.5 units ExTaq polymerase (TaKaRa Bio Inc), 0.2 mM 
dNTPs, 1x ExTaq buffer, 4 ng genomic or plasmid DNA and molecular-biology 
grade water.  PCR conditions were 5 minutes 95°C, 35 cycles of 94°C (1 
minute) 55°C (1 minute) 72°C (1 minute per kb DNA amplified), then 10 minutes 
72°C.  The size of PCR products were verified by running samples on 1% (w/v) 
agarose gels made with 0.5x Tris-Borate-EDTA pH 8.3 (Bio-Rad) and 1x SyBr 
Safe (1/10,000 dilution; Life Technologies).  Gels were imaged using a FujiFilm 
LAS Image 4000.  If to be subsequently used for transformation, PCR products 
were pooled and purified using a QIAquick PCR purification kit (Qiagen), 
otherwise products were used without purification.   
 
2.10 Colony PCR 
 
Colony PCR was used to confirm antibiotic/amino acid marker integration after 
lithium acetate transformation (see below).  PCR primers were designed such 
that the forward primer was within the inserted marker and the reverse primer 
was around 800bp downstream of the insert location. 10 μL PCR reactions 
using fresh colonies comprised 0.3 μM each primer, 25 mM MgCl2, 0.5 units 
GoTaq HotStart polymerase (Promega), 0.25 mM dNTPs, 1x green GoTaq 
buffer, 1 μL cell suspension (in sterile water) and molecular biology-grade 
water.  PCR conditions were 15 minutes 95°C, 35 cycles of 94°C (1 minute) 
55°C (1 minute) 72°C (1 minute per kb DNA amplified), then 10 minutes 72°C.  
The size of PCR products were verified by running samples on 1% (w/v) 
agarose gels made with 0.5x tris-borate-EDTA pH 8.3 (TBE: Bio-Rad) and 1x 
SyBr Safe (Life Technologies).  Gels were imaged using a FujiFilm LAS Image 
4000. 
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2.11 Lithium acetate transformation 
 
Single colonies were inoculated into 2 mL YPD and incubated overnight in a 
wheel at 23°C (if temperature-sensitive) or 30°C.  1 mL of culture was added to 
49 mL YPD and cultures were incubated in a shaking water bath at 23°C/30°C 
until the cell concentration was 2 x 107 cells/mL.  Cultures were washed once in 
25 mL water and were resuspended in 1 mL 100 mM lithium acetate pH 7.5 
(LiAc).  The cell pellet was resuspended in 100 mM LiAc to a final concentration 
of 2 x 109 cells/mL.  The cell suspension was divided into 50 μL aliquots, cells 
were spun down and the supernatant removed.  The following were added to 
the cell pellets: 240 μL 50% (v/v) polyethylene glycol (PEG)-4000, 36 μL 1 M 
LiAc pH 7.5, 50 μL salmon sperm DNA (2 mg/mL), 30 μL purified PCR product 
or linearised vector (60 ng/μL), 20 μL water.  50 μL water were used for a no-
DNA control. Cells were resuspended and incubated at 23°C for 30 minutes.  
Cells were heat-shocked at 42°C for 20 minutes and then spun down and 
resuspended in 200 μL sterile water.  Cells were plated onto appropriate 
selective media and incubated at 23°C /30°C until single colonies were visible.  
If strains were transformed with an antiobiotic-resistance marker (e.g. KANMX, 
HPHMX or NATMX), transformants were grown on YPD plates overnight before 
replica-plating to media containing the appropriate antibiotic.  Individual 
colonies were picked and streaked for single colonies on selective media.  A 
single colony was picked and patched onto selective media.  Transformants 
were verified by colony PCR as described above. 
 
2.12 Gene deletion 
 
Forward primers contained 40bp homology to immediately upstream of the 
gene start codon and 20bp homology to a plasmid containing an antibiotic 
resistance or auxotrophy marker (pAG25 or pAG32, details in Appendix C).  
Reverse primers contained 40bp homology to immediately downstream of the 
gene stop codon and 20bp homology to the same plasmid as before.  
Alternatively, genomic DNA was prepared as described below and PCR primers 
homologous to 500 bp upstream and downstream of a single gene deletion 
mutant from the Synthetic Gene Deletion Library, Version 4 (Tong et al., 2001) 
were used.  PCR was conducted as above.  PCR products were pooled and 
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purified in 30μL molecular biology-grade water using a PCR purification kit 
(Qiagen).  30μL of purified PCR product were used for LiAc transformation of 
the required yeast strain, as described above.  Transformants were plated onto 
selective media (or YPD overnight then replica-plated to selective media if 
transformed with an antibiotic resistance marker).  Transformant colonies were 
streaked for single colonies on selective media.  Single colonies were picked 
and checked for correct insertion of the deletion cassette by colony PCR (as 
described above), using a forward primer recognising inside the deletion 
cassette and a reverse primer recognising 600+bp downstream of the gene that 
had been deleted. 
 
2.13 Epitope tagging 
 
Forward primers contained 40 bp homology to immediately upstream of the 
gene stop codon and 20 bp homology to a plasmid containing an epitope tag 
with an antibiotic resistance or auxotrophy marker (Longtine et al., 1998).  
Reverse primers contained 40 bp homology to immediately downstream of the 
gene stop codon and 20 bp homology to the same plasmid as before.  PCR 
using the tagging plasmids was conducted as above.  LiAc transformation of 
yeast strains, transformant selection and verification was conducted as above.  
Transformants were further verified using Western blot (see below). 
 
2.14 In vivo cloning 
 
0.3-1 μg plasmid vector were cut with 10 units of appropriate restriction 
enzymes (New England Biolabs), 2 μL 10x bovine serum albumin (BSA; New 
England Biolabs), 4 μL 5x NEBuffer4 (New England Biolabs) and 10 μL water 
(20 μL total volume).  Digestion was confirmed by running cut and uncut vector 
on a 1% (w/v) agarose gel made with 0.5x TBE (Bio-Rad) and stained with 1x 
Sybr Safe (Life Technologies). 
 
The vector insert was obtained by PCR (described above) using genomic DNA 
from a wild-type strain (DLY640) and primers to amplify ±500 bp upstream and 
downstream side of the target gene (for genes expressed under native 
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promoter).  Alternatively, primers contained 40bp homology to the linearised 
plasmid vector and 20 bp homology to the target gene (forward primer starting 
at the initial ATG and reverse primer starting from the stop codon). 
 
The LiAc method of transformation was used (see above) except 20 μL purified 
PCR product (60 ng/μL), 12.5 μL digested plasmid (300 ng/μL), 17.5 μL water 
were used in the transformation.  A no-DNA control contained 50 μL water and 
no plasmid.  A vector control contained 12.5 μL digested plasmid and 37.5 μL 
water. Transformant selection and verification was conducted as described 
above.  
 
2 mL saturated cultures of transformants were centrifuged at 3000 x g for 5 
minutes and resuspended in 100 μL STET (8% (v/v) sucrose, 50 mM Tris-HCl 
pH 8, 50 mM EDTA pH 8, 5% (v/v) Triton X-100).  0.2g glass beads were added 
and samples were vortexed for 5 minutes.  100 μL STET were added and 
samples were incubated at 100°C for 3 minutes then cooled on ice.  Samples 
were centrifuged at 13,000 rpm for 10 minutes at 4°C.  The top 100 μL were 
transferred to 50 μL 7.5 M ammonium acetate and samples were freeze-
precipitated at -20°C for 1 hour.  Samples were centrifuged at 13,000 rpm for 10 
minutes at 4°C and 100 μL were transferred to 200 μL ice-cold ethanol (100% 
v/v).  Samples were centrifuged at 13,000 rpm for 10 minutes.  Pellets were 
resuspended in 300 μL 70% (v/v) ethanol and were centrifuged for 5 minutes at 
13,000 rpm.  DNA pellets were air-dried for 5 minutes and then resuspended in 
30 μL water.  100 µL E.coli DH5α competent cells were transformed with 15 μL 
of plasmid DNA (300 ng/μL).  Cells and DNA were incubated on ice for 20 
minutes in 14 mL round-bottomed tubes.  Cells were heat-shocked in a 42°C 
water bath for 45 seconds and then incubated on ice for 5 minutes.  0.9 mL pre-
warmed (42°C) SOC medium (20g Bactotryptone, 5g yeast extract, 0.585 g 
NaCl, 0.166 g KCl, 10 mL 1M MgCl2, 10 mL 1M MgSO4, 3.6g glucose, in 1 litre) 
were added to the cells, which were then incubated in a rotating wheel for 30 
minutes at 37°C.  Cells were then transferred to 1.5 mL microcentrifuge tube 
and spun for 5 minutes at 5,000 rpm.  750 µL of supernatant were removed and 
the cells were resuspended by gentle pipetting in the remaining supernatant.  
Cells were spread onto LB+ampicillin plates (10 g Bactopeptone, 5 g yeast 
extract, 10 g NaCl, 20 g agar, 100 mg Ampicillin, in 1 litre) and incubated 
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overnight at 37°C. Transformants were inoculated into 5 mL LB + ampicillin 
(100 mg/L) and incubated overnight at 37°C.  Plasmid DNA was recovered 
using a QIAprep Spin Miniprep Kit (Qiagen).   
 
Plasmids were verified by restriction digest, 0.2 μg plasmid DNA were cut with 
10 units restriction enzyme (New England Biolabs), 1x restriction enzyme buffer 
(New England Biolabs), 1x BSA and sterile water.  Digests were incubated at 
37°C (or other temperature, as appropriate for enzyme) for 2-3 hours. Samples 
were run on a 1% (w/v) agarose gel made with 0.5x TBE (Bio-Rad) 1x Sybr 
Safe (Life Technologies). 
 
2.15 In vitro cloning 
 
2.5 µg plasmid vector DNA were cut with 15 units of the appropriate restriction 
enzyme (New England Biolabs) and the appropriate restriction enzyme buffer 
(New England Biolabs) in a 20 µL volume digest for 90 minutes at 37°C.  2.5 µg 
plasmid DNA containing the required insert were digested as before.  Then 2.2 
µL 10x CIP phosphatase (New England Biolabs) were added to the digested 
vector. 1 µL of each digest was run on a 1% (w/v) agarose gel made with 0.5x 
TBE (Bio-Rad) and 1x SyBr Safe (Life Technologies) to check that the digest 
was complete.  The cut vector and insert bands were removed from the gel 
using a scalpel and a SafeLight box (Life Technologies).  DNA was purified from 
the gel using a Biomiga Gel Purification kit.  Vector and insert were ligated by 
adding 400 units T4 DNA ligase (New England Biolabs) to 2 µL purified vector 
and 6 µL purified insert in a 10 µL reaction containing 1x T4 DNA ligase buffer 
(New England Biolabs).  Ligation was carried out by incubating for 1 hour at 
16°C (sticky ends) or overnight at 16°C (blunt ends).  Digested vector-only and 
insert-only ligations were performed as negative controls.  5 µL of the ligated 
DNA was transformed into 100 µL E.coli DH5α competent cells as in 2.14, 
above. 
 
2.16 Transformation of plasmids into budding yeast 
 
Fresh cells were scraped from an agar plate using a toothpick end and 
 45 
resuspended in 100 µL of one-step buffer (0.2M LiAc, 40% (v/v) PEG, 100 mM 
DL-dithiolthreitol (DTT)).  300 ng of plasmid DNA were added along with 5.3 µL 
salmon sperm DNA (10 mg/mL), boiled at 100°C for 5 minutes then cooled 
rapidly in iced water) and the cells were vortexed.  Cells were incubated at 45°C 
for 30 minutes and were then plated onto the appropriate selective media.  
Transformants were streaked for single colonies and a single colony was picked 
for further experiments. 
 
2.17 Southern blotting 
 
10 μL plasmid pDL987, containing 120bp of TG repeats and 752bp of the 
upstream Y' element from telomere VIII-R, were cut with 10 units BamHI and 10 
units XhoI in a 20 μL digest containing 2 μL 10x NEBuffer 4, 2 μL 10x BSA, 5μL 
sterile water.  The plasmid was digested for 2-3 hours at 37°C.  Digested 
plasmid was run on a 1% (w/v) agarose gel made with 0.5x TBE and 1x Sybr 
Safe (Life Technlogies) and the 1kb band, containing the TG repeats and Y' 
element, was cut out to use as the Southern blot probe.  Probe DNA was 
purified from the agarose using a Qiaprep Gel Extraction Kit (Qiagen).  The 
probe was Digoxygenin-dUTP (DIG) labelled using random oligonucleotide 
primers as per the DIG High Prime Labelling and Detection Starter Kit II 
(Roche). 
 
2.5 μL of DNA (prepared by the Yale method) was run on a 1% (w/v) agarose 
gel made with 0.5x TBE (Bio-Rad) and 1x Sybr Safe (Life Technologies) and 
samples were equalized for loading using ImageJ analysis of band intensity.  
2.5 μL equalized DNA were digested with 0.5 μL XhoI (20 units/μL), 2 μL 5x 
NEBuffer 4, 1 μL 10x BSA, 4 μL water for 3 hours at 37°C.  Samples were run 
on a 1% (w/v) agarose gel (made with 0.5x TBE (Bio-Rad) and 1x SybrSafe 
(Life Technologies)) at 22 volts for 15 hours 30 minutes.  The gel was 
photographed using a Fuji LAS 4000 imager to determine loading.  The gel was 
depurinated in 0.25M hydrochloric acid for 15 minutes, rinsed twice in sterile 
water then denatured in 0.5M sodium hydroxide for 30 minutes. The gel was 
blotted to positively-charged nylon membrane (Roche) using a vacuum blotter 
(Model 785, BioRad) at 5 inches Hg in 10x saline-sodium citrate (SSC; 0.15M 
sodium citrate; 1.5M NaCl) for 90 minutes.  DNA was cross-linked to the wet 
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membrane using auto UV cross-linking (Stratalinker).  The membrane was 
rinsed briefly in sterile water and allowed to air-dry.  The probe was hybridized 
to the membrane using the labelled probe and the DIG High Prime Labelling 
and Detection Starter Kit II (Roche).  The probe was detected using the same 
kit and the membrane was imaged using a Fuji LAS 4000 imager for 
chemiluminescence, for 20 minutes. 
 
2.18 Quantitative reverse transcriptase PCR 
 
RNA was isolated as follows.  25 mL of exponentially growing yeast culture 
were centrifuged for 2 minutes and 3,000 rpm at 4°C.  The supernatant was 
removed, cells were resuspended in 0.5 mL ice-cold diethyl pyrocarbonate 
(DEPC)-treated water (Sigma Aldrich) and transferred to a 1.5 mL 
microcentrifuge tube.   Samples were centrifuged for 30 seconds at 13,000 rpm 
in a benchtop centrifuge, the supernatant was removed and the cell pellet was 
washed again in 0.5 mL DEPC-treated water.  Samples were centrifuged for 30 
seconds at 13,000 rpm and the supernatant was removed completely.  Pellets 
were frozen at -80°C.  Pellets were thawed on ice for 1 hour and then 
resuspended in 300 μL RNA buffer (0.5M NaCl, 0.2M Tris-HCl pH 7.5, 10 mM 
EDTA pH 8.0).  The cell suspension was transferred to a 2 mL skirted screw 
cap tube containing 200 μg acid-washed glass beads (ice cold).  300 μL 
phenol:chloroform:isoamyl alcohol (25:24:1 (v/v/v)) saturated with RNA buffer 
were added and the samples were mixed with the beads by inverting the tube 
gently.  Cells were lysed in a Precellys 24 ribolyser (Bertin Technologies) using 
two cycles of 30 seconds at 6500 rpm with a 15 seconds pause between 
cycles.  Samples were centrifuged at 13,000 rpm for 1 minute at 4°C in a 
benchtop centrifuge.  The upper phase was transferred to a new 1.5 mL 
microcentrifuge tube and 300 μL phenol:chloroform:isoamyl alcohol (25:24:1 
(v/v/v)) saturated with RNA buffer were added.  Samples were vortexed briefly 
then centrifuged for 1 minute at 13,000 rpm at 4°C.  The upper phase was 
transferred to a new 1.5 mL microcentrifuge tube and 900 μL of 100% (v/v) 
ethanol were added.  Samples were incubated at -80°C for 2 hours and were 
then centrifuged for 2 minutes at 13,000 rpm at 4°C.  The supernatant was 
removed and the sample was centrifuged for 10 seconds at 4°C and the 
remaining supernatant was removed.  Pellets were air-dried for 15 minutes then 
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the RNA was dissolved in 50 μL RNAse-free water (Gibco).  RNA 
concentrations were determined using the Nanodrop 2000 (Thermo Scientific).  
A 1/50 dilution of each RNA sample was run on a 1% (w/v) 0.5x TBE (Bio-Rad) 
agarose gel containing 1 x SyBr Safe (Life Technologies) to verify the integrity 
of the RNA and the presence of the 28S and 18S ribosomal RNA bands. 
 
100 μg of RNA sample was made up to 100 μL volume by adding the 
appropriate amount of RNAse-free water.  Samples were purified by column 
using the Qiagen RNEasy Mini kit, following the RNA Cleanup protocol.  RNA 
samples were eluted in 30 μL RNAse free water, the eluate was then re-applied 
to the column and eluted again to maximize RNA concentration.  RNA 
concentrations were determined using the Nanodrop 2000 (Thermo Scientific) 
and samples were diluted to 1 μg/μL.  5 μL of 1 μg/μL RNA sample were 
digested with 1 unit of DNAse I (Amplification Grade; Life Technologies), 2 μL 
10X DNAse I buffer (Life Technologies) and 10 μL DEPC-treated water (Sigma 
Aldrich), at 37°C for 30 minutes.  The digestion was stopped by adding 2 μL of 
25 mM EDTA pH 7.5 (Life Technologies) and incubating samples at 65°C for 10 
minutes in a heat block.  40 μL of DEPC-treated water (Sigma Aldrich) were 
added to each sample to make a final RNA concentration of 82 ng/μL.   
 
RNA transcript levels were analysed by quantitative reverse-trancriptase PCR 
(qRT-PCR), using the Superscript III Platinum SyBr green one-step qRT-PCR 
kit (Life Technologies) and an ABI Systems StepOne Plus thermocycler.  
Primers were used that amplified a 100bp region within the gene of interest and 
measurements were performed in triplicate for each sample.  The qRT-PCR 
mastermix per reaction contained 0.2 μL Superscript III Platinum Taq Mix, 5 μL 
2x SyBr Green Reaction Mix, 0.2 μL forward primer (10 μM), 0.2 μL reverse 
primer (10 μM), 0.2 μL ROX reference dye and 0.2 μL DEPC-treated water 
(Sigma Aldrich).  Per reaction, 6 μL master mix were added to 4 μL RNA 
sample (82 ng/μL) in a 96-well reaction plate.  The no-template control 
contained 4 μL DEPC-treated water (Sigma Aldrich) instead of RNA.  A 
standard curve of DNA concentrations was generated from 2 ng/μL, 0.2 ng/μL 
and 0.02 ng/μL wild-type (DLY640) genomic DNA standards.  6 μL master mix 
were added to 4 μL of genomic DNA standard and each standard was 
measured in triplicate.  The qRT-PCR programme was 50°C for 3 minutes, 
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95°C for 5 minutes, 40 cycles of 95°C for 15 seconds and 60°C for 30 seconds, 
then 40°C for 1 minute followed by melting curve analysis, using an ABI 
Systems StepOnePlus thermal cycler.  As a loading control, RNA 
concentrations were normalized according to BUD6 mRNA expression levels. 
 
2.19 Chromatin immunoprecipitation (ChIP) 
 
Strains were inoculated into 2 mL YPD and incubated at 23°C or 30°C (as 
appropriate for the strain) overnight in a wheel.  The following evening, 5-20L 
of overnight culture were added to 100 mL YPD and incubated at 23°C or 30°C 
overnight.  In the morning, cultures were diluted to 2.5 x 106 cells/mL and grown 
at the same temperature until 1 x 107 cells/mL.   
 
For chromatin immunoprecipitation (ChIP) of Cdc13-Myc, Stn1-Myc and Ten1-
Myc, strains 40 mL culture were washed twice with either 40 mL tris-buffered 
saline pH7.5 (TBS) (1.5 M sodium chloride, 100 mM Tris-HCl pH 7.5) or 
phosphate-buffered saline pH 7.5 (PBS) when ethylene glycol-bis(succinic acid 
N-hydroxysuccinimide ester) (EGS) was used as an additional crosslinking 
agent.  Cells were resuspended in 40 mL TBS, then mixed with 1.1 mL 36.5% 
(w/v) formaldehyde (Sigma) and incubated at room temperature for 15 minutes.  
For ChIP of Stn1-Myc and Ten1-Myc, 160 μL of 500 mM EGS (Pierce) in 
dimethyl sulfoxide (DMSO; Sigma Aldrich) were also added and cultures were 
incubated at room temperature for 30 minutes, prior to crosslinking with 
formaldehyde.  6 mL of 2.5 M glycine were added to quench the formaldehyde 
and samples were incubated for 5 minutes at room temperature.   
 
Samples were then spun for 5 minutes at 3000 rpm at 4°C and the supernatant 
was discarded.  Cell pellets were washed twice in 20-40 mL ice-cold TBS and 
spun at 3000 rpm at 4°C for 5 minutes.  The supernatant was poured off and 
samples were resuspended in the residual supernatant before being transferred 
to a 2 mL Sarstedt tube.  Tubes were spun for 1 minute at 13,000 rpm at 4°C 
and the supernatant was discarded.  Cell pellets were frozen at -80°C.  
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Protein G dynabeads (Life Technologies; 30 μL per immunoprecipitation) were 
washed twice in 500 μL PBS-BSA (125 mg BSA fraction V (Sigma Aldrich)/25 
mL PBS) and resuspended in a volume of PBS 1.15x the initial volume of 
beads.  1.8-5 μg antibody per 30 μL dynabeads were added and beads were 
incubated overnight in a wheel at 4°C.  Antibodies used were: for ChIP of Myc-
tagged proteins, monoclonal mouse anti-c-myc 9E10 (AbCam, ab32; 1.8 μg/30 
mL dynabeads); for ChIP of RPA, rabbit polyclonal anti-Saccharomyces 
cerevisiae RPA (Agrisera, AS07 214; 5 μg/30 uL dynabeads).  For all ChIPs 
rabbit anti goat IgG (Abcam, ab97096; 1.8 μg or 5 μg) was used as a non-
specific antibody control. 
 
Cell pellets were thawed on ice for 30 minutes. Pellets from 40 mL cultures 
were resuspended in 1000 μL of lysis buffer (20 mM Hepes-KOH pH 7.5, 140 
mM NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 0.1% (w/v) Na-deoxycholate) 
and 5 μL of protease inhibitors (P1860, Sigma Aldrich).  Pellets from 20 mL 
cultures were resuspended in 500 μL lysis buffer and 2.5 μL protease inhibitors.  
Samples from 40 mL cultures were split into two 500 μL aliquots, one for 
specific antibody immunoprecipitation (IP) and one for non-specific antibody 
immunoprecipitation (background).  0.5 mL cold acid-washed glass beads (0.5 
mm) were added to the tubes and cells were ribolysed for three cycles of 6200 
rpm for 30 seconds, with a 3 minute pause on ice water between cycles 
(Precellys 24, Bertin Technologies).  The bottom of the tube was punctured 
using an incandescent needle (Microlance 3, Becton Dickinson) and placed in a 
1.5 mL microcentrifuge tube with the lid removed.  The tube assembly was 
placed in a 15 mL conical tube and samples were centrifuged at 1000 rpm for 1 
minute at 4°C.  The tube assembly was removed from the 15 mL conical  tube 
and the lid was replaced on the 1.5 mL microcentrifuge tube containing the 
sample.  Samples were vortexed briefly.  Samples were sonicated using a 
Bioruptor (Diagenode) for 4 x 5 minutes of 30 seconds off, 30 seconds on, 
highest power setting, to generate chromatin fragments of 100-200 bp.  
Samples were then spun for 5 minutes at 12,000 rpm, 4°C.  The supernatant 
(450 μL) was removed to a fresh 1.5 mL microcentrifuge tube and 10 μL were 
extracted for ‘input’ samples.  The input samples were stored at 4°C overnight.  
The remaining lysate (440 μL) was incubated with 30 μL of dynabeads/antibody 
overnight at 4°C in a wheel. 
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The following morning, samples were washed as follows (all buffers were ice-
cold): 
1x with 1 mL lysis buffer 
2x with 1 mL RIPA buffer  
(0.1% (w/v) SDS, 10mM Tris-HCl pH7.5, 1mM EDTA, 0.1% (w/v) 
sodium deoxycholate, 1% (v/v) Triton X-100) 
2x with 1 mL RIPA buffer containing 300mM NaCl 
2x LiCl buffer (0.25M LiCl, 0.5% (v/v) NP40, 0.5% (w/v) sodium 
deoxycholate)  
1x with 1 mL TE and 0.2% (v/v) Triton-X-100 
 
Washing consisted of holding the beads with a magnet, removing the 
supernatant with a vacuum pump, and resuspending the beads in the 
appropriate washing solution by inverting tubes 20 times.  After the final wash 
was removed, beads were resuspended in 200 μL of 10% (w/v) Chelex (Bio-
Rad) in sterile DNAse/RNAse free water (Sigma Aldrich).  Samples were boiled 
in a heat block at 100°C for 10 minutes and then cooled to room temperature.  
Samples were spun for 2000 rpm for 7 seconds and 2.5 μL proteinase K (10 
mg/mL) were added.  Samples were incubated for 30 minutes at 55°C and were 
then boiled for 10 minutes at 100°C to inactivate proteinase K.  Tubes were 
spun for 7 seconds at 2000 rpm and 120 μL of supernatant was extracted.  
 
qPCR was used to determine the relative expression levels of proteins of 
interest at the specific loci (primers amplified a 100-150bp region within the 
target gene) using an ABI Systems StepOne Plus thermocycler.  An internal 
control was PAC2 on chromosome III (primers M1367, M1368).  The qPCR 
reaction mix contained 5 μL Platinum SyBr Green qPCR SuperMix-UDG with 
ROX (Life Technologies), 0.2 μL forward primer (10 uM), 0.2 μL reverse primer 
(10 μM) and 2.6 μL sterile water.  2 μL DNA was added to 8 μL master mix in a 
96-well plate.  There were three replicates for each sample and a no template 
control contained 2 μL sterile water rather than DNA.  The qPCR programme 
was 50°C for 2 minutes, 95°C for 2 minutes, followed by 40 cycles of 95°C for 
15 seconds and 60 °C for 30 seconds, then a melting curve analysis, using an 
ABI Systems StepOnePlus thermal cycler.  The IP efficiency was defined as the 
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percentage of the input that was in the IP.  This percentage was calculated 
using the following formula: 2.273/2(IP CT – Input CT) (the value 2.273 was used 
since input was 10 μL, IP was 440 μL.  Ratio input:IP is 1:44; 100/44 = 2.273). 
 
2.20 Co-immunoprecipitation (Co-IP) 
 
Strains were inoculated into 2 mL YPD and incubated at 23°C or 30°C overnight 
in a wheel.  The following evening, a sufficient volume of overnight culture was 
added to 100 mL YPD and incubated at 23°C or 30°C overnight, so that 
cultures were in mid-log phase by the following morning.  25 mL of each culture 
were washed once in 25 mL ice-cold water, transferred to a 1.5 mL 
microcentrifuge tube and washed in 1 mL ice-cold water.  The supernatant was 
removed and samples were frozen at -80°C.  Cell pellets were resuspended in 
240 μL lysis buffer (as used for ChIP, above) with 5 μL protease inhibitors 
(P8215, Sigma Aldrich) and 5 μL 100 mM phenylmethylsulfonyl fluoride 
(PMSF).  0.5 mL cold acid-washed glass beads (0.5 mm) were added and cells 
were ribolysed for 4 cycles of 2 x 20 seconds, 20 second pause, 5000 rpm 
(Precellys 24, Bertin Technologies).  Samples were incubated for 2 minutes on 
ice water between cycles. The bottom of the tube was punctured using an 
incandescent needle (Microlance 3, Becton Dickinson) and placed in a 1.5 mL 
microcentrifuge tube with the lid removed.  The assembly was placed in a 15 
mL conical  tube and samples were centrifuged at 2000 rpm for 2 minutes at 
4°C.  Samples were washed with 125 μL of lysis buffer with protease inhibitors 
and PMSF (as before). The tube assembly was removed from the 15 mL 
conical  tube and the lid was replaced on the 1.5 mL microcentrifuge tube 
containing the sample.  Samples were spun at 13,000 rpm, 4°C, for 10 minutes 
and the supernatant was removed to a fresh tube (about 370 μL).  15 μL of cell 
lysate were taken for the ‘input’, to which 15 μL Laemmli buffer (Bio-Rad) with 
5% (v/v) β-mercaptoethanol were added.  Samples were boiled for 5 minutes at 
95°C, and then frozen at -20°C.  The remainder of the cell lysates were 
incubated with 5 μg of antibody (monoclonal mouse anti-c-myc antibody 9E10 
(Abcam, ab32) or rabbit polyclonal anti-HA (Abcam, ab9110), whilst 25 μL 
aliquots of protein G dynabeads (Life Technologies) were washed 3 x 10 
minutes in 250 μL lysis buffer on a wheel at 4°C.  Protein G dynabeads (Life 
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Technologies) were then combined with cell lysates and incubated overnight on 
a wheel at 4°C. 
 
The following morning, the cell lysate was removed from the beads using a 
magnet, and beads were washed 3 times by resuspending the beads in lysis 
buffer.  The final wash was removed and the beads were resuspended in 40 μL 
Laemmli buffer with 5% (v/v) β-mercaptoethanol (Bio-Rad).  The beads were 
then boiled at 95°C for 5 minutes in a heat block, and input samples were also 
reboiled at 95°C for 5 minutes.  10 μL of samples (input and immunoprecipitate) 
were loaded immediately onto a 7.5% (v/v) pre-cast SDS-PAGE gel (Bio-Rad 
Mini-Protean TGX) and run at 100V in Tris/Glycine/SDS running buffer (Bio-
Rad).  Gels were then western blotted (see below).   
 
After anti c-Myc immunoprecipitation, western blot membranes were incubated 
first overnight (4°C, shaking) with polyclonal rabbit anti Saccharomyces 
cerevisiae Rfa1, Rfa2 (AgriSera AS07214).  Antibody concentration was 2 μg in 
11 mL 1% (w/v) skimmed milk powder in PBS with 0.1% (v/v) Tween-20 
(PBST).  After anti-HA immunoprecipitation, blots were incubated with mouse 
anti-c-myc antibody 9E10 (Abcam, ab32 5 μg/11 mL 1% (w/v) milk-PBST).  
 
Membranes incubated with AS07214 were then probed with goat anti-rabbit-
horseradish peroxidase (HRP; Dako P0448; 2 μg/10 mL 1% (w/v) milk-PBST).  
Membranes that were incubated with ab325 were probed with goat anti-mouse-
HRP for two hours before detection (Dako P0447; 2 μg/10 mL 1% (w/v) milk-
PBST).  Before probing, membranes were washed for 2 x 5 minutes with PBST 
and were then incubated overnight (4°C, shaking) with the appropriate antibody 
solution, followed by chemiluminescent detection (see western blotting, below). 
 
2.21 Western blotting 
 
Proteins were extracted using TCA extraction (see below) or were produced 
from Co-IP (see above) and were suspended in Laemmli buffer with 5% (v/v) β-
mercaptoethanol (Bio-Rad).  Protein extracts were loaded onto a 7.5% (v/v) pre-
cast gel (Bio-Rad Mini-Protean TGX) and run at 100V in Tris/Glycine/SDS 
running buffer (Bio-Rad).  The gel was transferred by the wet-transfer method to 
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a nitrocellulose membrane (Amersham Hybond ECL) in ice-cold transfer buffer 
(Tris-Glycine (Bio-Rad) with 20% (v/v) ethanol) for 1.5 hours at 100V.  The 
membrane was washed in 50 mL 5% (w/v) milk-PBST (5% (w/v) skimmed milk 
powder dissolved in PBST) for 1 hour on a rocking stage at room temperature.  
The 5% (w/v) milk was removed and the membrane was covered with 11 mL 
1% (w/v) milk in PBST with 5 μg primary antibody, overnight on a rocking stage 
at 4°C.  The following morning the antibody solution was removed and the 
membrane was washed 4 x 15 minutes in PBST on a rocking stage.  The 
membrane was then covered with 10 mL 1% (w/v) milk in PBST and 2 μg HRP-
conjugated secondary antibody and was incubated for two hours at room 
temperature on a rocking stage.  The membrane was washed 4 x 15 minutes 
with PBST.  The membrane was removed from the PBST, laid on cling film, 
covered with 4 mL Thermo Scientific SuperSignal West Pico Chemiluminescent 
Substrate, covered with cling film and foil and incubated for 5 minutes.  The 
membrane was then imaged using a Fujifilm LAS 4000 with chemiluminescent 
detection. 
 
2.22 Trichloroacetic acid protein extraction 
 
25 mL mid log phase cells (1 x 107 cells/mL) were washed once with 25 mL 
water and resuspended in 2 mL water.  500 μL cells were centrifuged briefly (30 
seconds, 13,000 rpm) and resuspended in 500 μL 10% (w/v) trichloroacetic acid 
(TCA).  Cells were centrifuged as before and resuspended in 100 μL 10% (w/v) 
TCA.  An equal volume (100 μL) of glass beads was added.  Samples were 
vortexed for 4 minutes.  The supernatant was transferred to a fresh tube (50-
100 μL).  The beads were washed twice with 100 μL 10% (w/v) TCA, the 
supernatant was extracted and added to the existing extract.  Proteins were 
pelleted by centrifuging the sample at 13,000 rpm in a microcentrifuge for 10 
minutes (4C).  The supernatant was discarded.  100 μL Laemmli loading buffer 
with 5% (v/v) β-mercaptoethanol (Bio-Rad) were added to the protein pellet.  
The sample was neutralized by adding 40 μL 1M Tris.  The pellet was then 
resuspended by vortexing.  Samples were boiled for 3 minutes at 95°C using a 
heat block before being centrifuged at 3,000 rpm (4°C) for 10 minutes.  The 
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supernatant was removed to a fresh 2 mL skirted screw cap tube. 10 μL of 
sample was used for a Western blot.   
 
2.23 Synthetic Genetic Array 
 
All S. cerevisiae yeast strains used for synthetic genetic array (SGA) high-
throughput screens were in the S288C genetic background.  The two SGA 
screens carried out have references SGA153 (nmd2Δ exo1Δ cdc13Δ) and 
SGA156 (nmd2Δ exo1Δ).  The MATα query strain (containing the query 
mutations with NATMX, HPHMX, and LEU2 markers, the MATa-specific STE2 
promoter cassette can1delta::STE2pr-Sp_his5 and lyp1Δ) was cultured in YPD 
overnight at 23°C and spread onto YPD+clonNAT plates.  Plates were 
incubated for two days at 23°C until a lawn of query culture was visible.   All 
manipulations hereinafter described were conducted using a BM3 robot (S&P 
Robotics) and plates were photographed at each stage using a robotic plate 
imager (SPImager, S&P Robotics).  The query plates were then pinned to 18 
fresh YPD+clonNAT plates as 1536 individual colonies per plate and were 
incubated for 2 days at 20°C.  The MATa library of 5000 single deletion mutants 
(80% of all S. cerevisiae genes) and 842 strains where essential genes were 
depleted by mRNA perturbation (Decreased Abundance by mRNA Perturbation, 
DAmP) (Synthetic Deletion Library Version 4 (SDLV4); Tong and Boone, 2006) 
was pinned to YPD+G418 plates as 384 individual strains per plate and was 
incubated at 30°C for two days.  The library was then pinned as 1536 colonies 
per plate (4 replicates of each strain from each 384-format plate) onto 
YPD+G418 plates and were incubated for 2 days at 30°C.  The 1536-format 
query strains were then mated with the 1536-format library on YPD and diploids 
were formed during 24-48 hours at 23°C.  Diploids were then pinned to 
YPD+G418+clonNAT and incubated for 1.5 days at 30°C before being pinned 
to sporulation media (ESM+G418) and sporulated for 5 days at 23°C.  Plates 
were inspected visually for spore formation.  Spores were pinned sequentially 
(and incubated for 2 days at 20°C) to: 
 
 SD/MSG -HIS/ARG/LYS +canavanine/thialysine  
 SD/MSG -HIS/ARG/LYS +canavanine/thialysine  
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 SD/MSG -HIS/ARG/LYS +canavanine/thialysine/G418  
 SD/MSG -HIS/ARG/LYS/LEU +canavanine/thialysine/G418  
 SD/MSG -HIS/ARG/LYS/LEU +canavanine/thialysine/G418/hygromycin  
 SD/MSG -HIS/ARG/LYS/LEU 
+canavanine/thialysine/G418/hygromycin/clonNAT (final selection media) 
 
in order to select MATa haploids harbouring both the query and library mutation 
(HIS is histidine; ARG is arginine; LYS is lysine; LEU is leucine).  The robotic 
amino acid dropout recipe is given below.  Canavanine concentration was 50 
mg/L; thialysine concentration was 50 mg/L; G418 concentration was 200 mg/L; 
hygromycin concentration was 300 mg/L and clonNAT concentration was 100 
mg/L.  Photographs of the mutants on the final selection media were compared 
to a control SGA screen using a strain lacking the query mutation but 
harbouring NATMX, HPHMX, and LEU2 markers, the MATa-specific STE2 
promoter cassette can1delta::STE2pr-Sp_his5 and lyp1Δ.  Images were 
compared using COLONYZER image analysis software (Lawless et al., 2010) 
to generate a Genetic Interaction Score (GIS). 
 
Drop-out amino/nucleic acid recipe for robotic media 
Adenine    3g 
Inositol    2g 
Para-aminobenzoic acid  0.2g 
Alanine    2g 
Arginine    2g 
Asparagine    2g 
Aspartic Acid    2g 
Cysteine    2g 
Glutamic acid   2g 
Glutamine    2g 
Glycine    2g 
Histidine    2g 
Isoleucine    2g 
Leucine    10g 
Lysine     2g 
Methionine    2g 
Phenylalanine   2g 
Proline    2g 
Serine     2g 
Threonine    2g 
Tryptophan    2g 
Tyrosine    2g 
Valine     2g 
Uracil     2g  
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2.24 Growth of yeast strains in ethanol 
 
Single colonies of strains were grown overnight in 2 mL YPD at 30°C.  Cultures 
were counted, using a haemocytometer, and were used to inoculate 5 mL fresh 
YPD media (containing 0%, 1%, 3% or 5% (v/v) ethanol) at a density of 1 x 105 
cells/mL.  Cultures were grown in a wheel at 30°C until they had reached a 
density of 1 x 108 cells/mL (= 10 population doublings).  Fresh media was then 
inoculated with these cells at a density of 1 x 105 cells/mL.  Cells were then 
grown and passaged again as before.
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Chapter 3. Stn1 protects the telomere without Cdc13 
 
3.1 Viable cdc13 strains resemble telomerase-deficient survivors 
 
Cdc13 interacts with the Pol1 subunit of DNA Polymerase alpha and recruits 
telomerase via interaction with the Est1 subunit (Nugent et al., 1996; Qi and 
Zakian, 2000).  Moreover, Cdc13 may function as a loading complex for its 
partner proteins Stn1 and Ten1 since Stn1 fused to the Cdc13 DNA binding 
domain restores viability to a cdc13 strain, but has defective telomere 
replication because Cdc13 is required to load telomerase (Pennock et al., 2001; 
Mitton-Fry et al., 2004; Lewis et al., 2014).   Since Cdc13 recruits telomerase to 
extend the telomere end during replication, it is likely that in Cdc13 bypass cells 
(cdc13 nmd2 exo1 and/or rad24) there is no telomerase recruitment.  
Cells that lack telomerase undergo telomere shortening and lose viability, until a 
small proportion of cells begin to maintain telomeres by recombination and form 
either Type I or Type II survivors (Lundblad and Blackburn, 1993).  Viable 
cdc13 strains could be cultured for many passages and their fitness increased 
with passage (Holstein et al., 2014).  It was hypothesised therefore that Cdc13 
bypass cells would be deficient in telomerase recruitment and would therefore 
maintain telomeres by recombination.   
 
To test the hypothesis, telomere structure was determined for Cdc13 bypass 
strains after 1 and 9 passages.  Telomeres were examined using Southern 
blotting with a Y’ and TG repeat probe to detect terminal Y’ telomeres, internal 
Y’ elements and X telomeres (Figure 7 A; see also Figure 1 for a description of 
telomere subtypes).  Figure 7 B, lane 1 shows a wild-type telomere, lane 2 is 
telomere from a strain lacking telomerase (tlc1) and lane 3 is a telomerase-
deficient strain that has lost Y’ telomeres and has amplified TG repeats (a Type 
II survivor).  At passage 1, cdc13 strains have short Y’ telomeres (compare 
lanes 8-12 with lane 1) and their telomeres are similar to the corresponding 
CDC13 strains in lanes 4-6 (these are independent strains from those in lanes 
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8-18).  The CDC13 strains in lanes 4-6 all have short Y’ telomeres, most likely 
because they lack NMD2, which leads to short telomeres. 
 
After 9 passages, the telomeres of nmd2 exo1 cdc13 strains (lanes 15 and 
16) had amplified internal Y’ elements and had lost X telomeres.  The telomeres 
of these strains therefore bore some resemblance to Type I survivors, which 
amplify Y’ elements and lose X telomeres (Lundblad and Blackburn, 1993; 
Chen et al., 2001; Lydall, 2003).  However, Type I survivors lose TG1-3 repeats, 
which leads to very short Y’ telomeres.  In lanes 15 and 16 it is evident that 
there are both short and long TG1-3 tracts present in nmd2 exo1 cdc13 
strains.  nmd2 exo1 cdc13 strains may therefore be attempting to amplify 
TG1-3 repeats, perhaps in an attempt to switch to Type II recombination in which 
TG1-3 repeats are amplified.  Deletion of EXO1 in telomerase-deficient strains 
suppresses Type II survivor formation (Maringele and Lydall, 2004), therefore 
exo1 may cause nmd2 exo1 cdc13 strains to become Type I survivors due 
to defective telomerase recruitment in the absence of Cdc13. 
 
The telomeres of nmd2 rad24 cdc13 and nmd2 exo1 rad24 cdc13 
strains resembled those of Type II survivors (compare lanes 13-14 and 17-18 
with lane 3).  Interestingly, telomerase-deficient strains deleted for RAD24 have 
difficulty in forming Type II survivors (Grandin and Charbonneau, 2007) but 
nmd2 rad24 cdc13 still resemble Type II survivors.  Therefore, perhaps 
Rad24 control of telomere recombination is overridden in nmd2 rad24 
cdc13 and nmd2 exo1 rad24 cdc13 strains. 
 
Taking the telomere phenotypes of cdc13 strains together, there is evidence 
that may indicate that cdc13 strains prefer Type II telomere recombination.  
However, there is currently no evidence that nmd2 exo1 cdc13 strains 
switch to Type II recombination, only that their telomeres are not classical Type 
I survivors.  Therefore, future work should address whether nmd2 exo1 
cdc13 strains become Type II survivors, perhaps by passaging the strains for 
longer.  Also, examining the telomeres of a much larger number of independent 
cdc13 strains (over 50) would enable the survivor preference of the strains to 
be determined conclusively. 
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Figure 7. Telomeres of viable cdc13 strains resemble those of 
telomerase-deficient survivors 
(A) Diagram showing how XhoI digestion of genomic DNA and Y’ and TG1-3 
repeat probe generate Y’ telomere, X telomere and internal Y’ fragments for 
Southern blotting.  Information regarding XhoI digestion of telomeric DNA 
obtained from Makovets et al., 2008. (B) Genomic DNA was isolated from yeast 
strains indicated on the right.  Strains in lanes 9-10 and 11-12 are independent 
strains of the same genotype.  Strains in lanes 14-18 are the same strains in 8-
12 but passaged 9 times.  Telomere structures were analyzed by Southern 
blotting using the Y’ and TG probe indicated.  DNA was run on a 1% (w/v) 
agarose gel for Southern blotting was stained with SyBr Green and was used 
as a loading control.
 60 
 
3.2 Viable cdc13 strains can survive without telomerase 
 
Cdc13 bypass strains resembled telomerase-deficient survivors, therefore it 
was predicted that cdc13 strains would not require telomerase for viability.  To 
test this theory, a diploid heterozygous for NMD2, EXO1, RAD24, CDC13 and 
TLC1 deletions was sporulated and tetrads were dissected to obtain haploids.  
Viable cdc13 genotypes previously observed were viable in the absence of 
TLC1 (Figure 8 A).  Viable cdc13 tlc1 strains were passaged 9 times and 
viability increased with passage, similar to a tlc1 strain (Figure 8 B).  
Interestingly, tlc1 nmd2 rad24 cdc13 and tlc1 nmd2 exo1 cdc13 
strains had very low initial fitness and could not be grown to a sufficient density 
in liquid culture.  This contrasts with the fitness of the corresponding CDC13+ 
strains, which could be grown in liquid culture from the first passage. However, 
fitness improved with passage such that even passage 2 for these strains could 
be grown in liquid culture for Southern blotting (Figure 8 C, lanes 5 and 6).   
 
In Figure 8 C, the telomeres of cdc13 tlc1 strains (passage 1 or 2 and 
passage 9) were examined by Southern blotting, using the Y’ and TG1-3 probe 
described in Figure 7A.  cdc13 tlc1 strains showed dramatic telomere 
rearrangements by passage 9, similar to the equivalent TLC1+ strains (compare 
lanes 9-11, Figure 8 C, with lanes 13, 15 and 17, Figure 7 B).  However, cdc13 
tlc1 already showed dramatic telomere rearrangements at passage 1 or 2 
(Figure 8, lanes 5-7), whereas at passage 1 cdc13 TLC1 strains had short 
telomeres but did not yet exhibit dramatic telomere rearrangements (Figure 7 B, 
lanes 8, 9 and 11).  Presumably cdc13 tlc1 strains underwent earlier 
telomere rearrangements because of the lack of functional telomerase to 
maintain telomere length.   
 
nmd2 rad24 cdc13 tlc1  and nmd2 exo1 rad24 cdc13 tlc1 strains 
amplified TG repeats and resembled Type I survivors by passage 9, similar to 
the equivalent TLC1 strains (compare lanes 9 and 11, Figure 8, with lanes 13-
14 and 17-18, Figure 7).  The nmd2 exo1 cdc13 tlc1 strain amplified 
internal Y’ elements, contained no X telomeres, and compared to the equivalent 
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TLC1 strain had shorter tracts of Y’ telomeres with TG1-3 repeats (compare lane 
10, Figure 8, with lanes 15-16, Figure 7).  Therefore the nmd2 exo1 cdc13 
tlc1 strain more closely resembled a Type I survivor.  In conclusion, strains 
lacking Cdc13 can survive without telomerase and it is probable that telomere 
rearrangements, resulting from recombination and amplification of TG1-3 
repeats, allow telomerase-mediated telomere lengthening to be bypassed. 
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Figure 8. Viable cdc13 strains can survive without telomerase 
(A) A diploid heterozygous for TLC1, CDC13, NMD2, EXO1 and RAD24 
deletions was sporulated. Tetrads were dissected. Spores were allowed to form 
colonies for 5 days at 23°C before being photographed. Genotypes were 
determined by growth on appropriate selective plates. Viable cdc13 tlc1 
genotypes are given and the spore viability is shown in brackets. (B) Strains of 
the genotypes indicated on the right were repeatedly passaged every 4 days at 
23°C.  2 ml liquid cultures were grown overnight, serially diluted, spotted onto 
YPD plates and incubated for 2 days before being photographed. (C) Genomic 
DNA was isolated from yeast strains of the genotypes indicated (on the right) 
and telomere structures were analyzed by Southern blotting using the Y’ and 
TG1-3 probe as before (shown in Figure 7A). 
 64 
 
3.3 Cdc13 bypass is not dependent on Stn1 or Ten1 overexpression 
 
Stn1 and Ten1 are indispensable for cell survival in yeast (so far no genotypes 
allowing bypass of Stn1 or Ten1 have been discovered in either yeast or mice) 
but Cdc13 can be bypassed with certain genetic manipulations, which indicates 
that Stn1 and Ten1 may play essential roles in maintaining the viability of 
cdc13 strains. Stn1 may therefore carry out essential functions relating to 
telomere maintenance in the absence of a fully functional Cdc13, indeed it has 
been shown previously that overexpression of Stn1 and Ten1 together rescues 
the lethality of cdc13 (Petreaca et al., 2006).   
 
Given that deletion of NMD2 results in the overexpression of Stn1 and Ten1 
(Johansson et al., 2007), it was hypothesised that overexpression of Stn1 and 
Ten1 alone explained the viability of nmd2 exo1 cdc13, nmd2 rad24 
cdc13 and nmd2 exo1 rad24 cdc13 strains.  Another genetic background 
that permits CDC13 deletion, but not STN1 or TEN1 deletion, is pif1 exo1 
cdc13 (Dewar and Lydall, 2010; Holstein et al., 2014) so mRNA levels of 
STN1 and TEN1 in pif1, exo1 and pif1 exo1 strains were measured.  In all 
three genotypes STN1 and TEN1 mRNA levels were similar to wild-type levels, 
in contrast with nmd2 strains (Figure 9), therefore Cdc13 bypass is not 
dependent on high levels of STN1 and TEN1 mRNA.  However, future work 
needs to use western blotting to determine the expression levels of Stn1 and 
Ten1 proteins in pif1 exo1 strains, since protein expression and mRNA level 
are not necessarily linked. 
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Figure 9. STN1 and TEN1 mRNA are not overexpressed in a pif1 exo1 
background 
Quantitative reverse-transcriptase PCR analysis of Stn1 and Ten1 mRNA 
expression levels in the strains indicated.  All values were normalised to the 
control gene BUD6.  A single wild-type strain was given a value of 1 and all 
other strains were expressed relative to this value.  For each genotype, the 
mean of two independent strains is shown and error bars indicate the individual 
values for each strain. 
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3.4 The stoichiometry of CST components at telomeres can be altered 
 
Deletion of NMD2 increased the levels of STN1 and TEN1 mRNA (Figure 9) but 
it was unknown (in the published literature) whether increased expression of 
STN1 and TEN1 resulted in increased binding of Stn1 and Ten1 to the telomere 
end.  To assay levels of Cdc13, Stn1 and Ten1 telomere binding in wild-type 
and nmd2 cells, chromatin immunoprecipitation (ChIP) was used to detect 
Stn1 and Ten1 binding to telomeric DNA.  ChIP showed that Cdc13, Stn1 and 
Ten1 were bound to the end of the telomere of Chr. VI-R in a wild-type strain 
(Figure 10).  Cdc13 has a much stronger ChIP signal than Stn1 and Ten1 in a 
wild-type strain, perhaps because it is a larger protein and also perhaps 
because it binds more tightly to ssDNA than Stn1 and Ten1 (therefore 
formaldehyde crosslinking to DNA is more effective).   
 
In the absence of Nmd2, telomeric Cdc13 binding was only increased 1.8-fold, 
whereas Stn1 and Ten1 binding was increased 9-fold and 6-fold, respectively 
(Figure 10).  Cdc13 is not known to be overexpressed in the absence of Nmd2 
(Johansson et al., 2007) but the slight increase in binding could indicate that 
increased Stn1 and Ten1 levels lead to a marginal increase in Cdc13 
recruitment.  Stn1 and Ten1 binding to the telomere increased dramatically in 
the absence of Nmd2 and this could simply be a result of overexpression.  An 
alternative explanation is that nmd2 are known to have short telomeres (Figure 
18, lane 5), therefore short telomeres may recruit higher levels of replication 
factors such as CST.  However, since telomerase extends telomeres and 
Cdc13 recruits telomerase, it is surprising that Cdc13 is not more highly 
enriched at telomeres in the absence of Nmd2.  Also, Stn1 represses 
telomerase recruitment therefore increased binding of Stn1 may actually explain 
why nmd2 cells have short telomeres. 
 
It is possible that because the qPCR primers used recognise a unique 
sequence just upstream of the TG1-3 repeats, this amplifies the qPCR signal 
when telomeres are short.  This may be due to sonication of chromatin to 600bp 
fragments, in the ChIP protocol, which may increase the likelihood of obtaining 
fragments with TG1-3 repeats and the unique upstream sequence.  However, 
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Cdc13 levels are not known to increase in nmd2 cells and the increase in 
Cdc13 enrichment at nmd2 telomeres is less than twofold. This suggests that 
there may be a minor effect of the qPCR locus at short telomeres, but this does 
not wholly explain the large increases in telomeric Stn1 and Ten1. 
 
Another explanation why increased telomeric Stn1 and Ten1 is seen in the 
absence Nmd2 is that nmd2 cells have an extended S-phase, the time at 
which CST is recruited to the telomere to facilitate replication.  However, Stn1 is 
overexpressed in the absence of Nmd2 (Addinall et al., 2011) and Stn1 
overexpression overrides S-phase checkpoint signals (Gasparyan et al., 2009), 
therefore it seems unlikely that nmd2 cells would have an extended S-phase.  
On the other hand, human cells arrest in S-phase when the NMD factor UPF1 is 
depleted (Azzalin and Lingner, 2006), therefore it would be informative to 
subject yeast nmd2 cells to FACS analysis to see whether S-phase is 
extended. 
 
Overall, the simplest explanation for the increase in telomeric Stn1 and Ten1 in 
nmd2 cells is that overexpression of Stn1 and Ten1, in the absence of Nmd2, 
leads to more Stn1 and Ten1 binding to telomeres.  If the increase in Cdc13 
(1.8-fold), Stn1 (9-fold) and Ten1 (6-fold) binding in an nmd2 strain is 
expressed as a ratio, CST exists in a 1:5:3 ratio (Cdc13/Stn1/Ten1).  Evidence 
from Candida glabrata has shown that CST is in a 2:4:2 or 2:6:2 arrangement 
(Lue et al., 2013).  The 1:5:3 ratio in budding yeast suggests that CST may be 
formed of repeated subunits when Stn1 and Ten1 are overexpressed. 
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Figure 10. Stn1 and Ten1 binding to telomeres increases in the absence of 
Nmd2 
ChIP analysis of (A) Cdc13-13Myc, (B) Stn1-13Myc and (C) Ten1-13Myc 
binding to the Chromosome VI-Right arm telomere (Chr VI-R) and the internal 
locus PAC2 on Chromosome V in either wild-type or nmd2 strains. (A-C) 
Cultures of each genotype were grown at 23°C and cells were harvested in 
exponential phase. Duplicate samples were immunoprecipitated with an anti-
Myc antibody (IP) or a non-specific IgG control (BG). ChIP samples were 
measured in triplicate by qPCR and group means are shown with error bars 
indicating standard deviation. 
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3.5 Stn1 is at telomeres without Cdc13 
 
Since the genetic manipulations that allow bypass of Cdc13 do not allow 
bypass of Stn1 or Ten1, it was hypothesised that Stn1 and Ten1 carry out 
independent roles at the telomere.  Similarly, although Cdc13 bypass strains 
can maintain telomeres by recombination, independently of telomerase, the 
same genetic manipulations do not allow bypass of Stn1 and Ten1.  This 
implies that Stn1 and Ten1 still carry out essential roles at the telomere end in 
the absence of Cdc13.   
 
To test whether Stn1 and Ten1 had telomeric roles separate from Cdc13, it was 
investigated whether Stn1 and Ten1 could still be located on telomeric DNA in 
the absence of Cdc13 using ChIP.  In the absence of Cdc13, Stn1 was still 
enriched at telomeres (Chr. VI-R), but levels of DNA binding were lower (Figure 
11 A).  Levels of Ten1 binding in the absence of Cdc13 were below the 
detection limit of the ChIP assay (Figure 11 B).  The drop in Stn1 DNA binding 
was perhaps because Cdc13 was not available to load Stn1 onto the telomere 
end (Stn1 competes for the Est1 binding site on Cdc13 (Chandra et al., 2001)).  
An alternative explanation is that qPCR for a unique telomeric sequence 
(upstream of the TG1-3 repeats), using sheared DNA from a strain maintaining 
telomeres by recombination, may affect enrichment for this locus due to 
extended TG1-3 repeats in Type II survivors.  Since chromatin was sheared to 
600bp fragments, breaks may have occurred that separated Stn1, bound to 
single-stranded TG1-3 repeats, from the upstream qPCR sequence.  Also, since 
cdc13 strains maintain telomeres using recombination, it is possible that the 
qPCR sequence is lost to some degree, and this would also explain the drop in 
Stn1 enrichment in a cdc13 strain. 
 
However, that Stn1 binding persists in the absence of Cdc13 indicates that 
either Stn1 has DNA-binding capability through its single OB fold and/or that 
Stn1 interacts with another DNA-binding protein to protect the telomere end and 
facilitate replication. 
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Figure 11. Stn1 is at telomeres in the absence of Cdc13 
ChIP analysis of (A) Stn1-13Myc and (B) Ten1-13Myc binding to the 
Chromosome VI-Right arm telomere (Chr VI-R) and the internal locus PAC2 on 
Chromosome V in strains with the genotypes indicated. (A & B) Cultures of 
each genotype were grown at 23°C and cells were harvested in exponential 
phase. Duplicate samples were immunoprecipitated with an anti-Myc antibody 
(IP) or a non-specific IgG control (BG). ChIP samples were measured in 
triplicate by qPCR and group means are shown with error bars indicating 
standard deviation. 
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3.6 Telomeric RPA is increased in the absence of Cdc13 
 
Stn1 binds DNA more weakly than Cdc13 (Gao et al., 2007), therefore it is 
possible that Stn1 might form a complex with RPA in order to bind telomeric 
DNA in the absence of Cdc13.  RPA is a CST-like heterotrimer that binds 
ssDNA during replication and at DSBs.  RPA also appears to have structural 
similarity to CST, in that the large subunit (Rfa1 in yeast) has strong DNA-
binding capacity through an OB fold, similar to Cdc13 (Figure 5) (Maniar et al., 
1997; Gao et al., 2007; Miyake et al., 2009; Sun et al., 2009).  Similarly, both 
Stn1 and Rfa2 have a single OB fold and winged helix motifs, and Ten1 and 
Rfa3 have a single OB domain (Sun et al., 2011).  To see whether RPA bound 
to telomeres in the absence of Cdc13, RPA binding to telomeric DNA was 
measured by ChIP.   
 
There were slightly elevated levels of RPA binding at the telomere (Chr VI-R) in 
an nmd2 exo1 rad24 cdc13 strain compared to wild-type levels (Figure 
12).  Elevated RPA binding in the nmd2 exo1 rad24 cdc13 strain may be 
because the strain is a Type II survivor (which has long TG1-3 tracts that take 
longer to replicate) and this may cause RPA to bind for longer.  Also, repetitive 
DNA tracts are more difficult to replicate, therefore there may be fork stalling 
and ssDNA generation, which leads to RPA binding to telomeric DNA for longer.  
Since the ChIP used a qPCR locus that is upstream of TG1-3 repeats, it is not 
possible to determine whether telomeric RPA binding is at single-stranded TG1-3 
repeats at the telomere end.  Therefore, it is not possible to determine whether 
RPA is co-localising with Stn1. 
 
RPA bound strongly to telomeres in all genetic backgrounds tested, compared 
to the PAC2 internal control locus.  Telomeric RPA binding has been reported in 
a previous study, which showed that RPA was involved in the recruitment of 
telomerase during S-phase through Rfa2 interaction with Est1, which may 
promote Cdc13-Rfa2 interaction (Schramke et al., 2004).  In human cells and S. 
pombe, which have the POT1/Pot1 ssDNA binding protein in the 
shelterin/shelterin-like complex, there is a switch from Pot1 binding to RPA 
binding in S-phase to allow replication of the telomere (Flynn et al., 2011; Audry 
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et al., 2015).  A similar switch may occur between RPA and Cdc13.  In the 
absence of Cdc13, increased RPA binding may occur due to lack of Cdc13 
recruitment of telomerase.  Since Rfa2 interacts with Est1, Rfa2-mediated 
recruitment of telomerase may help to replicate telomeres in the absence of 
Cdc13. 
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Figure 12. Telomere-bound RPA is increased in the absence of Cdc13 
ChIP analysis of RPA binding to the Chromosome VI-Right arm telomere 
(ChrVI-R) and the internal locus PAC2 on Chromosome V. Cultures of strains 
with the genotypes indicated were grown at 23°C and cells were harvested in 
exponential phase. Duplicate samples were immunoprecipitated with an anti-S. 
cerevisiae RPA antibody (IP) or a non-specific IgG control (BG).  ChIP samples 
were measured in triplicate by qPCR and group means are shown with error 
bars indicating standard deviation. 
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3.7 STN1 genetically interacts with RFA3 
 
Since increased telomeric RPA was seen in the absence of Cdc13, this 
suggested that RPA might be important for Cdc13 bypass.  Given that RPA is 
analogous to CST, it was hypothesised that RPA subunits could interact with 
Stn1, in order to recruit Stn1 to the telomere in the absence of Cdc13.  All RPA 
genes (RFA1/2/3) deletions and STN1 deletions are lethal in budding yeast so a 
stn1-13 temperature-sensitive mutant was crossed with an rfa3-313 
temperature-sensitive mutant (both were taken from an S288C genetic 
background library of temperature-sensitive mutants, see Appendix B), the 
diploid was sporulated and tetrads were dissected.  All colonies appeared 
sectored, however this is normally observed for all S288C strains.  stn1-13 and 
rfa3-313 mutations were synthetic lethal (Figure 13 A).   
 
Rfa3 is the smallest subunit of RPA and is structurally analogous to Ten1 
(Figure 5).  Since the rfa3-313 mutation has an additive effect to the stn-13 
mutation (which disrupts Cdc13 and Ten1 binding to Stn1), this suggests that 
Rfa3 and Stn1 work in independent pathways.  It is possible that when telomere 
end protection by Stn1 is sub-optimal, Rfa3 may compensate, perhaps by 
promoting RPA binding to the telomere end.  Indeed, the rfa3-313 mutant has 
Rfa1 aberrantly localized to the cytoplasm rather than the nucleus (Belanger et 
al., 2011), which suggests that nuclear Rfa3 is required when Stn1 function is 
impaired.  This suggests that Rfa3 may be able to compensate for telomere 
replication or end protection defects caused by the stn1-13 mutation.  When 
both Stn1 and Rfa3 function is compromised, damage to the telomere may 
activate the DDR, causing cell cycle arrest and ultimately cell death.   
 
It is possible that Rfa1 might also be important for Stn1 activity.  To investigate 
this possibility, the same stn1-13 used previously was crossed to an rfa1-M2 
strain (from the same library as before).  However, there was no synthetic 
lethality between stn1-13 and rfa1-M2 (Figure 13 B).  Since there was no 
additive effect of rfa1-M2, this suggests that Rfa1 and Stn1 work together in the 
same pathway.   Since Stn1 interacts with Cdc13 to inhibit telomerase access, 
perhaps Rfa1 has a similar role in inhibiting telomerase.  Rfa2 is known to 
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promote Cdc13-Est1 interaction (Schramke et al., 2004), therefore since Stn1 
and Rfa1 appear to work in the same pathway, Rfa1 and Rfa2 may have an 
antagonistic role in regulating Cdc13 interaction with telomerase. 
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Figure 13. stn1-13 and rfa3-313 conditional alleles are synthetic lethal 
(A and B) Diploid strains, of the genotypes indicated above the images, were 
sporulated and tetrad spores were dissected using standard techniques.  
Spores were germinated at 23°C for 5 days before photographing.  Strains are 
in the S288C genetic background.  Strains were genotyped by replica-plating to 
selective media.  Spore genotypes are given underneath the images. (A) 
Inviable genotypes have the inferred genotypes shown in brackets in red. 
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3.8 No evidence of a physical interaction between Stn1 and Rfa1, Rfa2 or 
Rfa3 
 
Given that there was a genetic interaction between Stn1 and Rfa3 
thermosensitive alleles, it was investigated whether Stn1 and Rfa3 interacted 
physically, using co-immunoprecipitation (co-IP).  Rfa3-HA was 
immunoprecipitated but no Stn1-Myc could be detected (Figure 14 A).  A control 
co-IP to detect interaction between Mec3-HA and Ddc1-Myc (which are known 
to physically interact) was successful, indicating that the co-IP method worked 
(Figure 14 A).  There is evidence, therefore, of a genetic interaction between 
Stn1 and the RPA subunit Rfa3, but no evidence of a physical interaction. 
 
As increased telomeric RPA was seen in the absence of Cdc13 (Figure 12) it 
was hypothesised that Stn1 or Ten1 might only interact with RPA in the 
absence of Cdc13.  Also, since no interaction with Rfa3 was seen, Stn1 might 
interact physically with either Rfa1 or Rfa2.  Stn1-Myc and Ten1-Myc were 
immunoprecipitated using an anti-Myc antibody and, as a control, Rfa1-Myc and 
Rfa2.  Rfa2 could be detected in the Rfa1-Myc immunoprecipitate, therefore the 
co-IP method was successful.  However, Stn1-Myc was successfully 
immunoprecipitated in the absence of Nmd2 (most likely because of a much 
higher level of expression when NMD2 is deleted), but no Rfa1 or Rfa2 could be 
detected binding to Stn1-Myc (Figure 14 B).  Therefore there is no evidence that 
Stn1 physically interacts with Rfa1 or Rfa2 in the absence of Cdc13.  It was not 
possible to detect Stn1-Myc immunoprecipitation without the NMD2 deletion, 
since wild-type expression of Stn1 is too low to detect by western blotting 
(Dahlseid et al., 2003).  Ten1-Myc expression is too low to detect by western 
blotting in the presence or absence of Nmd2 (Dahlseid et al., 2003). 
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Figure 14. No evidence of a physical interaction between Stn1 and RPA 
(A) Lysate from strains with the genotypes shown was immunoprecipitated with 
anti-HA antibody.  Immunoprecipitated proteins were analysed by Western blot, 
using anti-Myc antibody, anti-HA antibody and anti-tubulin antibody.  (B) Lysate 
from strains with the genotypes shown was immunoprecipitated with anti-Myc 
antibody.  Immunoprecipitated proteins were analysed by Western blot, using 
an anti-S. cerevisiae RPA antibody and an anti-Myc antibody.  Lane 9 was a 
total cell extract control prepared using TCA extraction. 
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3.9 Discussion 
 
The telomere-capping protein Cdc13 has long been a focus of budding yeast 
telomere research and it has been assumed that Cdc13 is the major telomeric 
ssDNA binding protein.  In this chapter it has been demonstrated that Stn1 and 
Ten1, the partner proteins of Cdc13, play an important role in telomere 
protection independently of Cdc13.  All three CST genes are essential, however 
the requirement for Cdc13 can be bypassed in the absence of Nmd2 and Exo1 
or Rad24, but the requirement for Stn1 and Ten1 cannot be bypassed. 
 
The telomeres of Cdc13 bypass strains resemble those of telomerase-deficient 
survivors.  Whilst telomerase deficient survivors rapidly lose fitness with each 
passage, then enter ‘crisis’ and recover, viable cdc13 strains continually 
increase their fitness with passage and had no detectable ‘crisis’.  The lack of 
an observable crisis in cdc13 strains indicates that cells have no crisis, or that 
they undergo crisis much earlier than the first passage.  When the telomerase 
RNA component TLC1 was deleted from Cdc13 bypass strains, strains formed 
survivors at an early passage number but again increased in fitness with 
passage.  Survivor formation at an early passage indicates that telomere crisis, 
occurred much earlier than passage 1, and perhaps earlier than in cdc13 
TLC1 strains. 
 
It was found that the stoichiometry of CST components could be altered in the 
absence of Nmd2, when Stn1 and Ten1 are known to be overexpressed 
(Addinall et al., 2011).  It was found that in the absence of NMD2, Cdc13 
telomere binding increased less than 2-fold, but Stn1 and Ten1 binding 
increased 9-fold and 6-fold, respectively (Figure 10). It is possible that ChIP 
analysis (by qPCR) amplified Stn1 and Ten1 binding to telomeres, because 
telomeres are short in nmd2 cells.  Since the ChIP assay uses 600bp DNA 
fragments and a qPCR sequence in a unique sequence proximal to the TG1-3 
repeats, when telomeres are short there may be an increased likelihood of 
immunoprecipitating CST proteins bound to TG1-3 repeats.  Conversely, when 
telomeres are long and heterogeneous (as in strains bypassing Cdc13 in 
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Figures 11 and 12), the chances of obtaining TG1-3 repeats proximal to the 
qPCR sequence may be reduced.  This would reduce the levels of CST proteins 
detected by qPCR, e.g. in Figure 11, the drop in Stn1 binding to the telomere in 
the absence of Cdc13 could be due to telomere rearrangements affecting the 
qPCR signal or lack of Cdc13 to bind to (or both).  However, there was no 
substantial increase in Cdc13 binding in nmd2 cells despite short telomeres, 
therefore it is difficult to judge the significance of the effect of short telomeres on 
the ChIP qPCR.  The simplest explanation for increased enrichment of Stn1 and 
Ten1 at telomeric DNA, in nmd2 cells, is that more Stn1 and Ten1 binding 
increases when Stn1 and Ten1 are overexpressed. 
 
Since nmd2 cells overexpress over 200 proteins, including Stn1 and Ten1 
(Johansson et al., 2007), it is possible that Stn1 and Ten1 overexpression 
solely explained Cdc13 bypass.  However, it has previously been shown that it 
is impossible to obtain any nmd2 cdc13 cells (Holstein et al., 2014).  
Furthermore, in a pif1 exo1 strain, from which CDC13 but not STN1 or TEN1 
can be deleted (Holstein et al., 2014), STN1 and TEN1 mRNA levels were not 
increased.  Therefore, STN1 and TEN1 mRNA overexpression most likely does 
not explain Cdc13 bypass. 
 
In the absence of Cdc13 it was found that Stn1 bound telomeric DNA (Ten1 
binding was below the detection limit of the ChIP assay).  The possibility that 
Stn1 bound to another ssDNA-binding protein, in the absence of Cdc13, was 
considered since Stn1 binds ssDNA more weakly than Cdc13 (Gao et al., 2007; 
Sun et al., 2009).  Stn1 binding to the ssDNA-binding complex RPA was 
considered, however although increased levels of telomeric RPA were seen in 
the absence of Cdc13 and Stn1 appeared to work in the same pathway as 
Rfa1, no evidence of physical interaction between Stn1 and RPA subunits could 
be found.  It is possible that without Cdc13, multiple units of Stn1-Ten1 bind 
telomeric ssDNA.  Stn1-Ten1 may bind to telomeric DNA using the single OB 
fold of Stn1 when Cdc13 is absent.  Also, RPA may bind telomeric ssDNA in the 
absence of Cdc13, since Rfa1 may act in the same pathway as Stn1 (Figure 15) 
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The Cdc13 orthologue CTC1 is mutated in diseases such as Coats plus and 
dyskeratosis congenita but no mutations have so far been reported in STN1 
and TEN1 in the same sets of patients (Walne et al., 2013).  A CTC1-null 
mouse is viable but exhibits severe telomere defects and dies prematurely (Gu 
et al., 2012).  To date, no STN1 and TEN1-null mice have been produced.  This 
suggests that in higher eukaryotes, as in yeast, STN1 and TEN1 are more 
important than CTC1 for cell viability.  Since it has been demonstrated in this 
thesis that Stn1 and Ten1 can compensate for Cdc13 deficiency when NMD 
and the DDR are attenuated, it is possible that future therapies could stimulate 
and support STN1 and TEN1 activity to treat diseases involving CTC1 
mutations.  NMD inhibitors (e.g. inhibitors of UPF1) could be employed to 
overexpress STN1 and TEN1, together with suppression of the DDR.  However, 
downsides to this treatment would be the expression of abnormal proteins 
containing a premature stop codon and accumulation of damaged DNA, which 
increases the risk of cancer.   
 
In conclusion, Stn1 and Ten1 might be more important for telomere end 
protection than Cdc13 and are able to carry out their protective roles in the 
absence of Cdc13.  CST in budding yeast is not an obligate heterotrimer and 
Stn1 and Ten1 are likely to carry out independent roles.  STN1 and TEN1 may 
be similarly independent in humans, and their activities could be promoted in 
order to bypass faulty CTC1 in diseases such as Coat’s plus and dyskeratosis 
congenita. 
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Figure 15. Hypothetical model of telomere end protection in the absence 
of Cdc13 
(Top panel) In the presence of Cdc13, Stn1 and Ten1 bind Cdc13 to cap the 
telomere end and promote lagging strand fill-in.  (Bottom panel) In the absence 
of Cdc13, Stn1 and Ten1 still maintain telomeric roles, perhaps by binding of 
multiple Stn1-Ten1 heterodimers to telomeric ssDNA.  RPA (Rfa1, Rfa2, Rfa3) 
may also bind telomeric ssDA in the absence of Cdc13.   
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Chapter 4. Rif1 is required for Cdc13 bypass 
 
4.1 Genome-wide single gene deletion screens using cdc13 and 
CDC13+ query strains 
 
In order to understand the cellular mechanisms allowing Cdc13 bypass, other 
than the roles of Stn1 and Ten1, yeast genetics was used to see which genes 
were important for the viability of a Cdc13 bypass strain.  Robotic synthetic 
genetic array (SGA) technology allows for a single query strain to be mated with 
a single gene deletion library and DAmP (decreased abundance by mRNA 
perturbation) library of essential genes, totalling over 5,000 strains (Tong and 
Boone, 2006).  In essence, the query strain is first mated with the library strains 
on agar plates using a robotic pin tool.  This creates diploids, which are then 
sporulated to obtain haploid spores.  Spores with the desired genotype are then 
selected by sequential pinning to selective media.  Once haploids have been 
selected, the colony size is compared to a control screen conducted using the 
same media.   
 
The SGA process is summarised graphically in Figure 16 A. The two SGA 
screens were performed (1) by mating an nmd2 exo1 cdc13 query strain 
(denoted 'cdc13') with a single gene deletion library and DAmP alleles (Figure 
16 A) and (2) by mating an nmd2 exo1 query strain (denoted 'control') with 
the same libraries (Figure 16 B).  The single gene deletion library and query 
strain were in the S. cerevisiae S288C genetic background (rather than W303 
which is used in this thesis).  Each mating during the SGA screen had 4 
replicates next to each other on the plate.  The resulting diploids were 
sporulated to obtain haploid progeny and haploids with the genotype of (1) 
nmd2 exo1 cdc13 yfg or (2) nmd2 exo1 yfg were obtained using 
selective media.   
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Figure 16. SGA protocols for cdc13 and CDC13+ screens 
(A) SGA protocol for crossing an nmd2 exo1 cdc13 query strain with single 
gene deletion and DAmP allele libraries, sporulating diploids and obtaining 
nmd2 exo1 cdc13 yfg haploids.  (B) SGA protocol for crossing an nmd2 
exo1 query strain with single gene deletion and DAmP allele libraries, 
sporulating diploids and obtaining nmd2 exo1 yfg haploids.  
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4.2 Gene deletions for a number of known complexes behaved similarly 
in both cdc13 and CDC13+ genome-wide screens 
 
Figure 17 shows the colony sizes from the nmd2 exo1 cdc13 and nmd2 
exo1 SGAs plotted against each other.  To remove genetic interactions due to 
linkage with the genes deleted in the screens, genes 20 kb upstream and 
downstream of the deleted genes were removed from the analysis. 
 
One measure of the accuracy of an SGA screen is the clustering of complexes 
in similar locations on the plot of control versus query screen (Figure 17).  To 
determine whether single gene deletions relating to complexes clustered 
together, the locations of a list of functional complexes (Benschop et al., 2010) 
were determined.  It was found that components of the Replication Factor C 
(RFC) complex CTF8, CTF18 and DCC1; RAD51 and RAD55 which interact 
during DSB repair; the tRNA methyltransferase complex TRM8 and TRM82 and 
the DNA Polymerase Zeta complex REV3 and REV7 all clustered in similar 
locations to their partner genes (Figure 17).  CTF8, CTF18 and DCC1 deletions 
are also synthetically sick with the cdc13-1 allele (Addinall et al., 2011), which 
provided further evidence that CDC13 had been deleted in the SGA query 
strain.  All complexes mentioned here reduced the fitness of a Cdc13 bypass 
strain when their genes were deleted.  Since deleting genes within complexes 
has similar effects, this indicates that the SGAs conducted can accurately show 
genetic effects on Cdc13 bypass. 
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Figure 17. Single gene deletions and complexes affecting Cdc13 bypass 
Mean colony sizes from the two SGA screens indicated were plotted against 
each other.  Red upwards arrows indicate a single gene deletion/DAmP allele 
that significantly increases nmd2 exo1 cdc13 colony size (t-test on variance 
in colony size of 4 independent colonies, p<0.05).  Blue downwards arrows 
indicate a single gene deletion/DAmP allele that significantly decreases nmd2 
exo1 cdc13 colony size (t-test as before).  The solid line is a regression line 
denoting the colony size expected on the y axis of each strain given its colony 
size on the x axis.  The dashed line is indicates 1:1 growth.  The positions of 
gene deletions relating to complexes are indicated by coloured dots. 
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4.3 Viable cdc13 yfg strains resemble telomerase-deficient survivors 
 
It was surprising that there was no discernible fitness defect arising from 
CDC13 deletion, since the lines of no interaction and 1:1 growth coincided.  
One possible explanation for this was that deletion of CDC13 had not been 
selected for during the rounds of plating to selective media during the SGA. To 
confirm whether the CDC13 had selected for, nmd2 exo1 cdc13 yfg 
strains were picked at random from the upper fitness segment (above or on the 
line of no interaction) and passaged.  The telomeres of some these strains 
resembled telomerase-deficient survivors by passage 6 (Figure 18 B, lanes 9-
10, 13-15) and telomeres were short even at passage 1 (Figure 18, lanes 5-10 
and 12-17).  This concurred with previously published data that cdc13 strains 
resembled Type I and Type II survivors after 9 passages (Figure 7;Holstein et 
al. (2014)).  Since S288C nmd2 exo1 cdc13 yfg strains had abnormal 
telomeres, similar to W303 nmd2 exo1 cdc13 strains, it was evident that the 
CDC13 deletion had been correctly selected for during the GA.   
 
Perhaps the lack of a fitness defect in the cdc13 query strain resulted from the 
passages onto selective media during the haploid selection stage of the SGA.   
In this phase, strains are pinned sequentially onto selective media of increasing 
stringency to build up sufficient numbers of strains with the required genotype.  
It is known that W303 nmd2 exo1 cdc13 strains increase fitness with 
passage, therefore repeated passaging of the S288C strains may have resulted 
in a fitness increase.  An alternative explanation for the lack of overall fitness 
defect, and most likely, is that the size of nmd2 exo1 cdc13 colonies are 
similar to wild-type colonies, although colonies are sectored (Holstein et al., 
2014).  Since fitness was determined by colony size, similar nmd2 exo1 
cdc13 and nmd2 exo1 colony size would lead to a a similar estimation of 
fitness. 
 
Interestingly, the nmd2 exo1 cdc13 rif2 strain maintained long Y’ 
telomeres in passage 0 and passage 6 (Figure 18, lane 11 in A and B). Also, 
deleting POL4 and FOB1 increased Y’ telomere length.  It is possible that 
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absence of Rif2, Pol4 and Fob1 may be beneficial to Cdc13 bypass. Both 
nmd2 exo1 cdc13 rif2 and nmd2 exo1 rif2 strains appeared to have 
increased fitness (Figure 17).  This suggests that elongated telomeres, caused 
by RIF2 deletion, is beneficial in both strains – most likely because both strains 
have short telomeres. 
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Figure 18. cdc13 strains generated by SGA had abnormal telomeres by 
passage 6 
(A-B) SGA strains (genotypes given on the right) were passaged by repeated, 
sequential robotic pinning to selective media and analysed by Southern blotting 
using a Y’ and TG1-3 repeat probe as before (see Figure 7A).  The loading 
control is SyBr green staining as before.  
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4.4 Rif1 is required for Cdc13 bypass 
 
One set of interacting proteins whose genes did not cluster together was Rif1, 
Rif2 and Rap1 (Figure 17).  rif2 and rap1-DAmP had little effect on cdc13 
colony size versus the control colony size (rap1-DAmP may not be effective, 
however, as mRNA abundance in this strain was not tested).  However, deleting 
RIF1 was completely lethal to the cdc13 strain (Figure 17).  It has previously 
been shown that deleting RIF1 is lethal in a cdc13-1 temperature-sensitive 
mutant grown at 23°C (Anbalagan et al., 2011), however at 20°C the double-
mutant is viable (Addinall et al., 2011; Anbalagan et al., 2011).  The cdc13 
SGA was conducted at 20°C but nmd2 exo1 cdc13 rif1 was nonetheless 
inviable.  To confirm that Rif1 was indeed required for Cdc13 bypass an nmd2 
exo1 cdc13 strain was crossed with a rif1 strain in the S. cerevisiae W303 
genetic background.  The diploid strain was sporulated and spores were 
analysed using tetrad dissection and random spore analysis.  100% of nmd2 
exo1 cdc13 strains were viable (14/14), however I obtained no cdc13 rif1 
genotypes by tetrad dissection (Figure 19).  54 tetrads were analysed but only 1 
inviable nmd2 rif1 exo1 cdc13 strain could be determined (Figure 19, 
tetrad 3c).  All other inviable genotypes that could be determined were not 
quadruple mutants (among the inviable genotypes that could not be 
determined, there may have been quadruple mutants). 
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Figure 19. Rif1 is required for Cdc13 bypass: evidence from tetrad 
dissections 
A diploid was generated by crossing a rif1 strain (DLY9697) with an nmd2 
exo1 cdc13 strain (DLY8457).  Spores were separated by tetrad dissection 
and plates were incubated for 5 days at 23°C before photographing.  Two 
example plates are shown out of 54 tetrads analysed.  Spore viability of the 
encircled genotypes is given in brackets after the genotype. 
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To generate larger numbers of spores, random spore analysis was conducted 
using the same spores.  After determining the genotypes of 300 strains, no 
quadruple mutants were obtained.  However, all other rif1 mutants that were 
CDC13+ were obtained at or above the expected level (Figure 20).  The 
expected number of spores (19) was calculated simply by dividing the number 
of strains analysed (302) by 16, the number of genotypes possible (assuming 
all genotypes were viable).  Also, all other RIF1+ CDC13+ and RIF1+ cdc13 
strains (known previously to be viable) were obtained at or above the expected 
level.  The finding that RIF1+ cdc13 (i.e. nmd2 exo1 cdc13) strains were 
obtained above the expected level is supported by a previous publication in 
which nmd2 exo1 cdc13 strains had 100% viability (Holstein et al., 2014).   
The fact that no cdc13 rif1 spores were obtained indicated that Rif1 is 
required for Cdc13 bypass (Figure 20). 
 
Previously published data showed that a rif1 cdc13-1 accumulated ssDNA, 
resulting from enhanced resection in the absence of Rif1 (Anbalagan et al., 
2011).  Deleting EXO1 reduced ssDNA accumulation to almost wild-type levels 
and increased rif1 cdc13-1 fitness at restrictive temperatures (Anbalagan et 
al., 2011).  Therefore, Rif1 may be important for cdc13-1 and Cdc13 bypass 
strain viability by repressing resection and ssDNA accumulation. However, 
Cdc13 bypass occurs in a strain deleted for EXO1 and NMD2 and deletion of 
either of these reduces ssDNA accumulation (Holstein et al., 2014).   Together 
with evidence that deletion of RIF1 only slightly increases resection at a de 
novo telomere (Bonetti et al., 2010), it would seem reasonable to assume that 
deletion of RIF1 from an nmd2 exo1 cdc13 strain would not increase 
ssDNA accumulation enough to stop Cdc13 bypass.  This is underlined by the 
SGA screen data, which showed that deletion of RIF2 from an nmd2 exo1 
cdc13 strain actually increased fitness (Figure 17) when rif2 cells degrade a 
de novo telomere more extensively than rif1 cells (Bonetti et al., 2010).  In 
conclusion, the role of Rif1 in preventing telomere resection may not be 
important for Cdc13 bypass.   
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Figure 20. Rif1 is required for Cdc13 bypass: evidence from random spore 
analysis 
The same spores from Figure 19 were analysed by random spore analysis.  
Numbers obtained per genotype are shown.  Genotypes in red indicate that no 
rif1 spores were obtained for this genotype. 
 
 94 
 
4.5 Evidence that Rif1 DNA damage checkpoint repression is not 
required for Cdc13 bypass 
 
A genetic background that permits Cdc13 bypass is absence of NMD2 and the 
DNA damage checkpoint protein RAD24, which loads the Rad17-Mec3-Ddc1 
sliding clamp and promotes DSB resection.  It has been shown previously that 
Rif1 blocks Rad24 association with tracts of ssDNA (Xue et al., 2011).  In the 
absence of Cdc13, a degree of telomere uncapping may occur that generates 
ssDNA lesions.  If these lesions are short and located at the telomere then Rif1 
may mask these lesions from DDR factors such as Rad24, suppressing 
checkpoint activation and resection.  It is possible that checkpoint suppression 
by Rif1 explains the requirement for Rif1 in an nmd2 exo1 cdc13 strain.   
 
It was hypothesised that an nmd2 rad24 cdc13 rif1 strain was viable, since 
checkpoint suppression by rad24 might negate the anti-checkpoint role of Rif1.  
To test this hypothesis, two diploids heterozygous for NMD2, EXO1, RAD24, 
CDC13 and RIF1 deletions (two nmd2/NMD2 rad24/RAD24 exo1/EXO1 
cdc13/CDC13 diploids transformed with rif1::NATMX ) were sporulated and 
random spore analysis was conducted) (Figure 21).  No cdc13 rif1 genotypes 
were obtained (numbers of strains obtained for each genotype and the 
expected number are given in the upper panels and graphically in the lower 
panels).  However, the expected number of rif1 CDC13+ and viable cdc13 
RIF1+ strains were obtained (apart from nmd2 rad24 cdc13 where 5 strains 
were obtained instead of the expected 6).  No strains were obtained for cdc13 
genotypes previously known to be inviable (single and double mutants and 
triple mutants lacking nmd2) which confirmed previously published data 
(Holstein et al., 2014).  The fact that no nmd2 rad24 cdc13 rif1 strains 
were viable indicates that inhibition of the Rad24 checkpoint by Rif1 is 
unimportant for Cdc13 bypass.  This suggests that Rif1 has roles other than 
checkpoint repression (perhaps with Stn1 and Ten1) that allow Cdc13 bypass. 
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Figure 21. Absence of the Rad24 checkpoint protein does not permit 
Cdc13 bypass without Rif1 
Two diploids (DDY835 and DDY836) heterozygous for NMD2, RAD24, EXO1, 
CDC13 and RIF1 deletions was sporulated and spores were analysed by 
random spore analysis.  177 (DDY835) and 200 (DDY836) haploid strains were 
genotyped and the numbers for each genotype are given in the tables and the 
graphs.  Expected numbers of strains were calculated by dividing the number of 
spores analysed with the number of possible genotypes.  Genotypes in red are 
where spores were obtained in a RIF1+ background but not in a rif1 
background. 
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4.6 The two most N-terminal Protein Phosphatase I (Glc7) interaction 
sites on Rif1 are not required for Cdc13 bypass 
 
Since neither the role of Rif1 in resection nor DNA damage checkpoint 
suppression were important for Cdc13 bypass, other roles of Rif1 were 
investigated using rif1 mutants defective in other functions.  Rif1 contains RVxF 
and SILK domains which are conserved between yeast and mammals, however 
in higher eukaryotes the domains are found in the C-terminus rather than the N 
terminus (Sreesankar et al., 2012).  It was previously shown that Rif1 represses 
initiation of replication origins, genome-wide, by recruiting the Protein 
phosphatase 1 (PP1) Glc7 (Hiraga et al., 2014; Mattarocci et al., 2014).  rif1 
strains also have very long telomeres and this is due to aberrantly early 
telomere replication and also lack of Rif1 counting of telomeric TG repeats 
(Levy and Blackburn, 2004).   
 
Since Rif1 recruitment of PP1 is important for replication timing it was 
hypothesised that mutating the RVxF and SILK motifs would reduce the fitness 
of nmd2 exo1 cdc13 strains or make them inviable.  To test this hypothesis, 
an nmd2 exo1 cdc13 strain was crossed with a rif1-RVxF-SILK mutant 
allele, which is defective in PP1 recruitment.  The rif1-RVxF-SILK strain is 
mutated in the two most N-terminal RVxF (residues 114-118) and SILK  
(residues 147-149) motifs (referred to hereinafter as RVxF (1) and SILK (1).  
The mutations were V116R, F118R, I147R, L148R, R149A and have been 
previously shown to interrupt Rif1 interaction with PP1 (Mattarrocci et al., 2014).  
67 tetrads were dissected and nmd2 exo1 cdc13 rif1-RVxF-SILK strains 
were obtained with 100% viability although colony size was slightly reduced 
(10/10 strains; Figure 22 B).  Some spore inviability was seen (Figure 22 B, 
tetrads 2, 5 and 7). 
 
The fitness of the nmd2 exo1 cdc13 rif1-RVxF-SILK strains was compared 
with nmd2 exo1 cdc13 RIF1 strains by spot-testing.  nmd2 exo1 cdc13 
rif1-RVxF-SILK strains were slightly less fit than nmd2 exo1 cdc13 RIF1 
strains (Figure 22 C).  rif1-RVxF-SILK exhibit earlier firing of replication origins 
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(Hiraga et al., 2014), therefore the fitness data suggests that early telomere 
replication moderately reduces the fitness of a Cdc13 bypass cell.  
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Figure 22. Rif1 interaction with PP1 via two N-terminal PP1 interaction 
motifs is not required for Cdc13 bypass 
(A) Diagram of the Rif1 protein, showing the PP1 interaction motifs RVxF1 and 
SILK1. These motifs were mutated as follows in the rif1-RVxF-SILK strain: 
V116R, F118R, I147R, L148R, R149A.  (B) Example tetrad dissection (67 
tetrads dissected in total) from a sporulated diploid (DLY9699 x DLY8167).  
Spores were germinated for 5 days at 23°C before photographing.  Spore 
viability is given for the encircled spore genotypes (in brackets).  (C) Spot-test of 
serial 1 in 6 dilutions, in water, of the strains indicated.  Cultures were spotted 
onto a YPD plate and incubated at 23°C for 3 days before photographing.  
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4.7 The Rif1 N terminus promotes Cdc13 bypass 
 
To see whether other, as yet unidentified, domains within the Rif1 N-terminus 
were important for Cdc13 bypass, a rif1N strain (2-176 residues, Figure 23 A) 
was crossed with an nmd2 exo1 cdc13.  After sporulating the diploid and 
dissecting 59 tetrads, I found that nmd2 exo1 cdc13 rif1N strains were 
100% viable (4/4 spores, Figure 23 B).  The colony size of nmd2 exo1 
cdc13 rif1N strains was dramatically reduced compared to nmd2 exo1 
cdc13 and nmd2 exo1 cdc13 rif1-RVxF-SILK strains.  This indicated that 
there was a fitness defect in nmd2 exo1 cdc13 rif1N strains.  However, 
after streaking the strains to obtain more cells, fitness increased and cells could 
be grown to saturation in liquid media.  Interestingly, far fewer nmd2 exo1 
cdc13 rif1N strains were obtained from tetrad dissection than nmd2 exo1 
cdc13 strains (4 compared to 12) and significant spore inviability was seen 
(Figure 23, tetrads 5, 8 and 9).  The spore inviability could potentially mask 
inviability of some nmd2 exo1 cdc13 rif1N strains. 
 
The relative fitness of rif1N and RIF1 strains was determined by spot-testing.  
This assay showed that nmd2 exo1 cdc13 rif1N strains had dramatically 
reduced fitness compared to nmd2 exo1 cdc13 RIF1 strains (Figure 23 C).  
In fact, nmd2 exo1 cdc13 rif1N fitness appeared lower than nmd2 exo1 
cdc13 rif1-RVxF-SILK fitness (Figure 22 C).  This perhaps indicates that there 
are unknown domains within the N-terminus that are important for Cdc13 
bypass, and hence the activity of Stn1 and Ten1.  One possibility is the putative 
Rif1 nuclear localization sequence (NLS) that is very near the N terminus 
(Hiraga et al., 2014).  Without the NLS, Rif1 would be unable to interact with 
telomeres in the nucleus.  It is therefore possible that nmd2 exo1 cdc13 
rif1N strains are less fit because Rif1 is not located at the telomere. 
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Figure 23. The N terminus of Rif1 promotes Cdc13 bypass 
(A) Diagram of the Rif1 protein, with the red line showing the N terminal 
deletion.  (B) Example tetrad dissection (59 tetrads dissected in total) from a 
sporulated diploid (DLY10255 x DLY10290).  Spores were germinated for 5 
days at 23°C before photographing.  Spore viability is given for the encircled 
spore genotypes (in brackets).  (C) Spot-test of serial 1 in 6 dilutions, in water, 
of the strains indicated.  Cultures were spotted onto a YPD plate and incubated 
at 23°C for 3 days before photographing.  
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4.8 Rif1 C-terminal interactions with Rap1 or Dbf4 are not required for 
Cdc13 bypass 
 
The Rif1 C-terminal domain is conserved between yeast and humans and binds 
to the Rap1 C-terminal domain (Shi et al., 2013).  Rif1-Rap1-Rif2 forms a 
shelterin-like complex at telomeres, regulates telomere length and seems to 
promote CST activity, since Rif1 is essential for Cdc13 bypass (Anbalagan et 
al., 2011).  The complex also protects the telomere end from being recognised 
as a DSB and represses non-homologous end joining at the telomere to prevent 
circular chromosomes and hence genome instability.  However, within the 
aforementioned activities, Rif1, Rap1 and Rif2 can carry out separate roles, for 
example Rap1 and Rif2 inhibit NHEJ at telomeres but Rif1 does not (Bonetti et 
al., 2010; Anbalagan et al., 2011).   Rif1 C-terminus also binds to Dbf4, which  
is the regulatory subunit of the Cdc7 kinase that phosphorylates the MCM 
complex to initiate DNA replication (Hiraga et al., 2014).  The Dbf4 binding site 
overlaps with that of Rap1, therefore Rap1 and Dbf4 may compete to bind to 
Rif1 (Hiraga et al., 2014). 
 
The C terminus of Rif1 interacts with Rap1, thus it was hypothesised that 
deleting the Rif1 C-terminal would stop Cdc13 bypass since this would disrupt 
Rif1-Rap1 binding.    A rif1C strain (Figure 24 A) was crossed with an nmd2 
exo1 cdc13 strain and tetrads were dissected.  nmd2 exo1 cdc13 rif1C 
strains were viable (5/6 possible spores) (Figure 24 B).  One nmd2 exo1 
cdc13 rif1C was inviable and overall there was spore inviability seen similar 
to previous nmd2 exo1 cdc13 rif1-mutant dissections (e.g. tetrad 9, Figure 
24 B). 
 
Strain fitness analysis by spotting serial dilutions of saturated culture (in water) 
onto agar plates showed that nmd2 exo1 cdc13 rif1C strains were much 
less fit than nmd2 exo1 cdc13 RIF1 strains (Figure 24 C).  Rif1 interaction 
with Rap1 may assist Cdc13 bypass since Rap1 tethers Rif1 to telomeric 
dsDNA.  If Rif1 promotes CST activity (Anbalagan et al., 2011) then in the 
absence of Cdc13 perhaps Rif1, whilst binding telomeric dsDNA, helps to 
 103 
recruit Stn1 and Ten1 to the telomere or promotes Stn1-Ten1 interaction.  
Alternatively, or additionally, Rif1 interaction with the pre-replication complex 
activator Dbf4 (which occurs via the Rif1 C-terminus) may be important, since 
this regulates the timing of telomere replication.   
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Figure 24. The Rif1 C terminus promotes Cdc13 bypass 
(A) Diagram of the Rif1 protein, with the C-terminal deletion shown as a red line.  
(B) Tetrad dissection from a sporulated diploid (DLY10255 x DLY9714).  Spores 
were germinated for 5 days at 23°C before photographing.  Strains were 
patched to YPD and replica-plated to selective media for genotyping.  Spore 
viability is given for the encircled spore genotypes (in brackets).  (C) Spot-test of 
serial 1 in 6 dilutions, in water, of the strains indicated.  Cultures were spotted 
onto a YPD plate and incubated at 23°C for 3 days before photographing.  
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4.9 Domains within the Rif1 HEAT repeats are required for Cdc13 bypass 
 
Rif1 contains HEAT (Huntingtin, elongation factor 3, Protein Phosphatase 2A, 
and yeast kinase TOR1) repeats, which are a conserved domain comprising 
around 50 amino acids found in a number of different proteins, although there is 
variable sequence homology (Sreesankar et al., 2012; Hiraga et al., 2014).  It is 
thought that these residues become packed together to form super-helices 
(‘solenoids’ or ‘springs’) and that these structures mediate protein-protein 
interactions (Andrade et al., 2001).  HEAT repeats are an ill-defined domain in 
Rif1.  In humans, the Rif1 HEAT repeats are thought to be located from the 
beginning of the N terminus; in yeast the Rif1 core HEAT repeats are amino 
acids 434-579, but the region is very likely to extend further from here towards 
the C and N termini (Xu et al., 2010; Sreesankar et al., 2012).  In both yeast 
and humans the exact function of the Rif1 HEAT repeats is unknown.  In yeast, 
there is evidence that the HEAT repeats are important for the regulation of DNA 
replication timing by Rif1 (Hiraga et al., 2014).   
 
It was hypothesized that Rif1 HEAT repeats were important for Cdc13 bypass, 
given that deletions of N (residues 2-176) and C (residues 1323-1916) terminal 
regions of Rif1 were not lethal to nmd2 exo1 cdc13.  The importance of the 
Rif1 HEAT repeats and domains within for Cdc13 bypass was determined by 
transforming a number of plasmids with Rif1 HEAT-repeat truncations into an 
nmd2 exo1 cdc13 rif1 strain expressing RIF1 on a plasmid (Figure 25 A).  
Internal deletions were made by in vitro mutagenesis and cloning and had no 
linker inserted between N- and C-terminal truncations (Hiraga et al., 2014).  
Loss of the RIF1 plasmid left the Rif1 truncation plasmid only, therefore cells 
with Rif1 mutated in domains important for Cdc13 bypass would be inviable on 
5-FOA.   
 
When the nmd2 exo1 cdc13 rif1 had a RIF1-URA3 plasmid and a vector 
only, the strain died on 5-FOA after losing the RIF1-URA3 plasmid.  This 
confirmed that Rif1 is essential for Cdc13 bypass and that RIF1 had been 
correctly deleted from the strain used.  When the strain had a RIF1-URA3 and a 
 106 
RIF1-TRP1 plasmid, the strain was viable after losing the RIF1-URA3 plasmid, 
since it could still express RIF1.  This again confirmed that the strain used had 
RIF1 correctly deleted and that Rif1 is required for Cdc13 bypass.  The strain 
was quite sick on 5-FOA, indicating that perhaps the expression level of Rif1 
was lower than optimal or that the plasmid was unstable.  Future work could 
examine the expression levels of Rif1 in Cdc13 bypass, as these may be 
elevated to compensate for defects in telomere capping by Cdc13. 
 
It was found that Cdc13 bypass strains containing only plasmids with the C-
terminal domain of Rif1 deleted (1790-1916 and 997-1916) were viable 
(Figure 25 B) which confirmed the previous finding that a strain with an 
integrated Rif1 C-terminal deletion was viable (Figure 24 B, C).  Interestingly, 
deletion of the very end of the C-terminal (1790-1916) made the strain less fit 
than a strain expressing a much larger deletion (997-1916).  1790-1916 is 
required for Dbf4 binding (Hiraga et al., 2014), however Rif1 can bind to Rap1 
with a minimal binding region of 1752-1772.  Therefore, one reason that Rif1 
997-1916 is fitter than 1790-1916 in cdc13 strain is that Rif1-Rap1 
interaction may be more persistent and this appears to be harmful.  
Alternatively, Rif1 1790-1916 may be less stable than 997-1916, leading to 
lower levels of Rif1. 
 
It was further found that the domain including the SILK2 motif (222-225 
residues, Figure 25A) was important for Cdc13 bypass, since the 114-225 
plasmid led to complete loss of viability of the nmd2 exo1 cdc13 rif1 strain 
(Figure 25 B).  The rif1-RVxF-SILK allele previously used, which allowed Cdc13 
bypass, was mutated only in the RvXF (1) motif (residues 114-118) and the 
SILK (1) motif (147-149 residues) (Figure 22 A).  However, Hiraga et al. (2014) 
identified two further RVxF/SILK motifs: SILK2 (residues 222-225) and RVxF2 
(residues 316-320).  Mutation of all four RVxF and SILK motifs (Rif1-PP1, 
Figure 25 B) were lethal.  This indicates either that the SILK2 and RvXF2 motifs 
are required for Cdc13 bypass, or that there is redundancy between the motifs 
i.e. in the absence of RVxF1 and SILK1, Glc7 can bind to RVxF2 and SILK2.  
Triple, pairwise and single deletions of the four motifs are necessary to 
determine which motifs are essential for Rif1 function in Cdc13 bypass.  Overall, 
SILK and RVxF motifs are important for Cdc13 bypass.  These motifs are 
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thought to be required for interactions with PP1 (Glc7) (Hendrickx et al., 2009).  
Rif1 recruitment of PP1 to the telomere, via the SILK2/RvXF2 motifs may 
therefore be important for Cdc13 bypass. 
 
The SILK2 and RVxF2 motifs lie within a region thought to comprise HEAT 
repeats, which may extend into residues 213-836 (Hiraga et al., 2014), although 
the strict HEAT repeat region is residues 434-579, which contain repeats 
conserved between yeast and higher eukaryotes (Andrade et al., 2001).  
Interestingly, deletions of an N-terminal portion of the putative HEAT repeats 
(321-455), the entire region of putative HEAT repeats (213-836) and a C-
terminal portion (321-836) were all lethal (Figure 25 B).  This suggests that the 
structure of the putative HEAT repeats (213-455) is important for Cdc13 bypass.  
Also, the fact that deletions within the 213-836 residues of Rif1 attenuate Cdc13 
bypass suggests that this area has a common function, therefore it is likely that 
the HEAT repeats are as extensive as previously thought. 
 
Since HEAT repeats across species promote protein-protein interactions 
(Andrade et al., 2001), it is possible that Rif1 is interacting with another protein 
to maintain telomere protection in the absence of Cdc13.  The protein 
interacting with Rif1 that is essential for Cdc13 bypass could be the essential 
protein Ten1, which binds to the N-terminus of Stn1.  Co-IP between Rif1 and 
Ten1 could potentially uncover an interaction.  Alternatively, the Rif1 HEAT 
repeats could promote interaction between Stn1 and Ten1, since both proteins 
are required for Cdc13 bypass. 
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Figure 25. Domains within the Rif1 HEAT repeats are required for Cdc13 
bypass 
(A) An nmd2 exo1 cdc13 rif1 strain expressing RIF1 on a URA3 plasmid 
was transformed with rif1 mutant alleles shown on a TRP1 plasmid.  HEAT 
repeats are from residues 213-836 (Hiraga et al., 2014) and are shown in 
orange.  Rif1-PP1 interaction motifs (RVxF/SILK motifs, as shown in Hiraga et 
al., 2014) are shown by vertical blue, green, black and yellow lines.  Red lines 
indicate the deletions made in Rif1.  For the ‘Rif-PP1’ plasmid, each RvXF/SILK 
motif was mutated (red lines indicate mutations, details of mutations given in 
Hiraga et al., 2014).  (B) Cultures were serially diluted (1 in 4) and spotted onto 
–TRP –URA (control) and 5-FOA to lose the RIF1-URA3 plasmid, leaving the 
mutant allele (rif1-M) on a TRP1 plasmid.  
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4.10 Discussion 
 
A genome-wide screen was conducted by crossing a single gene 
deletion/DAmP allele library with a Cdc13 bypass strain and a control CDC13+ 
strain.  It was found that Rif1 was essential for Cdc13 bypass.  Rif1 is a 
multifunctional protein and its role in Cdc13 bypass was investigated.  Mutating 
the two most N-terminal PP1 interaction sites did not affect Cdc13 bypass, 
however mutation of all four PP1 interaction sites was lethal, indicating that 
replication timing control by Rif1-PP1 interaction is important for cells to survive 
without Cdc13.  Deleting the C or N-termini did not completely abolish Cdc13 
bypass, but strain fitness was greatly reduced.  This may be because the N 
terminus contains a putative NLS (Hiraga et al., 2014) and the C-terminus is 
important for Rif1 binding to Rap1, which is important for telomere end 
protection (Hardy et al., 1992). 
 
It was found that the HEAT repeats are required for Cdc13 bypass.  The 
function of the Rif1 HEAT repeats is currently unknown, however HEAT repeats 
across species promote protein-protein interactions (Andrade et al., 2001).  It is 
possible that Rif1 interacts with another protein using its HEAT repeats to 
promote Cdc13 bypass.  A hypothetical model is that Rif1 interacts with CST at 
the telomere end by interacting with Ten1 – possibly using the HEAT repeats 
(Figure 26). Cdc13 binds tightly by itself to telomeric ssDNA, then recruits Stn1 
(which binds ssDNA more weakly) and Ten1, to replicate the telomere and 
promote lagging strand fill-in.  Rif1 and Ten1 may then interact to lead to the 
formation of a shelterin-like complex at the telomere end.  Future work could 
address whether Rif1 interacts with Ten1-Stn1 by using co-IP. 
 
An alternative explanation for the lethality of HEAT repeat deletions and 
mutation of the four PP1 interaction sites (Figure 25) is that such mutations 
render Rif1 unstable or misfolded.  Similarly, the integrated rif1-RVxF-SILK, C 
and N alleles (Figures 22-24) may have reduced the fitness of Cdc13 bypass 
strains, due to these mutations producing unstable or misfolded Rif1.  Since 
Rif1 is essential for Cdc13 bypass, unstable Rif1 would most likely to be lethal.  
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However, two of the Rif1 truncation plasmids (114-225 and Rif1-PP1) are 
known to stably express Rif1 at levels that are similar to wild-type (Hiraga et al., 
2014), therefore in both cases lethality is most likely due to the attenuation of 
essential Rif1 functions.  Future work could determine the effect of the other 
mutations on Rif1 function by Southern blotting of the telomeres of Cdc13 
bypass strains with Rif1 truncations and nmd2 exo1 cdc13 rif1 strains 
expressing the plasmids used in Figure 25.  Unstable or misfolded Rif1 would 
most likely lead to dramatic telomere lengthening in these strains.  Also, 
western blotting could be used to determine Rif1 expression levels in strains 
carrying these plasmids. 
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Figure 26. Hypothetical model in which Rif1 interacts with Ten1 at the 
telomere end to form a shelterin-like complex 
 
(A) During telomere replication in late S-phase, Cdc13 binds telomeric ssDNA 
and recruits telomerase (Est1/Est2/Est3/Tlc1 RNA (red line)) to extend the 
leading strand.  (B) Stn1 and Ten1 are recruited to repress telomerase and Pol 
 is recruited to fill in the lagging strand after replication. (C)  Ten1 interacts 
with Rif1 and Stn1 to form a shelterin-like complex to protect the telomere end. 
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Chapter 5. Rad52 is required for Cdc13 bypass 
 
5.1 Rad51-dependent recombination is not required for Cdc13 bypass 
 
Cdc13 bypass cells resemble telomerase-deficient survivors, which maintain 
telomeres by recombination.   To determine whether telomere maintenance by 
homologous recombination was important for Cdc13 bypass, the effect of 
Rad51 on Cdc13 bypass was investigated.  Deleting Rad51 reduced colony 
size in nmd2 exo1 cdc13 strains, when 56 tetrads were dissected from a 
diploid heterozygous for NMD2, EXO1, CDC13 and RAD51 deletions (Figure 
27).  nmd2 exo1 cdc13 rad51 strains had 100% viability (5/5 possible 
strains were viable).  These data indicate that Rad51-dependent recombination 
is not required for Cdc13 bypass.  Since Rad51 is required for the formation of 
Type I survivors and rad51 strains only form Type II survivors (Lundblad and 
Blackburn, 1993), perhaps nmd2 exo1 cdc13 rad51 cells only form Type II 
survivors.  Future work could examine the telomere phenotypes of these cells 
using Southern blotting. 
 
The SGA screen showed that RAD50 deletion (and deletion of the two other 
MRX components MRE11 and XRS2) severely reduced the colony size of both 
nmd2 exo1 cdc13 and nmd2 exo1 cells (data not shown).  This is most 
likely because there is a negative genetic interaction between exo1 and MRX 
gene deletions (Collins et al., 2007).  Therefore, the effect of Rad51-
independent (Rad50-dependent) recombination on Cdc13 bypass is difficult to 
analyse in an nmd2 exo1 cdc13 strain.  However, in future work it could be 
analysed in an nmd2 rad24 cdc13 strain.
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Figure 27. Cdc13 bypass occurs without Rad51 
A diploid of the genotype indicated (made from crossing DLY3485 and 
DLY8167) was sporulated and 56 tetrads were dissected.  Spores were 
germinated for 5 days at 23°C before photographing.  The number of strains 
obtained, out of the number of possible strains, is given in brackets for the 
encircled genotypes. 
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5.2 Rad52 is required for Cdc13 bypass 
 
Rad52 is required for both Rad51-dependent and Rad50-dependent 
recombination, the two recombination pathways in budding yeast (Lundblad and 
Blackburn, 1993).  Figure 27 showed that nmd2 exo1 cdc13 strains could 
survive without Rad51, therefore Rad51-independent recombination is not 
required for Cdc13 bypass.  It was not to see whether Rad50-dependent 
recombination was required for Cdc13 bypass, since RAD50 has a negative 
genetic interaction with EXO1 (although future work could be to dissect tetrads 
from a sporulated diploid heterozygous for rad50 nmd2 rad24 cdc13).   
However, Rad52 is required for both recombination pathways, therefore if 
rad52 was essential for Cdc13 bypass then this would suggest that Rad50-
dependent recombination was important for Cdc13 bypass (since Rad51-
dependent recombination is not essential. 
 
To see whether Rad52 is required for Cdc13 bypass, a diploid heterozygous for 
NMD2, EXO1, CDC13 and RAD52 deletions was sporulated and 69 tetrads 
were dissected to determine whether nmd2 exo1 cdc13 rad52 strains 
were viable (Figure 28).  It was found that nmd2 exo1 cdc13 rad52 strains 
were inviable, therefore it is likely that Rad50-dependent recombination is 
essential for Cdc13 bypass (Figure 28).  Rad52 is essential for recombination 
pathways and is thus required for the formation of both Type I and Type II 
survivors, which maintain telomeres by recombination (Lundblad and Blackburn, 
1993).   As Rad51 is not essential for Cdc13 bypass, and Rad51 is required for 
the formation of Type I survivors, it is likely that Cdc13 bypass cells lacking 
Rad51 maintain telomeres by Type II recombination.  The fact that deletion of 
RAD52, which is required for both Type I and Type II recombination, is lethal to 
Cdc13 bypass strains provides evidence that Type II recombination is 
necessary for cells to survive without Cdc13.  However, it is possible that when 
Type II recombination is defective (e.g. in the absence of Rad50), Cdc13 
bypass cells can switch to Type I recombination.  Overall, telomere 
recombination (either Type I or Type II) is essential for Cdc13 bypass. 
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Figure 28. Rad52 is required for Cdc13 bypass (tetrad dissection) 
A diploid of the genotype indicated (made from crossing DLY5872 and 
DLY8167) was sporulated and 69 tetrads were dissected.  Spores were 
germinated for 5 days at 23°C before photographing.  The number of strains 
obtained, out of the number of possible strains, is given in brackets for the 
encircled genotypes. 
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Some spore inviability was seen (e.g. tetrads 4 and 9, Figure 28), therefore to 
confirm that nmd2 exo1 cdc13 rad52 strains could not be generated, 
haploid strains were generated using random spore analysis.  From analysing 
250 strains, no nmd2 exo1 cdc13 rad52 strains were obtained (23 strains 
were expected (assuming 11 viable genotypes) or 15 strains were expected, 
assuming 16 viable genotypes) (Figure 29).  This shows that Cdc13 bypass 
cells require Rad52 and that telomere maintenance by HR is essential for these 
cells. 
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Figure 29. Rad52 is required for Cdc13 bypass (random spore analysis) 
A diploid (DLY5872 x DLY8167) was sporulated and spores were separated by 
random spore analysis.  Spores were germinated on YPD for 4 days before 
genotyping.  The number of strains for each genotype are given in tabular and 
graphical form.  The dashed line on the graph shows the expected number of 
spores, assuming all genotypes are viable (15).  The genotype highlighted in 
red indicates that no strains were obtained for this genotype. 
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5.3 Discussion 
 
 
Deletion of the HR gene RAD51 reduces the colony size of Cdc13 bypass 
strains, and deletion of the HR gene RAD52, which is essential for both Rad51-
dependent and Rad50–dependent HR, is lethal.  The importance of Rad50 for 
Cdc13 bypass could be determined by crossing a rad50 strain with an nmd2 
rad24 cdc13 strain, since rad50 is synthetic sick with exo1 (therefore an 
nmd2 exo1 cdc13 strain crossed with rad50 would not be informative).  
 
Deleting RAD51 was not lethal to nmd2 exo1 cdc13 strains, suggesting 
either that Type I recombination is not essential for Cdc13 bypass, or that 
Cdc13 bypass strains employing Type I recombination to maintain telomeres 
may be able to switch to Type II recombination instead.  This could be tested by 
Southern blotting of the telomeres of nmd2 exo1 cdc13 rad51 strains. 
Furthermore, if future work showed that deleting RAD50 from nmd2 rad24 
cdc13 strains was not lethal (Rad50 is required for Type II recombination) then 
it is likely that Type II recombination is not essential for Cdc13 bypass and that 
Cdc13 bypass strains can switch between the two types of recombination. 
 
Rad52 is required for both yeast recombination pathways (Rad51-dependent 
and Rad50-dependent) and thus is essential for both Type I and Type II 
survivors.  Deleting RAD52 is lethal to Cdc13 bypass strains, therefore it is 
likely either that availability of at least one recombination pathway is essential 
for these strains to survive, or that Type II recombination is essential (since 
absence of Rad51 is not lethal to Cdc13 bypass).   
 
If it were the case that Type II recombination was required for Cdc13 bypass, 
then it would seem somewhat paradoxical that deletion of Rif1, which promotes 
Type I recombination and inhibits Type II recombination (Teng et al., 2000), is 
lethal.  Therefore, it is probably most likely that Cdc13 bypass strains require 
the availability of at least one recombination pathway, rather than primarily Type 
II recombination. The lethality of RIF1 deletion for Cdc13 bypass, despite rif1 
 119 
promoting Type II survivor formation, may support the conclusions of the 
previous chapter that it is Rif1 interactions with CST that are important for 
Cdc13 bypass.   
 
Also, if Type II recombination was required for Cdc13 bypass, a second 
apparent paradox is that the nmd2 exo1 cdc13 strains tested (Figure 7) 
resembled Type I survivors more closely than Type II survivors.  These strains 
did appear to have extended Y’ telomeres indicating possible amplification of 
TG1-3 repeats.  It is plausible that nmd2 exo1 cdc13 strains may resemble 
Type II survivors more closely after extensive passaging.  However, at face 
value the nmd2 exo1 cdc13 strains tested resemble Type I survivors more 
closely than Type II.  Therefore, it is more likely that Cdc13 bypass strains 
require at least one recombination pathway, but does not require a specific 
pathway. 
 
Overall, Rad52 is essential for Cdc13 bypass and Rad51 is not.  Rad52 is 
required for Type I and Type II survivors, whereas Rad51 is required for Type I 
survivors, therefore Type II recombination may be essential for cells to survive 
without Cdc13.  In Type II survivors, TG1-3 repeats are amplified, therefore long 
tracts of TG repeats may promote survival without Cdc13, perhaps by allowing 
greater Rif1-Rif2-Rap1 binding or Stn1-Ten1 binding.  To see whether Type II 
recombination is required, future work needs to address whether Rad50 
(required for Type II survivors) is essential for Cdc13 bypass.  However, there is 
evidence to suggest that Type II recombination may not be essential for Cdc13 
bypass.  Rif1 inhibits Type II recombination yet deletion of RIF1 is lethal to 
Cdc13 bypass cells, also nmd2 exo1 cdc13 strains resembled Type I 
survivors more closely than Type II.  In conclusion, the most likely explanation is 
that Cdc13 bypass cells require at least one recombination pathway to survive, 
but do not require a specific pathway. 
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Chapter 6. Long telomeres promote Cdc13 bypass 
 
6.1 Generation of cdc13 strains not previously known to be viable 
It was previously published that the only Cdc13 bypass strains that could be 
obtained from a diploid heterozygous for NMD2, EXO1, RAD24, RIF1 and 
CDC13 deletions were nmd2 exo1 cdc13, nmd2 rad24 cdc13 and 
nmd2 exo1 rad24 cdc13 (Holstein et al., 2014).  Remarkably, however, it 
was possible to obtain nmd2 cdc13 strains from diploids created by mating a 
Cdc13 bypass strain with a single gene deletion strain. 
 
When an nmd2 rad24 cdc13 strain was crossed with a rif1 strain, after the 
diploid was sporulated and 20 tetrads were dissected it was found that nmd2 
cdc13 strains were obtained (Figure 30 A).  Such strains have not been 
obtained from previous dissections of diploids heterozygous for NMD2, EXO1, 
RAD24 and CDC13 deletions (Holstein et al., 2014).  Furthermore, when an 
nmd2 exo1 cdc13 strain was crossed with a dxo1 strain and 33 tetrads 
were dissected, nmd2 cdc13 and nmd2 cdc13 dxo1 strains were 
obtained (Figure 30 B).   
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Figure 30. Generation of unexpected Cdc13 bypass strains 
(A) An nmd2 rad24 cdc13 strain (DLY8455) was crossed with a rif1 strain 
(DLY9697) and 20 tetrads were dissected.  A representative dissection is 
shown.  Viability is shown in brackets by the encircled genotypes. (B) An nmd2 
exo1 cdc13 strain (DLY8167) was crossed with a dxo1 strain (DLY10209) 
and 33 tetrads were dissected.  A representative dissection is shown.  Viability 
is shown in brackets by the encircled genotypes. 
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The telomeres of Cdc13 bypass strains resemble those of telomerase-deficient 
survivors, which rearrange and maintain telomeres by recombination.  Also, it is 
known that mating a strain with rearranged telomeres to another strain does not 
result in a diploid with wild-type telomeres, even when the diploid is 
heterozygous for all gene deletions (Zubko and Lydall, 2006).  Furthermore, it 
has previously been shown that cells with telomeres resembling Type I and 
Type II survivors can adapt to the loss of Cdc13 (Larrivée and Wellinger, 2006).  
Therefore, perhaps the telomere structure of the resultant diploid allows 
unexpected Cdc13 bypass genotypes to arise in the haploid progeny.  
 
6.2 Long telomeres promote growth of cdc13 strains that are not 
normally viable 
 
To test the hypothesis that unexpected Cdc13 bypass strains could be obtained 
by crossing a Cdc13 bypass strain with a single gene deletion strain, the 
telomere composition of diploids generated from these crosses were examined 
by Southern blotting.  The diploids were passaged to see whether alterations in 
telomere composition occurred.  It was hypothesised that diploids that produced 
unexpected Cdc13 bypass strains would have long telomeres.   
 
NMD2/nmd2 EXO1/exo1 RAD24/rad24 CDC13/cdc13 diploids (DDY567 
and DDY568), generated by transformation with a cdc13 cassette, had Y’ 
telomeres of a similar length to a wild-type strain (Figure 31; compare lane 1 
with lanes 4-5).  However, diploids generated by crossing an nmd2 exo1 
cdc13 strain with a rif1 strain initially had long, heterogeneous Y’ and X 
telomeres but resembled wild-type telomeres more closely with passaging 
(Figure 31; compare lanes 6-7 with lanes 24-25).  Interestingly, even though this 
diploid has long telomeres, no unexpected Cdc13 bypass strains were obtained 
from this cross (see Figure 20).  These data are inconsistent with the 
hypothesis that unexpected Cdc13 bypass strains are obtained from diploids 
with long telomeres.  However, it is possible that the telomere rearrangements 
are less severe than the other Cdc13 bypass diploids tested since telomeres 
recover with passage.   
 
 124 
Diploids generated by crossing an nmd2 rad24 cdc13 strain with a rif1 
strain maintained long, heterogeneous Y’ and X telomeres with each passage 
and telomere length appeared to increase (Figure 31; compare lanes 8-9, 14-15 
and 26-27).  Diploids generated by crossing an nmd2 exo1 cdc13 strain 
with a dxo1 strain had terminal fragments that were of wild-type length but also 
appeared to have long, heterogeneous Y’ and X telomeres.  This structure also 
did not change with passage (Figure 31; compare lanes 10-11, 16-17 and 28-
29).  These data are consistent with the hypothesis that unexpected Cdc13 
bypass strains are generated from long telomeres. 
 
Overall, it appears that long telomeres are a contributing factor to Cdc13 
bypass, but do not explain Cdc13 bypass overall.  It is possible that extensive 
telomere rearrangements, which cannot be resolved by passaging, promote 
Cdc13 bypass.  This is perhaps because such haploids already have telomeres 
maintained by recombination, which is known to occur in the Cdc13 bypass 
strains previously published (Holstein et al., 2014). 
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Figure 31. Diploids with a Cdc13 bypass strain parent have long telomeres 
The diploids indicated were passaged, genomic DNA was prepared and 
telomeres were analysed using Southern blotting and a Y’ and TG1-3 repeat 
probe as before (see Figure 7A).  DDY567 and DDY568 (lanes 4 and 5) were 
diploids in which CDC13 was deleted from the diploid using a deletion cassette.  
Diploids A-C were created by mating a Cdc13 bypass strain with a single gene 
deletion strain.  ‘A’ diploids were DLY9697 x DLY8457; ‘B’ diploids were 
DLY9697 x DLY8455; ‘C’ diploids were DLY10209 x DLY8167.  Replicates are 
independent colonies from each cross. 
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6.3 Ethanol exposure alters the telomere length of diploids 
 
Growth in YPD with ethanol concentrations of up to 7% have previously been 
shown to lengthen the telomeres of budding yeast (Romano et al., 2013).  To 
further test whether telomere length was important for Cdc13 bypass, the 
telomeres of two NMD2/nmd2 EXO1/exo1 RAD24/rad24 CDC13/cdc13 
diploids were lengthened by exposure to ethanol.  The diploids were DDY567 
and DDY568; independent strains made by transformation of a diploid with a 
cdc13 cassette.  It was essential to use diploids where CDC13 had been 
deleted by transformation of the diploid, since crossing a Cdc13 bypass strain 
with another haploid can produce heterogeneous telomeres (as shown in Figure 
31).  
The diploids were grown for 50 population doublings in 0%, 1%, 3% or 5% (v/v) 
ethanol.  These concentrations were chosen because initial growth rates 
showed that both 0% and 1% cultures took 1 day to undergo 10 population 
doublings; 3% took two days and 5% took three days.  Growth in 7% (v/v) 
ethanol was attempted but after inoculating at a density of 1 x 105 cells/mL 
cultures only reached ≈ 5 x 107 cells/mL after 4 days in culture and failed to 
double thereafter.  This could be because the yeast genetic background being 
used (W303) was different to that used in Romano et al. (2013) (who used 
BY4741/2 haploids); or perhaps diploids are more sensitive to ethanol than 
haploids. 
Table 2 shows the number of days in culture required for strains to undergo 50 
population doublings.  Diploids grown in 0% and 1% (v/v) ethanol underwent 50 
population doublings after 5 days in culture, however strains in 3% and 5% (v/v) 
ethanol grew more poorly and required longer for 50 population doublings.  
The telomere length of the strains grown in ethanol was examined by Southern 
blotting (Figure 32).  It was found that increasing the percentage of ethanol 
increased Y’ and X telomere length, similar to previously published data 
(Romano et al., 2013).  However, telomere length heterogeneity increased with 
ethanol concentration, such that strains grown in 5% ethanol also had very 
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short as well as very long Y’ telomeres.  This perhaps shows telomere 
degradation, since strains grown in 5% ethanol grew poorly compared to 0% 
ethanol growth. 
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Ethanol % 
Time taken to undergo 50 population 
doublings (days) 
0% 5 
1% 5 
3% 12 
5% 17 
 
Table 2. Ethanol increases the time taken for diploids to complete 50 
population doublings 
DDY567 and DDY568 diploids were grown in YPD with the given percentage of 
ethanol for 50 population doublings.  Cells numbers were determined by 
counting with a haemocytometer. 
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Figure 32. Ethanol exposure lengthens diploid telomeres 
nmd2/NMD2 exo1/EXO1 rad24/RAD24 cdc13/CDC13 diploids (DDY567 
and DDY568) were grown in YPD with the ethanol concentrations shown and 
for the given number of population doublings.  Genomic DNA was prepared and 
telomeres were analysed by Southern blotting using a Y’ and TG1-3 repeat 
probe as before (see Figure 7A).  Type I survivor is DLY2146 (tlc1), Type II 
survivor is DLY2148 (tlc1 exo1), short telomere is DLY4528 (nmd2), long 
telomere is DLY4451 (rif1). 
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6.4 Diploids grown in ethanol produce cdc13 strains that are not 
normally viable 
To see whether long Y’ and X telomeres caused the occurrence of cdc13 
genotypes that are not normally viable, diploids grown in 0% and 1% ethanol 
were sporulated and spores were analysed using random spore analysis.  
Diploids grown in 5% ethanol were eliminated from the analysis as growth was 
very poor and telomeres showed evidence of degradation after Southern blot 
analysis.   
Diploids grown in 0% ethanol for 50 population doublings produced above the 
expected number of all genotypes (previously known to be viable), apart from 
nmd2 exo1 cdc13 and nmd2 rad24 cdc13 genotypes, which were 
below the expected level (perhaps indicating spore inviability).  Figure 33 shows 
the number of strains per genotype, after growth in 0% or 1% ethanol, in tables 
with the expected number per genotype given below the table (upper panel).  
The number of strains per genotype and condition are also shown in a bar 
graph (lower panel) with the expected number of spores given as a dashed line.  
Importantly, cdc13 genotypes that are not normally viable were not observed 
for diploids grown in YPD (0% ethanol), showing that in the absence of ethanol 
these strains behaved as previously published (Holstein et al., 2014).  However, 
diploids grown in 1% ethanol for 50 population doublings produced seven 
cdc13 genotypes that are not normally viable: two exo1 cdc13, one rad24 
cdc13, two exo1 rad24 cdc13 and two cdc13 strains were obtained 
(Figure 33) 
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Figure 33. Genotypes obtained after diploid growth in 1% ethanol  
(I) is DDY567 and (II) is DDY568.  The numbers of each haploid genotype, 
obtained from the sporulation of the diploids, are given in the table and graph.  
Diploids were grown for 50 population doublings (PDs) in 1% ethanol.  The bars 
of the graph show the average number of haploid genotypes obtained from the 
two independent diploid strains.  The expected number of genotypes is given 
underneath the tables and as a dashed line in the bar graph.  The upper and 
lower bounds of the error bars represent the numbers obtained from the 
individual diploid.  cdc13 genotypes that are not normally viable are shown in 
red.  Red and green arrows are to indicate genotypes of interest and are 
discussed in section 6.5.  
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Diploids that were grown in 3% ethanol for 50 population doublings produced 
fewer cdc13 genotypes (3 in total) that are not normally viable than diploids 
grown in 1% ethanol: one cdc13 and two exo1 cdc13 strains (Figure 34).  
The number of strains per genotype in 3% and 0% ethanol were compared (0% 
ethanol numbers are the same as in Figure 33).  Taken together, there is 
evidence that elongated telomeres allow survival of a small proportion of 
cdc13 spores.  However, the slightly longer telomeres of strains grown in 3% 
ethanol did not increase the frequency of cdc13 genotypes that are not 
normally viable, in fact the frequency decreased.  This indicates that long 
telomeres promote Cdc13 bypass but do not wholly explain the existence of 
strains with cdc13 genotypes that are not normally viable. 
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Figure 34. Genotypes obtained after diploid growth in 3% ethanol  
As for Figure 33. 
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6.5 The frequency of Cdc13 bypass strains increases with telomere 
length 
 
The number of expected Cdc13 bypass strains (nmd2 exo1 cdc13; nmd2 
rad24 cdc13; nmd2 exo1 rad24 cdc13) was below what was expected 
when diploids DDY567 and 568 were grown in YPD (0% ethanol) (see columns 
indicated by red arrows in Figure 33).  However, it appeared that the number of 
nmd2 exo1 cdc13 and nmd2 rad24 cdc13 strains was increasing with 
the percentage of ethanol in the media (compare these genotypes for 0% (red 
arrow) and 1% (green arrow) in Figure 33 and for 0% (red arrow) and 3% 
(green arrow) in Figure 34).  Since ethanol increases telomere length, I 
hypothesised that diploids with longer telomeres produced a higher frequency 
of Cdc13 bypass strains. 
 
To test the hypothesis, genotype frequency was expressed as a percentage for 
each condition (i.e. 0% ethanol, 1% ethanol, 3% ethanol; 50 population 
doublings) (Figure 35).  It was found that the percentage of nmd2 exo1 
cdc13 strains obtained dramatically increased, relative to 0% ethanol, when 
grown in 1% and 3% ethanol (error bars for 0%, 1% and 3% did not overlap).  
The percentage of nmd2 rad24 cdc13 strains also increased, compared to 
growth in 0% ethanol, after exposure to 3% ethanol (error bars for 0% and 3% 
did not overlap).  Furthermore, a diploid made from a rif1 x nmd2 exo1 
cdc13 cross, which has long telomeres initially, produced similarly high 
frequency of nmd2 exo1 cdc13 spores (18%; Figure 20).  Interestingly, 
there was no change in the frequency of nmd2 exo1 rad24 cdc13 strains 
between 0% to 1% and 3% ethanol, perhaps because these have higher spore 
viability. 
 
It appears that longer diploid telomeres lead to an increased frequency of 
nmd2 exo1 cdc13 and nmd2 rad24 cdc13 strains.  It is possible that 
there is a higher degree of spore inviability for nmd2 exo1 cdc13 and 
nmd2 rad24 cdc13 genotypes when grown in YPD (0% ethanol), perhaps 
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because of short telomeres.  Indeed, absence of nmd2 leads to short 
telomeres, so perhaps this reduces spore viability in Cdc13 bypass strains.    
When diploids have longer telomeres this could increase the telomere length of 
the haploid progeny, allowing more Cdc13 bypass strains to form viable 
colonies. 
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Figure 35. Percentage of Cdc13 bypass strains obtained after diploid 
growth in ethanol 
 
% obtained is the percentage of the total number of haploid strains analysed 
(for each % ethanol condition after 50 population doublings (PDs)), using the 
data shown in Figure 33 and Figure 34.  The bars show the average from two 
independent diploid strains (sporulated to produce the haploids), the upper and 
lower bounds of the error bars show the individual value for each strain. 
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6.6 Discussion 
The data in this chapter has shown that diploids with long, heterogeneous 
telomeres can generate cdc13 genotypes that are not normally viable.  Such 
diploids can be produced when crossing a Cdc13 bypass strain with another 
haploid.  In addition, diploids with slightly elongated telomeres (after growth in 
ethanol) also produce cdc13 genotypes that are not normally viable when 
telomeres are of wild-type length.  Also, the frequency of nmd2 exo1 cdc13 
and nmd2 rad24 cdc13 strains, previously identified as Cdc13 bypass 
strains, increased with telomere length.  This indicates that longer telomeres 
increase the spore viability of these genotypes, perhaps because deletion of 
NMD2 leads to short telomeres which could lead to cell cycle arrest in strains 
lacking Cdc13.  Since longer Y’ and X telomeres occurs by extension of TG1-3 
repeats, it is possible that long tracts of these repeats promote survival without 
Cdc13.  This hypothesis is support by the fact that cdc13 cells are inviable 
without Rad52, which promotes Type II recombination in which TG1-3 repeats 
are amplified. 
Long telomeres do not wholly explain Cdc13 bypass since an nmd2 exo1 
cdc13 strain crossed with a rif1 strain had long telomeres but did not produce 
any cdc13 genotypes that are not normally viable.  Nonetheless, the telomeres 
of this diploid recovered with passage, resembling a wild-type diploid telomere 
more closely after three passages.  Therefore, perhaps Type II recombination is 
partially inhibited in the diploids heterozygous for NMD2, EXO1, CDC13 and 
RIF1 deletions but is not inhibited in diploids heterozygous for NMD2, RAD24, 
CDC13 and RIF1 deletions.  Moreover, strains with the longest telomeres 
produced fewer cdc13 genotypes (that are not normally viable) than those with 
slightly shorter telomeres.   
Further work needs to be conducted to identify the other factors contributing to 
the growth of cdc13 genotypes that are not normally viable.  One possible 
explanation for such genotypes is aneuploidy, when a strain has an extra 
chromosome carrying CDC13 as well as the deletion.  To determine whether 
this is the case, PCR of the CDC13 gene in these strains could be carried out.  
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It would furthermore be informative to examine the telomere structure of haploid 
strains from diploids grown in ethanol compared to YPD.  This would show 
whether telomere rearrangements and length are inherited by haploids.  If so, 
this would provide further evidence that long telomeres promote Cdc13 bypass. 
Long telomeres have been thought to be beneficial to health, since telomeres 
shorten with age and short telomeres may lead to genome instability and 
cancer (Lapham et al., 2015; Needham et al., 2015).  Indeed, companies have 
been set up to offer telomere length assessment for individuals, for use as a 
biomarker for ageing and health.   This is because shorter telomeres have been 
associated with alcohol consumption, smoking and obesity and it has been 
reported that healthy lifestyle changes increase telomere length in immune cells 
in individuals with cancer (Strandberg et al., 2012; Ornish et al., 2013; Joshu et 
al., 2015; Verde et al., 2015).   
However, this chapter has provided evidence that long, heterogeneous 
telomeres contribute to cells surviving without the essential telomere-capping 
protein Cdc13.  Furthermore, ethanol-lengthened telomeres in yeast lead to 
cdc13 genotypes not normally obtained and increases the frequency of Cdc13 
bypass strains.  Cell division in the absence of an essential telomere-capping 
protein is not necessarily beneficial, since the telomere end may have greater 
exposure to the DDR, which ultimately leads to genome instability.  On the other 
hand, one cause of ageing is telomere shortening.  Absence of a telomere 
capping protein may allow an ageing cell to maintain its viability by allowing 
telomeres to be extended and maintained by recombination.  The disadvantage 
of telomere maintenance by recombination is that this can increase the risk of 
cancer, for example ALT cancer cells maintain telomeres by recombination. 
Recent research has cast doubt on whether long telomeres are always 
beneficial to health.  Shorter telomeres are not necessarily associated with an 
increased cancer risk, although they do reduce cancer survival rates (Weischer 
et al., 2013).  Also, it has been reported that subjects with a genetic 
predisposition to short telomeres (those with SNPs associated with short 
leukocyte telomere length, e.g. SNPs in OBFC1) have lower cancer mortality, 
therefore those with genetically long telomeres have higher cancer mortality 
(Rode et al., 2015).   
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Interestingly, SNPs in OBFC1 (also known as human STN1) are associated 
with short telomeres but subjects do not have increased cancer mortality (Rode 
et al., 2015).  This suggests that maximally functional (or indeed over-active) 
human STN1 may actually be harmful, leading to telomere maintenance of cells 
that should senesce or die due to their age or accumulated mutations (Rode et 
al., 2015).  This appears to be the case in budding yeast, where increased Stn1 
and Ten1 activity can allow Cdc13 bypass to occur, if the DDR is attenuated 
(Holstein et al., 2014).  Long telomeres appear to contribute to bypass of Cdc13 
without any other gene deletions (shown in this chapter), and it has been further 
shown that cells resembling Type I and Type II survivors, with substantial 
telomere rearrangements, lose Cdc13 and maintain viability (Larrivée and 
Wellinger, 2006).  It is possible that Stn1 and Ten1 provide sufficient telomere 
protection when telomeres are long, such that cells can survive without Cdc13. 
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Chapter 7. General Discussion 
 
My data suggests that Stn1 (and presumably Ten1) are at the telomere in the 
absence of Cdc13, and therefore carry out telomeric roles independently of 
Cdc13. CST has been described as a telomeric RPA, since RPA is an ssDNA-
binding heterotrimer.  However, the essential telomere protection roles of Stn1 
and Ten1, in the absence of Cdc13, suggest that CST components act very 
differently to RPA components.  Indeed, I propose that Ten1 may interact with 
Rif1, to form a shelterin-like complex after telomere replication.   
 
Rif1 is of increasing interest in cancer research, since human RIF1 appears to 
be directly involved in maintaining genome stability in human cells, by regulating 
DNA damage repair through BRCA1 repression, signalling DNA damage at 
telomeres and ensuring timely sister chromatid separation (Silverman et al., 
2004; Chapman et al., 2013; Hengeveld et al., 2015).  Since Rif1 is required for 
Cdc13 bypass, Rif1 activities may promote the survival of strains with damaged 
or rearranged telomeres.  RIF1 may therefore have a role in promoting the 
formation or maintenance of ALT cancer cells and could be a potential 
therapeutic target in the treatment of cancer. 
 
I found that Rad52, a key HR protein, was essential for Cdc13 bypass. Rad52 is 
required for Type I and Type II recombination, therefore at least one 
recombination pathway is required for cells to survive without Cdc13.  Since 
Rad51 (which is required for the formation of Type I survivors) was not required 
for Cdc13 bypass, it is possible that cells lacking Cdc13 require Type II 
recombination.  However, deletion of RIF1 promotes Type II recombination 
(Teng et al., 2000) but is lethal to Cdc13 bypass.  Also, nmd2 exo1 cdc13 
strains have telomeres that more closely resemble those of Type I survivors. 
Therefore, it seems most likely Cdc13 bypass requires recombination, but not a 
specific recombination pathway. 
 
 142 
I found evidence that long telomeres promoted Cdc13 bypass, as diploids with 
telomeres elongated by ethanol exposure (Both Y’ and X telomeres with 
extended TG repeats) produced cdc13 genotypes that were previously 
thought to be inviable (i.e. double mutants and triple mutants that were not 
deleted for NMD2).  Therefore, there is evidence that extended tracts of TG 
repeats promote Cdc13 bypass.  Furthermore, growth in ethanol led to an 
increased frequency of Cdc13 bypass genotypes (previously known to be 
viable).  These data suggest that longer TG1-3 repeats may promote the viability 
of Cdc13 bypass strains.  Perhaps long tracts of TG1-3 repeats promote 
telomere recombination, which is essential for the survival of cells lacking 
Cdc13. 
 
However, diploids heterozygous for NMD2, EXO1, CDC13 and RIF1 deletions 
had long telomeres but produced no unexpected cdc13 genotypes.  The 
telomeres of diploids heterozygous for NMD2, EXO1, CDC13 and RIF1 
deletions did recover with passage, however.  This suggests that their long, 
heterogeneous phenotype was not as severe as those of the other diploids 
tested and perhaps this explains why no unexpected cdc13 genotypes were 
obtained.   
 
Promotion of human STN1 and TEN1 protein activity, perhaps by suppression 
of NMD and DDR, may be helpful to patients with CTC1-mutation diseases, 
since there is evidence that Stn1 and Ten1 have the most important telomere 
protection roles in CST.  In ALT cancers, inhibition of RIF1 may reduce cell 
viability since in yeast Rif1 supports Cdc13 bypass, in which cells maintain 
telomeres by recombination in a manner similar to ALT cells.  Finally, there is 
evidence that alcohol exposure is harmful to telomeres, since ethanol exposure 
allows the bypass of protective telomere capping in yeast. 
 
Overall, this thesis concludes that Cdc13 bypass depends on Stn1 and Ten1 
binding to the telomere end, Rif1 and Rad52-mediated Type II recombination. 
Perhaps extended TG1-3 tracts encourage increased Stn1- Ten1 and Rif1 
binding and this helps to protect the telomere without Cdc13.  Since Stn1 and 
Ten1 appear to be more important for telomere end protection than Cdc13, and 
the fission yeast S. pombe has no Cdc13 orthologue, it is possible that Stn1 
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and Ten1 evolved earlier than Cdc13 and therefore have independent or 
overlapping telomere protection roles. 
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Appendix A. Yeast strains by figure number 
 
Strain numbers are prefixed DLY unless otherwise stated. 
 
Strain 
number 
Genotype  
(all W303 RAD5+ unless otherwise stated) 
Related 
figure 
 1628 MATalpha tlc1::HIS3 pTLC1::URA3 (streaked 
until plasmid lost) 
Figure 7 
 2148 MATalpha tlc1::HIS3 exo1::LEU2 (Type II 
survivor) 
Figure 7 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 7 
 
 8168 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 1 
Figure 7 
 
 8169 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 1 
Figure 7 
 8170 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 1 
Figure 7 
 8171 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 1 
Figure 7 
 8172 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 1 
Figure 7 
 8193 nmd2::HIS3 rad24::TRP1 Figure 7 
 8195 nmd2::HIS3 exo1::LEU2 Figure 7 
 8197 nmd2::HIS3 exo1::LEU2 rad24::TRP1 Figure 7 
 8199 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 9 
Figure 7 
 8200 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 9 
Figure 7 
 8201 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 9 
Figure 7 
 8202 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 9 
Figure 7 
 8203 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 7 
 8204 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 7 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 7 
 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 8 
 
 2146 MATa tlc1::HIS3 (Type I survivor) Figure 8 
 2148 MATalpha tlc1::HIS3 exo1::LEU2 (Type II 
survivor) 
Figure 8 
 8462 MATa tlc1::NATMX passage 1 Figure 8 
 8465 MATa tlc1::NATMX passage 9 Figure 8 
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 8467 MATa tlc1::NATMX nmd2::HIS3 rad24::TRP1 
cdc13::HPHMX passage 2 
Figure 8 
 8468 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 2 
Figure 8 
 8472 MATa tlc1::NATMX passage 3 Figure 8 
 8473 MATa tlc1::NATMX nmd2::HIS3 rad24::TRP1 
cdc13::HPHMX 
Figure 8 
 8474 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::hph 
Figure 8 
 8475 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
rad24::TRP1 cdc13::hph 
Figure 8 
 8509 MATa tlc1::NATMX Figure 8 
 8510 MATa tlc1::NATMX nmd2::HIS3 rad24::TRP1 
cdc13::HPHMX 
Figure 8 
 8511 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX 
Figure 8 
 8512 MATalpha tlc1::NATMX nmd2::HIS3 
rad24::TRP1 exo1::LEU2 cdc13::hph 
Figure 8 
 8601 MATa tlc1::NATMX nmd2::HIS3 rad24::TRP1 
cdc13::HPHMX passage 9 
Figure 8 
 8602 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 9 
Figure 8 
 8603 MATalpha tlc1::NATMX nmd2::HIS3 
rad24::TRP1 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 8 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 9 
 
 1272 MATa exo1::LEU2 Figure 9 
 1273 MATalpha exo1::LEU2 Figure 9 
 3001 MATalpha ade2-1  trp1-1 can1-100 leu2-3,112  
his3-11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 
(W303 wild-type) 
Figure 9  
 4765 MATa nmd2::HIS3 Figure 9 
 4766 MATalpha nmd2::HIS3 Figure 9 
 4872 MATa pif1::NATMX Figure 9 
 4873 MATalpha pif1::NATMX Figure 9 
 5915 MATa pif1::NATMX exo1::LEU2 Figure 9 
 5916 MATalpha pif1::NATMX exo1::LEU2 Figure 9 
 5759 MATa STN1-13MYC::TRP1 nmd2::HIS3 Figure 10 
 5761 MATa STN1-13MYC::TRP1 Figure 10 
 7273 MATalpha CDC13-13MYC::HIS3 Figure 10 
 7274 MATalpha CDC13-13MYC::HIS3 nmd2::URA3 Figure 10 
 8100 MATa TEN1-13MYC::KANMX nmd2::URA3 Figure 10 
 8101 MATa TEN1-13MYC::KANMX Figure 10 
 8432 MATa STN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1  
Figure 11 
 8434 MATalpha TEN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1  
Figure 11 
 8604 MATalpha STN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::HPHMX 
Figure 11 
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 8605 MATa TEN1::Myc::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::hph 
Figure 11 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 12 
 
 4528 MATa nmd2::HIS3 Figure 12 
 8198 nmd2::HIS3 exo1::LEU2 rad24::TRP1 Figure 12 
 8461 MATa nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX 
Figure 12 
 8766 MATalpha stn1-13::HPHMX lyp1::NATMX 
can1::STE2pr-Sp_his5 (S288C) 
Figure 13 
 9101 MATa rfa1-M2::KANMX (S288C) Figure 13 
 9102 MATa rfa3-313::KANMX (S288C) Figure 13 
 5761 MATa STN1-13MYC::TRP1  
Figure 14 
 8101 MATa TEN1-13MYC::KANMX  
Figure 14 
 8432 MATa STN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1  
 
Figure 14 
 8434 MATalpha TEN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1  
 
Figure 14 
 8461 MATa nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX 
 
Figure 14 
 1098 MATa rfa1::MYC18::RFA1 rad5-535  
Figure 14 
 8298 MATalpha RFA3-3HA::KANMX  
Figure 14 
 8429 MATalpha STN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::HPHMX 
 
Figure 14 
 8431 MATa TEN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::HPHMX 
 
Figure 14 
 8989 MATa cdc13-1 cdc15-2 int bar1 Ddc1-Myc-
HIS3MX6 Mec3-3HA-KanMX 
 
Figure 14 
 9527 MATalpha RFA3-3HA::KANMX STN1-
13MYC::TRP1 
 
Figure 14 
 9653 MATalpha nmd2::HPHMX exo1::NATMX 
cdc13::LEU2 lyp1Δ can1Δ::STE2pr-Sp_his5 
(S288C) 
Figure 17 
 9718 MATalpha nmd2::HPHMX exo1::NATMX 
lyp1::LEU2 can1-ste2_pr_his5 (S288C) 
Figure 17 
 
 2146 MATa tlc1::HIS3 (Type I survivor) Figure 18 
 2148 MATalpha tlc1::HIS3 exo1::LEU2 (Type II 
survivor) 
Figure 18 
 148 
 4451 MATalpha rif1::URA3 (long telomere) Figure 18 
 4528 MATa nmd2::HIS3 (short telomere) Figure 18 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 18 
 8457 MATa nmd2::HIS3 exo1::LEU2 cdc13::HPHMX Figure 20 
 9697 MATalpha rif1::NATMX Figure 20 
 835 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
rif1::NATMX/RIF1 
 
Figure 21 
 836 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
rif1::NATMX/RIF1 
 
Figure 21 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 22 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 22 
 
 1273 MATalpha exo1::LEU2 Figure 22 
 4528 MATa nmd2::HIS3 Figure 22 
 
 8457 MATa nmd2::HIS3 exo1::LEU2 cdc13::HPHMX Figure 22 
 
 8196 nmd2::HIS3 exo1::LEU2 Figure 22 
 9699 MATa rif1-RVxF-SILK Figure 22 
 10211 MATa nmd2::HIS3 rif1-RVxF-SILK Figure 22 
 10213 MATalpha exo1::LEU2 rif1-RVxF-SILK Figure 22 
 10215 MATa nmd2::HIS3 exo1::LEU2 rif1-RVxF-SILK Figure 22 
 10218 MATa nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
rif1- RVxF-SILK 
Figure 22 
 10219 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1- rif1- RVxF-SILK 
Figure 22 
 10254 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX 
Figure 22 
  8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 23 
  8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 23 
 
  1273 MATalpha exo1::LEU2 Figure 23 
  4528 MATa nmd2::HIS3 Figure 23 
 
  8457 MATa nmd2::HIS3 exo1::LEU2 cdc13::HPHMX Figure 23 
  8196 nmd2::HIS3 exo1::LEU2 Figure 23 
 10290 MATalpha rif1Δ2-176-13MYC::HIS3MX6 Figure 23 
 10757 MATalpha nmd2::URA3 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 
 10758 MATa exo1::LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 
 10760 MATa nmd2::URA3 exo1::LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 
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 10795 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 
 10796 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 
 10813 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1::NATMX pRIF1-URA3 
(pDL1714) 
Figure 25 
 10255 MATa nmd2::URA3 exo1::LEU2 cdc13::HPHMX Figure 23 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 24 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  his3-
11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 (W303 
wild-type) 
Figure 24 
 
 1273 MATalpha exo1::LEU2 Figure 24 
 4528 MATa nmd2::HIS3 Figure 24 
 
 8457 MATa nmd2::HIS3 exo1::LEU2 cdc13::HPHMX Figure 24 
 8196 nmd2::HIS3 exo1::LEU2 Figure 24 
 9714 MATalpha rif1Δ1323-1916-13MYC::HIS3MX6  Figure 24 
 10255 MATa nmd2::URA3 exo1::LEU2 cdc13::HPHMX Figure 24 
 10291 MATalpha exo1::LEU2 rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 
 10293 MATa nmd2::URA3 rif1 rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 
 10295 MATalpha nmd2::URA3 exo1::LEU2 rif1Δ1323-
1916-13MYC::HIS3MX 
Figure 24 
 10297 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 
 10298 MATa nmd2::URA3 exo1::LEU2 cdc13::HPHMX 
rif1Δ1323-1916-13MYC::HIS3MX 
Figure 24 
 10813 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1::NATMX pRIF1-URA3 
(pDL1714) 
Figure 25 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 27 
 5872 MATa rad52::TRP1 Figure 27 
 3485 MATa rad51::KANMX Figure 27 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 29 
 5872 MATa rad52::TRP1 Figure 29 
 8455 MATa nmd2::HIS3 rad24::LEU2 cdc13::HPHMX 
passage 1 
Figure 30 
 9697 MATalpha rif1::NATMX Figure 30 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 30 
 10209 MATa dxo1::KANMX Figure 30 
 8455 MATa nmd2::HIS3 rad24::LEU2 cdc13::HPHMX 
passage 1 
 
Figure 31  
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 9697 MATalpha rif1::NATMX  
Figure 31 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 31 
 10209 MATa dxo1::KANMX Figure 31 
 225 
(DDY) 
wt/wt Figure 31 
 812 
(DDY) 
rif1::NATMX/rif1::URA3 Figure 31 
 810 
(DDY) 
yku70::LEU2/yku70::HIS3 Figure 31 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 31 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 31 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Table 2 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Table 2 
 2146 MATa tlc1::HIS3 (Type I survivor) Figure 32 
 2148 MATalpha tlc1::HIS3 exo1::LEU2 (Type II 
survivor) 
Figure 32 
 4451 MATalpha rif1::URA3 Figure 32 
 4528 MATa nmd2::HIS3 Figure 32 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 32 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 32 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 33 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 33 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 34 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 34 
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 35 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 cdc13::HPHMX/CDC13 
Figure 35 
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Appendix B. Yeast strains by strain number 
 
Strain numbers are prefixed DLY unless otherwise stated 
 
Strain 
number 
Genotype  
(all W303 RAD5+ unless otherwise stated) 
Related 
figure 
Origin 
 225 
(DDY) 
wt/wt Figure 31  
 567 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 
cdc13::HPHMX/CDC13 
Figure 31, 
Figure 32, 
Figure 33, 
Figure 34, 
Figure 35, 
Table 2 
 
 568 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 
cdc13::HPHMX/CDC13 
Figure 31, 
Figure 32, 
Figure 33, 
Figure 34, 
Figure 35, 
Table 2 
 
 810 
(DDY) 
yku70::LEU2/yku70::HIS3 Figure 31 This 
work 
 812 
(DDY) 
rif1::URA3/rif1::NATMX Figure 31 This 
work 
 835 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 
cdc13::HPHMX/CDC13 rif1::NATMX/RIF1 
Figure 21 This 
work 
 836 
(DDY) 
nmd2::his3/NMD2 exo1::LEU2/EXO1 
rad24::TRP1/RAD24 
cdc13::HPHMX/CDC13 rif1::NATMX/RIF1 
Figure 21 This 
work 
 1098 MATa rfa1::MYC18::RFA1 rad5-535 Figure 14  
 1272 MATa exo1::LEU2 Figure 9  
 1273 MATalpha exo1::LEU2 Figure 9, 
Figure 22, 
Figure 23, 
Figure 24 
 
 1628 MATalpha tlc1::HIS3 pTLC1::URA3 
(streaked until plasmid lost) 
Figure 7  
 2146 MATa tlc1::HIS3 Figure 8  
 2148 MATalpha tlc1::HIS3 exo1::LEU2 Figure 8  
 3001 MATalpha ade2-1  trp1-1 can1-100 leu2-
3,112  his3-11,15  ura3  GAL+ psi+  ssd1-d2 
RAD5 (W303 wild-type) 
Figure 9   
 3485 MATa rad51::KANMX Figure 27  
 4451 MATalpha rif1::URA3 Figure 32  
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 4528 MATa nmd2::HIS3 Figure 12, 
Figure 22, 
Figure 23, 
Figure 24, 
Figure 32 
 
 4765 MATa nmd2::HIS3 Figure 9  
 4766 MATalpha nmd2::HIS3 Figure 9  
 4872 MATa pif1::NATMX Figure 9  
 4873 MATalpha pif1::NATMX Figure 9  
 5759 MATa STN1-13MYC::TRP1 nmd2::HIS3 Figure 10  
 5761 MATa STN1-13MYC::TRP1 Figure 10, 
Figure 14 
 
 5872 MATa rad52::TRP1 Figure 27, 
Figure 29 
 
 5915 MATa pif1::NATMX exo1::LEU2 Figure 9  
 5916 MATalpha pif1::NATMX exo1::LEU2 Figure 9  
 7273 MATalpha CDC13-13MYC::HIS3 Figure 10  
 7274 MATalpha CDC13-13MYC::HIS3 
nmd2::URA3 
Figure 10  
 8100 MATa TEN1-13MYC::KANMX nmd2::URA3 Figure 10  
 8101 MATa TEN1-13MYC::KANMX Figure 10, 
Figure 14 
 
 8167 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 1 
Figure 7, 
Figure 22, 
Figure 23, 
Figure 24, 
Figure 27, 
Figure 29, 
Figure 30, 
Figure 31 
 
 8168 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 1 
Figure 7, 
 
 
 8169 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 1 
Figure 7  
 8170 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 1 
Figure 7  
 8171 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 1 
Figure 7  
 8172 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 1 
Figure 7  
 8193 nmd2::HIS3 rad24::TRP1 Figure 7  
 8195 nmd2::HIS3 exo1::LEU2 Figure 7  
 8196 nmd2::HIS3 exo1::LEU2 Figure 22, 
Figure 23, 
Figure 24 
 
 8197 nmd2::HIS3 exo1::LEU2 rad24::TRP1 Figure 7  
 8198 nmd2::HIS3 exo1::LEU2 rad24::TRP1 Figure 12  
 8199 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 9 
Figure 7  
 8200 nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX passage 9 
Figure 7  
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 8201 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 9 
Figure 7  
 8202 nmd2::HIS3 rad24::TRP1 cdc13::HPHMX 
passage 9 
Figure 7  
 8203 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 7  
 8204 nmd2::HIS3 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 7  
 8298 MATalpha RFA3-3HA::KANMX Figure 14 This 
work 
 8429 MATalpha STN1-13MYC::KANMX 
nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX 
Figure 14 This 
work 
 8431 MATa TEN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::HPHMX 
Figure 14 This 
work 
 8432 MATa STN1-13MYC::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1  
Figure 11, 
Figure 14 
This 
work 
 8434 MATalpha TEN1-13MYC::KANMX 
nmd2::HIS3 exo1::LEU2 rad24::TRP1  
Figure 11, 
Figure 14 
This 
work 
 8455  MATa nmd2::HIS3 rad24::TRP1 
cdc13::HPHMX 
Figure 30, 
Figure 31 
This 
work 
 8457 MATa nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX 
Figure 20, 
Figure 22, 
Figure 23, 
Figure 24 
This 
work 
 8460 MATa ade2-1  trp1-1 can1-100 leu2-3,112  
his3-11,15  ura3  GAL+ psi+  ssd1-d2 RAD5 
(W303 wild-type) 
Figure 7, 
Figure 8, 
Figure 9, 
Figure 12, 
Figure 22, 
Figure 23, 
Figure 24 
 
 8461 MATa nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX 
Figure 12, 
Figure 14 
This 
work 
 8462 MATa tlc1::NATMX passage 1 Figure 8 This 
work 
 8465 MATa tlc1::NATMX passage 9 Figure 8 This 
work 
 8467 MATa tlc1::NATMX nmd2::HIS3 
rad24::TRP1 cdc13::HPHMX passage 2 
Figure 8 This 
work 
 8468 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 2 
Figure 8 This 
work 
 8472 MATa tlc1::NATMX passage 3 Figure 8 This 
work 
 8473 MATa tlc1::NATMX nmd2::HIS3 
rad24::TRP1 cdc13::HPHMX 
Figure 8 This 
work 
 8474 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::hph 
Figure 8 This 
work 
 8475 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
rad24::TRP1 cdc13::hph 
Figure 8 This 
work 
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 8509 MATa tlc1::NATMX Figure 8 This 
work 
 8510 MATa tlc1::NATMX nmd2::HIS3 
rad24::TRP1 cdc13::HPHMX 
Figure 8 This 
work 
 8511 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX 
Figure 8 This 
work 
 8512 MATalpha tlc1::NATMX nmd2::HIS3 
rad24::TRP1 exo1::LEU2 cdc13::hph 
Figure 8 This 
work 
 8601 MATa tlc1::NATMX nmd2::HIS3 
rad24::TRP1 cdc13::HPHMX passage 9 
Figure 8 This 
work 
 8602 MATa tlc1::NATMX nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX passage 9 
Figure 8 This 
work 
 8603 MATalpha tlc1::NATMX nmd2::HIS3 
rad24::TRP1 exo1::LEU2 cdc13::HPHMX 
passage 9 
Figure 8 This 
work 
 8604 MATalpha STN1-13MYC::KANMX 
nmd2::HIS3 exo1::LEU2 rad24::TRP1 
cdc13::HPHMX 
Figure 11 This 
work 
 8605 MATa TEN1::Myc::KANMX nmd2::HIS3 
exo1::LEU2 rad24::TRP1 cdc13::hph 
Figure 11 This 
work 
 8766 MATalpha stn1-13::HPHMX lyp1::NATMX 
can1::STE2pr-Sp_his5 (S288C) 
Figure 13  
 8989 MATa cdc13-1 cdc15-2 int bar1 Ddc1-Myc-
HIS3MX6 Mec3-3HA-KanMX 
Figure 14  
 9101 MATa rfa1-M2::KANMX (S288C) Figure 13 Newcastle 
University 
High 
Throughput 
Service 
 9102 MATa rfa3-313::KANMX (S288C) Figure 13 Newcastle 
University 
High 
Throughput 
Service 
 9527 MATalpha RFA3-3HA::KANMX STN1-
13MYC::TRP1 
Figure 14 This 
work 
 9653 MATalpha nmd2::HPHMX exo1::NATMX 
cdc13::LEU2 lyp1Δ can1Δ::STE2pr-Sp_his5 
(S288C) 
Figure 17 This 
work 
 9697 MATalpha rif1::NATMX Figure 20 David 
Shore 
 9699 MATa rif1-RVxF-SILK Figure 22 David 
Shore 
 9714 MATalpha rif1Δ1323-1916-
13MYC::HIS3MX6  
Figure 24 David 
Shore 
 9718 MATalpha nmd2::HPHMX exo1::NATMX 
lyp1::LEU2 can1-ste2_pr_his5 (S288C) 
Figure 17 This 
work 
 10209 MATa dxo1::KANMX Figure 30, 
Figure 31 
This 
work 
 10211 MATa nmd2::HIS3 rif1-RVxF-SILK Figure 22 This 
work 
 10213 MATalpha exo1::LEU2 rif1-RVxF-SILK Figure 22 This 
work 
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 10215 MATa nmd2::HIS3 exo1::LEU2 rif1-RVxF-
SILK 
Figure 22 This 
work 
 10218 MATa nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1- RVxF-SILK 
Figure 22 This 
work 
 10219 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1- rif1- RVxF-SILK 
Figure 22 This 
work 
 10254 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX 
Figure 22 This 
work 
 10255 MATa nmd2::URA3 exo1::LEU2 
cdc13::HPHMX 
Figure 24, 
Figure 23 
This 
work 
 10290 MATalpha rif1Δ2-176-13MYC::HIS3MX6 Figure 23 This 
work 
 10291 MATalpha exo1::LEU2 rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 This 
work 
 10293 MATa nmd2::URA3 rif1 rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 This 
work 
 10295 MATalpha nmd2::URA3 exo1::LEU2 
rif1Δ1323-1916-13MYC::HIS3MX 
Figure 24 This 
work 
 10297 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 This 
work 
 10298 MATa nmd2::URA3 exo1::LEU2 
cdc13::HPHMX rif1Δ1323-1916-
13MYC::HIS3MX 
Figure 24 This 
work 
 10757 MATalpha nmd2::URA3 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 This 
work 
 10758 MATa exo1::LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 This 
work 
 10760 MATa nmd2::URA3 exo1::LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 This 
work 
 10795 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 This 
work 
 10796 MATalpha nmd2::URA3 exo1::LEU2 
cdc13::HPHMX LEU2 rif1Δ2-176-
13MYC::HIS3MX6 
Figure 23 This 
work 
 10813 MATalpha nmd2::HIS3 exo1::LEU2 
cdc13::HPHMX rif1::NATMX pRIF1-URA3 
(pDL1714) 
Figure 25 This 
work 
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Appendix C. Plasmids 
 
Plasmid 
number 
Construction Related 
figure/ 
Notes 
Reference 
pDL508 pFA6a-13Myc-kanMX6 For Myc 
tagging 
(Longtine et 
al., 1998) 
pDL987 pBluescriptII SK2 carrying 1.0-kb XhoI 
fragment of a yeast chromosomal end, 
which contains 120 base pairs of 
telomere repeats and part of the Y9 
subtelomeric repeat 
Figure 7; 
Figure 8 
(Tsubouchi 
and Ogawa, 
2000) 
pDL1535 pAG32 HPHMX4 For gene 
deletions 
(Goldstein 
and 
McCusker, 
1999) 
pDL1539 pRS314 TRP1 For cloning 
rif1 
truncations 
into/ 
amplifying 
TRP1 
 
pDL1599 pAG25 NATMX4 For gene 
deletions 
(Goldstein 
and 
McCusker, 
1999) 
pDL1714 pRIF1 URA3 (yeast centromeric) Figure 25 Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1705 pRS316 TRP1 swapped for URA3 Figure 25 This work 
pDL1706 rif1Δ114-225 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1707 rif1Δ997-1916 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1708 rif1Δ1790-1916 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
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pDL1709 rif1Δ321-455 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1710 rif1Δ321-836 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1711 rif1-PP1 (RvXF1-2 and SILK1-2 motifs 
mutated) TRP1 (plasmid from A.D. was 
URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1712 rif1Δ213-836 TRP1 (plasmid from A.D. 
was URA3, this was swapped for TRP1) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1738 RIF1 TRP1 (RIF1 from A. D. URA3 
plasmid cloned into pDL1539) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1739 rif1Δ1417-1492 TRP1 (rif1Δ1417-1492  
from A. D. URA3 plasmid cloned into 
pDL1539) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
pDL1740 rif1Δ266-455 TRP1 (rif1Δ266-455 from 
A. D. URA3 plasmid cloned into 
pDL1539) 
Figure 25 This work; 
Anne 
Donaldson 
(Hiraga et 
al., 2014) 
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Appendix D. PCR primers 
Ordered by gene target. 
 
Ref. 
No. 
Primer Sequence Target Usage and related 
figures 
M1172 CAGACCGAACTCGGTGATT
T  
BUD6 qRT-PCR 
Figure 9 
M1173 TTTTAGCGGGCTGAGACCT
A 
BUD6 qRT-PCR 
Figure 9 
 
M2245 CGTATGCTAAAGTATATATT
ACTTCACTCCATT 
chrVI-R ChIP/DNA-IP 
Figure 10, Figure 11, 
Figure 12 
M2246 TCCGAACTCAGTTACTATTG
ATGGAA 
chrVI-R ChIP/DNA-IP 
Figure 10, Figure 11, 
Figure 12 
M1367 AATAACGAATTGAGCTATG
ACACCAA 
PAC2 ChIP/DNA-IP 
Figure 10, Figure 11, 
Figure 12 
M1368 AGCTTACTCATATCGATTTC
ATACGACTT 
PAC2 ChIP/DNA-IP 
Figure 10, Figure 11, 
Figure 12 
M3487 AAGTCAACAGAAGGCAGGT
G 
RIF1 For amplification of 
rif1::NATMX from 
DLY9697 
 
Figure 21 
M2822 GGTATGACACAAGAGGCTA
A 
RIF1 For amplification of 
rif1::NATMX from 
DLY9697 
 
Figure 21 
M1003 AGAGATGCGCCGTTATTGA
CGATGCGAGTTTTCTAACA
AAGAATTCGAGCTCGTTTA
AAC 
STN1 For C-terminal Myc-
tagging of STN1 
Figure 10, Figure 11, 
Figure 14 
M1734 TCGAGCAACTGCAAGAAGA
A 
STN1 qRT-PCR 
Figure 9 
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M1735 CGAAATGACAAGGAATGCA
C 
STN1 qRT-PCR 
Figure 9 
M2752 TGGAATATTATTACATTTGG
AATACGCAGCAGCATATTC
ACGGATCCCCGGGTTAATT
AA 
STN1 For C-terminal Myc-
tagging of STN1 
Figure 10, Figure 11, 
Figure 14 
 
M1794 ATACACCAAAGTCCGCCAA
T 
TEN1 qRT-PCR  
Figure 9 
M1795 CACCAAGTGGTGATTTGAC
A 
TEN1 qRT-PCR 
Figure 9 
M2355 ATCACCACTTGGTGAGAAG
TTTCTGAACATCTCTAACTC
CCGGATCCCCGGGTTAATT
AA 
TEN1 For C-terminal Myc-
tagging of TEN1 
Figure 10, Figure 11, 
Figure 14 
 
M2356 AAAGGTATTATATAATCTCA
GTATATGCCAAACGTCTGA
CGAATTCGAGCTCGTTTAA
AC 
TEN1 For C-terminal Myc-
tagging of TEN1 
Figure 10, Figure 11, 
Figure 14 
M1803 CCAACGTCAACGCACC TLC1 To confirm integration 
of NATMX cassette  
Figure 8 
M1807 CGTGAGTCTGTGGAATCC TLC1 To confirm integration 
of NATMX cassette 
Figure 8 
M2013 CAATTAAAAGACCTTCTTTG
TAGCTTTTAGTGTGATTTTT
CTGGTTTGAGCACATACGA
TTTAGGTGACAC 
TLC1 To integrate NATMX 
cassette at TLC1 
locus 
Figure 8 
M2014 TGTATATTGTATATTCTAAA
AAGAAGAAGCCATTTGGTG
GGCTTTATTAAATACGACTC
ACTATAGGGAG 
TLC1 To integrate NATMX 
cassette at TLC1 
locus 
Figure 8 
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